Processing 00000000.tx.1: Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302* Eric D. 

Phrase: "Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   799   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]
   760   C0021655:Insulin Resistance [Pathologic Function]
   760   C2700570:INSULIN RESISTANCE [Gene or Genome]
   757   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   757   C1334133:INSULIN RECEPTOR [Gene or Genome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0237834:Resistance [Mental Process]
   739   C1514892:Resistance [Physiologic Function]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   722   C0332325:Resistant to [Functional Concept]

Phrase: "at Serine 302"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "* Eric D."
Processing 00000000.tx.2: Werner, Jongsoon Lee, Lone Hansen, Minsheng Yuan, and Steven E. 

Phrase: "Werner,"

Phrase: "Jongsoon Lee,"

Phrase: "Lone Hansen,"

Phrase: "Minsheng Yuan,"

Phrase: "and"

Phrase: "Steven E."
Processing 00000000.tx.3: Shoelson From the Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215 Received for publication, October 10, 2003 , and in revised form, May 13, 2004.  

Phrase: "Shoelson From the Joslin Diabetes Center"

Phrase: "and"

Phrase: "Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 02215"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024874:Massachusetts [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "October 10,"

Phrase: "2003 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "May 13,"

Phrase: "2004."
Processing 00000000.tx.4: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Inhibitory serine phosphorylation is a potential molecular mechanism for insulin resistance. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inhibitory serine phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "a potential molecular mechanism for insulin resistance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1522618:resistance mechanism [Clinical Attribute]
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.5: We have developed a new variant of the yeast two-hybrid method, referred to as disruptive yeast tri-hybrid (Y3H), to identify inhibitory kinases and sites of phosphorylation in insulin receptors (IR) and IR substrates, IRS-1. 

Phrase: "We"

Phrase: "have"

Phrase: "developed"

Phrase: "a"

Phrase: "new variant of the yeast two-hybrid method,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variant [Qualitative Concept]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "disruptive yeast tri-hybrid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020205:Hybrid [Organism]
   812   C0814229:TRI [Intellectual Product]

Phrase: "(Y3H"

Phrase: ")"

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "inhibitory kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "sites of phosphorylation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   866   C2945843:Site of [Qualitative Concept]
   841   C1519063:Phosphorylation Site [Amino Acid Sequence]
   790   C0205145:Sites [Spatial Concept]
   756 E C1515974:Site [Body Location or Region]
   756 E C2825164:Site [Spatial Concept]

Phrase: "in insulin receptors (IR)"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IR substrates,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1710236:Substrate [Manufactured Object]
   734   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   701 E C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "IRS-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.6: Using IR and IRS-1 as bait and prey, respectively, and c-Jun NH2-terminal kinase (JNK1) as the disruptor, we now show that phosphorylation of IRS-1 Ser-307, a previously identified site, is necessary but not sufficient for JNK1-mediated disruption of IR/IRS-1 binding. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "IR"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IRS-1 as bait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "prey,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540252:PreY [Gene or Genome]

Phrase: "respectively,"

Phrase: "and"

Phrase: "c-Jun NH2-terminal kinase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   937   C0248813:jun-NH2-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   708   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "(JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: ")"

Phrase: "as the disruptor,"

Phrase: "we now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that phosphorylation of IRS-1 Ser-307,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "a previously identified site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "necessary"

Phrase: "but"

Phrase: "not sufficient for JNK1-mediated disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205410:Sufficient [Qualitative Concept]

Phrase: "of IR/IRS-1 binding."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   897   C1623517:insulin binding [Molecular Function]
   894   C1149501:insulin receptor binding [Molecular Function]
   858   C0597358:Receptor Binding [Molecular Function]
   853   C1623518:IRS binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
Processing 00000000.tx.7: We further identify a new phosphorylation site, Ser-302, and show that this too is necessary for JNK1-mediated disruption. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "identify"

Phrase: "a new phosphorylation site,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1519063:Phosphorylation Site [Amino Acid Sequence]
   812   C0031715:Phosphorylation [Molecular Function]
   812   C0205145:Site [Spatial Concept]
   812   C1158886:Phosphorylation [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "Ser-302,"

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this too"

Phrase: "is"

Phrase: "necessary for JNK1-mediated disruption."
Processing 00000000.tx.8: Seven additional kinases potentially linked to insulin resistance similarly block IR/IRS-1 binding in the disruptive Y3H, but through distinct Ser-302- and Ser-307-independent mechanisms. 

Phrase: "Seven additional kinases potentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "linked to insulin resistance similarly"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   762   C0332325:Resistant to [Functional Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "IR/IRS-1 binding in the disruptive Y3H,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C1149501:insulin receptor binding [Molecular Function]
   762   C1623517:insulin binding [Molecular Function]
   762   C1623518:IRS binding [Molecular Function]
   745   C0597358:Receptor Binding [Molecular Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "but through distinct Ser-302-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233535:but [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "Ser-307-independent mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.9: Phosphospecific antibodies that recognize sequences surrounding Ser(P)-302 or Ser(P)-307 were used to determine whether the sites were phosphorylated under relevant conditions. 

Phrase: "Phosphospecific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "recognize"

Phrase: "sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "Ser(P)-302"

Phrase: "or"

Phrase: "Ser(P)-307"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "phosphorylated under relevant conditions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2347946:Relevant [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.10: Phosphorylation was promoted at both sites in Fao hepatoma cells by reagents known to promote Ser/Thr phosphorylation, including the phorbol ester phorbol 12-myristate 13-acetate, anisomycin, calyculin A, and insulin. 

Phrase: "Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "promoted at both sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205145:Sites [Spatial Concept]
   737   C0033414:Promote [Activity]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "in Fao hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0677626:hepatoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0023903:Hepatoma [Neoplastic Process]
   827   C2239176:Hepatoma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "by reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Ser/Thr phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the phorbol ester phorbol 12-myristate 13-acetate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   895   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   795   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   701   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: "anisomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "calyculin A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   861   C0597861:calyculin [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.11: The antibodies further showed that Ser(P)-302 and Ser(P)-307 are increased in animal models of obesity and insulin resistance, including genetically obese ob/ob mice, diet-induced obesity, and upon induction of hyperinsulinemia. 

Phrase: "The antibodies further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Ser(P)-302"

Phrase: "and"

Phrase: "Ser(P)-307"

Phrase: "are"

Phrase: "increased in animal models of obesity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0599779:Models, Animal [Animal]
   753   C0003062:Animal [Animal]
   753   C0028754:Obesity [Disease or Syndrome]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1963185:Obesity [Finding]
   753   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "genetically obese ob/ob mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0025933:Mice, Obese [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "diet-induced obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0028754:Obesity [Disease or Syndrome]
   827   C1963185:Obesity [Finding]

Phrase: "and upon induction of hyperinsulinemia."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020459:Hyperinsulinaemia [Disease or Syndrome]
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.12: These findings demonstrate that phosphorylation at both Ser-302 and Ser-307 is necessary for JNK1-mediated inhibition of the IR/IRS-1 interaction and that Ser-302 and Ser-307 are phosphorylated in parallel in cultured cells and in vivo under conditions that lead to insulin resistance.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that phosphorylation at both Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser-307"

Phrase: "is"

Phrase: "necessary for JNK1-mediated inhibition"

Phrase: "of the IR/IRS-1 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "that Ser-302"

Phrase: "and"

Phrase: "Ser-307"

Phrase: "are"

Phrase: "phosphorylated"

Phrase: "in parallel in cultured cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C2348042:Parallel [Qualitative Concept]
   760   C2826345:PARALLEL [Research Activity]

Phrase: "and"

Phrase: "in vivo under conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "that"

Phrase: "lead to insulin resistance."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   783   C0332325:Resistant to [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1514892:Resistance [Physiologic Function]
   770   C1522538:Lead [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Insulin resistance is the condition in which target tissues fail to respond appropriately to circulating insulin. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "the condition in which target tissues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0012634:condition [Disease or Syndrome]
   753   C0348080:Condition [Qualitative Concept]
   753   C1705253:Condition [Conceptual Entity]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "respond"

Phrase: "appropriately to circulating insulin."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0175630:Circulating [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.14: Although genetics may play a role in the pathogenesis of type 2 diabetes, it has become increasingly clear that acquired, non-genetic causes of insulin resistance represent a critical link between the rapidly growing national and worldwide epidemics in obesity and type 2 diabetes (15). 

Phrase: "Although"

Phrase: "genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the pathogenesis of type 2 diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "it"

Phrase: "has"

Phrase: "become"

Phrase: "increasingly"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that acquired, non-genetic causes of insulin resistance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0015127:causes [Functional Concept]
   744   C1314792:Causes [Functional Concept]
   711 E C1524003:Cause [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a critical link between the rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "growing"

Phrase: "national"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245503:national [Intellectual Product]

Phrase: "and"

Phrase: "worldwide epidemics in obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014499:Epidemics [Phenomenon or Process]
   770   C0220823:epidemics [Functional Concept]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.15: Obesity, fatty diet, and sedentary lifestyle directly promote insulin resistance, and exercise and weight loss reverse it. 

Phrase: "Obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "fatty diet,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: "and"

Phrase: "sedentary lifestyle directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1532253:Sedentary life style [Finding]
   827   C0023676:Life Style [Social Behavior]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "weight loss"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0043096:WEIGHTLOSS [Finding]
  1000   C2911645:Weight loss [Finding]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1517945:Loss [Quantitative Concept]
   861   C1705104:Weight [Idea or Concept]

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "it."
Processing 00000000.tx.16: Obesity and insulin resistance are also associated with and exacerbate hypertension and hyperlipidemia in addition to predisposing to the development of type 2 diabetes. 

Phrase: "Obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "also"

Phrase: "associated with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332281:Associated with [Qualitative Concept]
           Associated
   799 E C0750490:Associate [Idea or Concept]
   799 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "exacerbate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "and"

Phrase: "hyperlipidemia in addition to predisposing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020473:Hyperlipidaemia [Disease or Syndrome]

Phrase: "to the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.17: This constellation of conditions, referred to collectively as either the metabolic or dysmetabolic syndrome, represents a third interrelated epidemic with a prevalence of 24% of adults in the United States (6). 

Phrase: "This constellation of conditions,"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to collectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "either"

Phrase: "the metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311400:Metabolic [Functional Concept]
  1000   C1524026:Metabolic [Cell Function]
  1000   C2707259:Metabolic [Clinical Attribute]

Phrase: "or"

Phrase: "dysmetabolic syndrome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1262289:dysmetabolic syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a third interrelated epidemic with a prevalence of 24% of adults"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0014499:Epidemic [Phenomenon or Process]

Phrase: "in the United States"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0041703:United States [Geographic Area]
   861   C1301808:states [Geographic Area]
   827   C0166872:unite [Biomedical or Dental Material]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.18: Individuals with the metabolic syndrome have a seriously increased risk of developing atherosclerotic cardiovascular disease. 

Phrase: "Individuals with the metabolic syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "have"

Phrase: "a"

Phrase: "seriously increased risk of developing atherosclerotic cardiovascular disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1281905:disease risk [Finding]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   721   C0277564:Acquired disease [Disease or Syndrome]
Processing 00000000.tx.19: Elucidating the molecular pathways that connect obesity to pathogenesis of insulin resistance clearly has great public health importance. 

Phrase: "Elucidating"

Phrase: "the molecular pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1704259:molecular pathway [Molecular Function]
           Pathways
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "connect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986575:Connect [Activity]

Phrase: "obesity to pathogenesis of insulin resistance clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0028754:Obesity [Disease or Syndrome]
   748   C1963185:Obesity [Finding]

Phrase: "has"

Phrase: "great public health importance."
Processing 00000000.tx.20: Of hypothesized mediators of insulin resistance, recent findings have profiled potential roles for inflammation and proinflammatory cytokines, other fat cell-derived cytokines, free fatty acids, and inhibitory serine/threonine (Ser/Thr) phosphorylation of upstream elements of insulin signaling (714). 

Phrase: "Of hypothesized mediators"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   827 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "recent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "profiled potential roles for inflammation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "proinflammatory cytokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "other fat cell-derived cytokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "free fatty acids,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "inhibitory serine/threonine (Ser/Thr) phosphorylation of upstream elements of insulin signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   782   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "(714"

Phrase: ")."
Processing 00000000.tx.21: In fact, inflammation- and free fatty acid-mediated mechanisms may converge at the level of Ser/Thr phosphorylation of insulin receptors (IRs)1 and insulin receptor substrates (IRSs) to provide potentially unifying mechanisms for insulin resistance (1520). 

Phrase: "In fact,"

Phrase: "inflammation-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "free fatty acid-mediated mechanisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0441712:Mechanisms [Functional Concept]
   771 E C1706376:Mechanism [Manufactured Object]
   717   C0015688:free fatty acid [Lipid]
   717   C2698488:Free Fatty Acid [Laboratory Procedure]

Phrase: "may"

Phrase: "converge at the level of Ser/Thr phosphorylation of insulin receptors (IRs)1"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   770   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   753   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   751   C0074377:serine receptors [Amino Acid, Peptide, or Protein,Receptor]
   751   C0202098:Insulin level [Laboratory Procedure]
   751   C0428405:insulin level [Laboratory or Test Result]
   751   C0456947:Level 1 [Intellectual Product]
   736   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C0031715:Phosphorylation [Molecular Function]
   736   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0441889:Level [Qualitative Concept]
   736   C0456079:Level [Classification]
   736   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   736   C1158886:Phosphorylation [Molecular Function]
   736   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C1547707:Level [Geographic Area]
   736   C1579433:Insulin [Pharmacologic Substance]
   736   C2700387:Converge [Activity]
   736   C2946261:Level [Pharmacologic Substance]
   719 E C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "insulin receptor substrates (IRSs) to"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779   C1710236:Substrate [Manufactured Object]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "potentially unifying mechanisms for insulin resistance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1522618:resistance mechanism [Clinical Attribute]
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "(1520"

Phrase: ")."
Processing 00000000.tx.22: Consistent with this, insulin-sensitizing, anti-inflammatory salicylates reverse Ser/Thr phosphorylation of IR and IRSs in insulin-responsive tissues in obesity-, diet- and free fatty acid-induced models of insulin resistance (15, 16). 

Phrase: "Consistent with this,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "insulin-sensitizing,"

Phrase: "anti-inflammatory salicylates"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0036077:Salicylates [Organic Chemical,Pharmacologic Substance]
   793 E C0036075:salicylate [Organic Chemical,Pharmacologic Substance]
   734   C0003209:Anti-inflammatory [Pharmacologic Substance]
   734   C1515999:Anti-inflammatory [Qualitative Concept]

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "Ser/Thr phosphorylation of IR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "IRSs in insulin-responsive tissues"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   778   C1334133:INSULIN RECEPTOR [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C1710236:Substrate [Manufactured Object]

Phrase: "in obesity-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "diet-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012155:Diet [Food]
  1000   C1442959:Diet [Organism Function]
  1000   C1519433:DIET [Therapeutic or Preventive Procedure]
  1000   C2983588:DIET [Food]
   928 E C2699635:DIETARY [Functional Concept]

Phrase: "and"

Phrase: "free fatty acid-induced models of insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Models [Intellectual Product]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.23: Although IR is a tyrosine kinase, insulin also stimulates Ser/Thr phosphorylation of numerous signaling enzymes and other proteins (21, 22). 

Phrase: "Although"

Phrase: "IR"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a tyrosine kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "insulin also"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "Ser/Thr phosphorylation of numerous signaling enzymes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "other proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.24: Many are Ser/Thr kinases involved in kinase cascades. 

Phrase: "Many"

Phrase: "are"

Phrase: "Ser/Thr kinases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0072402:Serine-Threonine Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
   988 E C1414387:serine/threonine kinase [Gene or Genome]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "involved in kinase cascades."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1314939:Involved [Functional Concept]
   737   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.25: Those mediating some of the insulin cellular actions include Raf, MEK (mitogen-activated protein kinase/extracellular signal-regulated kinase kinase), MAPK, p90RSK, phosphatidylinositol 3-kinase, phosphoinositide-dependent protein kinase 1, protein kinase B/AKT, mTOR, p70 S6 kinase, GSK3, PKC1, PKC, and PKC. 

Phrase: "Those"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "some of the insulin cellular actions"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0007634:Cellular [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0178539:Cellular [Functional Concept]
   753   C0205392:Some [Quantitative Concept]
   753   C0441472:actions [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3540770:Some [Intellectual Product]
   719 E C3266814:Action [Activity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "Raf,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425569:RAF [Gene or Genome]
  1000   C1706586:RAF [Gene or Genome]

Phrase: "MEK (mitogen-activated protein kinase/extracellular signal-regulated kinase kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   872   C0211705:Mitogen-Activated Protein Kinase Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "MAPK,"

Phrase: "p90RSK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0248441:p90(rsk) [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphatidylinositol 3-kinase,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphoinositide-dependent protein kinase 1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0089793:Phosphoinositide Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031621:phosphoinositide [Biologically Active Substance,Lipid]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]

Phrase: "protein kinase B/AKT,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
           Protein Kinase B
   812   C0812228:AKT [Gene or Genome]
   756   C0285558:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mTOR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1307407:mTOR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1414805:MTOR [Gene or Genome]

Phrase: "p70 S6 kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1136240:p70 S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PKC1,"

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "and"

Phrase: "PKC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]
Processing 00000000.tx.26: Overexpression of many of these kinases paradoxically inhibits insulin signaling as opposed to activating it, suggesting that the same kinases that mediate insulin signaling might also play roles in negative feedback of it (23). 

Phrase: "Overexpression of many of these kinases paradoxically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "as"

Phrase: "opposed to activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:activating [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "it,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the same kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "might"

Phrase: "also"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "roles in negative feedback of it (23"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0035820:Roles [Social Behavior]
   714 E C1705810:Role [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.27: In fact, IR and IRSs are themselves Ser/Thr-phosphorylated in response to insulin, providing a potential mechanism for negative feedback. 

Phrase: "In fact,"

Phrase: "IR"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IRSs"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793   C1710236:Substrate [Manufactured Object]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "themselves Ser/Thr-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phosphorylated in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "a potential mechanism for negative feedback."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.28: Basal levels of IRS-1 Ser/Thr phosphorylation are increased in cells under various conditions, leading to observable shifts in electrophoretic mobility (15, 2427). 

Phrase: "Basal levels of IRS-1 Ser/Thr phosphorylation"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456947:Level 1 [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "under various conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "leading to observable shifts"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0332152:Leading [Temporal Concept]
   770   C0333051:shifts [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2347509:Shift [Phenomenon or Process]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in electrophoretic mobility"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0425245:Mobility [Finding]
   861   C0449580:Mobility [Qualitative Concept]
   789   C0013855:Electrophoreses [Laboratory Procedure]
   789 E C0231435:Mobile [Functional Concept]
   789 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "(15,"

Phrase: "2427"

Phrase: ")."
Processing 00000000.tx.29: The magnitudes of the shifts demonstrate that multiple sites are phosphorylated. 

Phrase: "The magnitudes of the shifts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1704240:Magnitudes [Quantitative Concept]
   726 E C0449286:magnitude [Quantitative Concept]

Phrase: "demonstrate"

Phrase: "that multiple sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "phosphorylated."
Processing 00000000.tx.30: In fact, IRS-1 contains 232 serines and threonines, nearly 19% of its 1231 residues, providing great potential for multisite phosphorylation. 

Phrase: "In fact,"

Phrase: "IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "232 serines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "threonines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "nearly 19% of its 1231 residues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "great potential for multisite phosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.31: The rapid accumulation of "hyper-phosphorylated" IRS-1 upon treatment with the Ser/Thr phosphatase inhibitors okadaic acid or calyculin A further indicates that it is constantly being Ser/Thr-phosphorylated. 

Phrase: "The rapid accumulation of """

Phrase: "hyper-phosphorylated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0424295:HYPER [Finding]

Phrase: """ IRS-1 upon treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with the Ser/Thr phosphatase inhibitors okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "calyculin A further"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   827   C0597861:calyculin [Pharmacologic Substance]

Phrase: "indicates"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "constantly"

Phrase: "being"

Phrase: "Ser/Thr-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phosphorylated."
Processing 00000000.tx.32: Normally this is countered by phosphatases like PP2A and PP1, such that under steady-state conditions there should be a given "responsiveness" to the system. 

Phrase: "Normally"

Phrase: "this"

Phrase: "is"

Phrase: "countered by phosphatases"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0031678:Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0677601:Counter [Manufactured Object]
   756 E C1149880:phosphatase [Molecular Function]
   756   C1705206:Counter [Medical Device]

Phrase: "like PP2A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0255156:PP2A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1704708:PP2A [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "PP1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369880:PP1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1418858:PP1 [Gene or Genome]
  1000   C1826646:PP1 [Gene or Genome]

Phrase: "such"

Phrase: "that under steady-state conditions there"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0678587:steady state [Natural Phenomenon or Process]
   753   C0205361:Steady [Qualitative Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "should"

Phrase: "be"

Phrase: "a"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: """responsiveness"""
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0205342:Responsive [Functional Concept]
   900 E C2371924:Responsivity [Mental Process]

Phrase: "to the system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.33: The balance might be shifted by activating Ser/Thr kinases that phosphorylate IRS or by inhibiting a relevant phosphatase. 

Phrase: "The balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014653:Balance [Organism Function]
  1000   C0205415:Balance [Functional Concept]
  1000   C0560184:Balance [Finding]

Phrase: "might"

Phrase: "be"

Phrase: "shifted by activating Ser/Thr kinases"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0072402:Serine-Threonine Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           Threonine Kinase
           Serine Kinase
   822 E C1414387:serine/threonine kinase [Gene or Genome]
   753   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0333051:shifted [Functional Concept]
   753   C1879547:activating [Activity]
   719 E C1515877:Activate [Functional Concept]
   719 E C2347509:Shift [Phenomenon or Process]

Phrase: "that"

Phrase: "phosphorylate"

Phrase: "IRS"

Phrase: "or by inhibiting a relevant phosphatase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1149880:phosphatase [Molecular Function]
   753   C2347946:Relevant [Qualitative Concept]
   753   C3463820:Inhibiting [Activity]
Processing 00000000.tx.34: The net result in these cases would be the same; 

Phrase: "The net result in these cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "would"

Phrase: "be"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.35: that is, Ser/Thr phosphorylation of IRS-1, diminished insulin signaling, and the development of insulin resistance. 

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "Ser/Thr phosphorylation of IRS-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "diminished insulin signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "the development of insulin resistance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.36: Conversely, insulin signaling should be sensitized either by inhibiting the relevant Ser/Thr kinase(s) or activating the appropriate phosphatase(s). 

Phrase: "Conversely,"

Phrase: "insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "should"

Phrase: "be"

Phrase: "sensitized"

Phrase: "either by inhibiting"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C3463820:Inhibiting [Activity]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "the relevant Ser/Thr kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0072402:Serine-Threonine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
   923   C1414387:serine/threonine kinase [Gene or Genome]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "s)"

Phrase: "or"

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the appropriate phosphatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1149880:phosphatase [Molecular Function]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.37: A host of Ser/Thr kinases can be shown to attenuate upstream insulin action in cultured cells, including PKA (2830), AKT/protein kinase B (31, 32), AMP-dependent protein kinase (33), PKCs (3438), MAPK (39), GSK3 (40, 41), casein kinase II, JNK (17, 18, 20, 42), mTOR (43, 44), phosphatidylinositol 3-kinase (45, 46, 4651), Rho kinase (ROK) (52), and salt-inducible kinase (SIK1/2) (53). 

Phrase: "A host of Ser/Thr kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1167395:Host [Organism]

Phrase: "can"

Phrase: "be"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "upstream insulin action in cultured cells,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0030281:Insulin Cell [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0441472:Action [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3266814:Action [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PKA (2830"

Phrase: ")"

Phrase: ","

Phrase: "AKT/protein kinase B"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0164786:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0285558:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "AMP-dependent protein kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "PKCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0657318:PKCS [Amino Acid, Peptide, or Protein]

Phrase: "(3438"

Phrase: ")"

Phrase: ","

Phrase: "MAPK (39"

Phrase: ")"

Phrase: ","

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: ","

Phrase: "casein kinase II,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0108555:Casein Kinase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "JNK (17,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150587:JNK [Molecular Function]
   861   C1367731:JNK [Gene or Genome]
   861   C1705632:JNK [Gene or Genome]

Phrase: "18,"

Phrase: "20,"

Phrase: "42"

Phrase: ")"

Phrase: ","

Phrase: "mTOR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1307407:mTOR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1414805:MTOR [Gene or Genome]

Phrase: "(43,"

Phrase: "44"

Phrase: ")"

Phrase: ","

Phrase: "phosphatidylinositol 3-kinase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   972 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(45,"

Phrase: "46,"

Phrase: "4651"

Phrase: ")"

Phrase: ","

Phrase: "Rho kinase (ROK)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(52"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "salt-inducible kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(SIK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420279:SIK1 [Gene or Genome]

Phrase: ")"

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.38: Specific Ser/Thr phosphorylation sites in IRS-1 identified in vitro include Ser-307 (17, 18, 20, 42, 51, 5456), Ser-612 (37), Ser-636 and Ser-639 (44), Ser-731 (57), and Ser-789 (33, 58). 

Phrase: "Specific Ser/Thr phosphorylation sites in IRS-1"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   800   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   783   C1515418:Threonine Phosphorylation Site [Amino Acid Sequence]
   776   C1519254:Serine Phosphorylation Site [Amino Acid Sequence]
   750   C0449604:Specific site [Spatial Concept]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C0205145:Sites [Spatial Concept]
   744   C1158886:Phosphorylation [Molecular Function]
   737   C1519063:Phosphorylation Site [Amino Acid Sequence]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "Ser-307"

Phrase: "(17,"

Phrase: "18,"

Phrase: "20,"

Phrase: "42,"

Phrase: "51,"

Phrase: "5456"

Phrase: ")"

Phrase: ","

Phrase: "Ser-612"

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "Ser-636"

Phrase: "and"

Phrase: "Ser-639"

Phrase: "(44"

Phrase: ")"

Phrase: ","

Phrase: "Ser-731"

Phrase: "(57"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Ser-789"

Phrase: "(33,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.39: Of these, Ser-3072 phosphorylation has been studied most intensively as a mechanism for disrupting IR/IRS-1 interactions (17, 18, 42, 51, 5456, 5961). 

Phrase: "Of these,"

Phrase: "Ser-3072 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "most intensively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "as"

Phrase: "a mechanism for disrupting IR/IRS-1 interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "(17,"

Phrase: "18,"

Phrase: "42,"

Phrase: "51,"

Phrase: "5456,"

Phrase: "5961"

Phrase: ")."
Processing 00000000.tx.40: Originally identified as a target of JNK in cells (17), Ser-307 was subsequently found to be phosphorylated as well in cells treated with tumor necrosis factor-, PMA, insulin, or insulin-like growth factor-1 (42, 51, 5456, 59, 61). 

Phrase: "Originally"

Phrase: "identified as a target of JNK"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205396:Identified [Qualitative Concept]
   753   C1150587:JNK [Molecular Function]
   753   C1367731:JNK [Gene or Genome]
   753   C1521840:Target [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1705632:JNK [Gene or Genome]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "Ser-307"

Phrase: "was"

Phrase: "subsequently"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205170:Well [Qualitative Concept]
   790   C3146287:Well [Manufactured Object]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with tumor necrosis factor-,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   862   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   862   C1323304:tumor necrosis factor [Molecular Function]
   862   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   806   C0333516:Tumor necrosis [Neoplastic Process]
   762 E C1300818:Necrotic tumor [Neoplastic Process]
   760   C0027540:Necrosis [Organ or Tissue Function]
   760   C0027651:Tumor [Neoplastic Process]
   760   C1334928:Necrosis [Finding]
   760   C1521761:Factor [Functional Concept]
   760   C1522326:Treated [Functional Concept]
   760   C1578706:Tumor [Intellectual Product]
   760   C2827422:Factor [Conceptual Entity]
   760   C3273930:Tumor [Finding]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin-like growth factor-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(42,"

Phrase: "51,"

Phrase: "5456,"

Phrase: "59,"

Phrase: "61"

Phrase: ")."
Processing 00000000.tx.41: Importantly, Ser-307 has been found to be phosphorylated in vivo in insulin-resistant rodent models (20) and in human skeletal muscle (54). 

Phrase: "Importantly,"

Phrase: "Ser-307"

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated"

Phrase: "in vivo in insulin-resistant rodent models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C1515657:In Vivo Model [Research Activity]
   778   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(20"

Phrase: ")"

Phrase: "and in human skeletal muscle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0242692:Muscle, Skeletal [Tissue]
   806   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   760   C0026845:Muscle [Tissue]
   760   C0037253:skeletal [Body System]
   760   C0086418:Human [Human]
   760   C0521324:Skeletal [Spatial Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.42: We have shown previously that Ser-307 phosphorylation blocks IR/IRS-1 binding in disruptive yeast tri-hybrid (Y3H) experiments (18). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "that Ser-307 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "IR/IRS-1 binding in disruptive yeast tri-hybrid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   761   C1149501:insulin receptor binding [Molecular Function]
   757   C1623517:insulin binding [Molecular Function]
   757   C1623518:IRS binding [Molecular Function]
   741   C0597358:Receptor Binding [Molecular Function]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]

Phrase: "(Y3H"

Phrase: ")"

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.43: We have now used the disruptive Y3H method to identify an additional serine (Ser-302) in IRS-1 that is equally necessary for JNK-mediated disruption. 

Phrase: "We"

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the disruptive Y3H method to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "identify"

Phrase: "an additional serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Ser-302"

Phrase: ")"

Phrase: "in IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is"

Phrase: "equally necessary for JNK-mediated disruption."
Processing 00000000.tx.44: We also show that Ser-302 and Ser-307 are phosphorylated in cells and in vivo under equivalent conditions of insulin resistance.  

Phrase: "We also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Ser-302"

Phrase: "and"

Phrase: "Ser-307"

Phrase: "are"

Phrase: "phosphorylated in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "in vivo under equivalent conditions of insulin resistance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.45: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Yeast Two-hybridMatchmaker LexA two-hybrid reagents were purchased from Clontech. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Yeast Two-hybridMatchmaker LexA two-hybrid reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "purchased from Clontech."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.46: Saccharomyces cerevisiae strain EGY48 (Mat trp1, his3, ura3, 6LexAop-LEU2, LYS2), transformed with p8op-lacZ (kindly provided by T. A. Gustafson, Metabolex), was used as the host for interaction studies. 

Phrase: "Saccharomyces cerevisiae strain EGY48"

Phrase: "(Mat trp1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0700256:trp 1 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1421165:TRP1 [Gene or Genome]
   861   C1421168:TRP1 [Gene or Genome]

Phrase: "his3,"

Phrase: "ura3,"

Phrase: "6LexAop-LEU2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1333223:LEU2 [Gene or Genome]
   861   C1705129:LEU2 [Gene or Genome]
   861   C1861281:LEU2 [Gene or Genome]
   861   C3540595:Leu2 [Gene or Genome]

Phrase: "LYS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2240229:LYS2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "transformed with p8op-lacZ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022959:LacZ [Gene or Genome]
   770   C1510411:Transformed [Pathologic Function]

Phrase: "(kindly"

Phrase: "provided by T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]

Phrase: "A. Gustafson,"

Phrase: "Metabolex"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "used as the host"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1167395:Host [Organism]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "for interaction studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.47: EGY48/p8op-lacZ was sequentially transformed with plasmid constructs using polyethylene glycol/lithium acetate according to manufacturer's protocols. 

Phrase: "EGY48/p8op-lacZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022959:LacZ [Gene or Genome]

Phrase: "was"

Phrase: "sequentially"

Phrase: "transformed with plasmid constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1510411:Transformed [Pathologic Function]
   737   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyethylene glycol/lithium acetate according to manufacturer's protocols."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0125995:Lithium acetate [Organic Chemical,Pharmacologic Substance]
   744   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.48: To determine protein-protein interactions as a function of leucine biosynthesis (LEU2), transformants were grown on synthetic dextrose agar plates for 3 days at 30 C. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "protein-protein interactions as a function of leucine biosynthesis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0597295:Protein Biosynthesis [Molecular Function]
   762   C0815043:function protein [Amino Acid, Peptide, or Protein]
   762   C0872079:interactions protein [Molecular Function]
           Protein-Protein Interaction
   762   C1527118:Protein Function [Molecular Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C1704675:Interaction [Functional Concept]

Phrase: "(LEU2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1333223:LEU2 [Gene or Genome]
  1000   C1705129:LEU2 [Gene or Genome]
  1000   C1861281:LEU2 [Gene or Genome]
  1000   C3540595:Leu2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "transformants"

Phrase: "were"

Phrase: "grown on synthetic dextrose agar"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001771:Agar [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0017725:Dextrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1883254:synthetic [Activity]

Phrase: "plates for 3 days"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0005971:Plate [Medical Device]
   770   C0439228:days [Temporal Concept]
   770   C1139930:plate [Medical Device]
   770   C3537155:Plate [Manufactured Object]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "at 30 C."
Processing 00000000.tx.49: Four independent colonies were streaked on synthetic dextrose glucose agar plates, grown overnight, replica-plated on synthetic galactose/raffinose agar plates, and regrown for 5 days at 30 C to induce expression of B42 fusion proteins. 

Phrase: "Four independent colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "streaked on synthetic dextrose glucose agar plates,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0001771:Agar [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0017725:Dextrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
           Glucose
   748   C1139930:plates [Medical Device]
   748   C1883254:synthetic [Activity]
   714 E C0005971:Plate [Medical Device]
   714   C2348542:Streak [Idea or Concept]
   714 E C3537155:Plate [Manufactured Object]

Phrase: "grown"

Phrase: "overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "replica-"

Phrase: "plated on synthetic galactose/raffinose agar plates,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0001771:Agar [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0016945:Galactose [Biologically Active Substance,Carbohydrate]
   748   C0034632:Raffinose [Carbohydrate]
   748   C1139930:plates [Medical Device]
           plate
   748   C1883254:synthetic [Activity]
   714   C0005971:Plate [Medical Device]
   714   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "regrown for 5 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "at 30 C to"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expression of B42 fusion proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1517332:Fusion Protein Expression [Cell or Molecular Dysfunction]
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.50: Disruptive Yeast Tri-hybridTo create the disruptive yeast tri-hybrid assay, we modified the existing LexA yeast two-hybrid method. 

Phrase: "Disruptive Yeast Tri-hybridTo"

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "the disruptive yeast tri-hybrid assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "the existing LexA yeast two-hybrid method."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   861   C0752172:Two-Hybrid Method [Molecular Biology Research Technique]
   827   C0599647:Two Hybrid [Molecular Biology Research Technique]
   799   C0020205:Hybrid [Organism]
   799   C0025663:Method [Intellectual Product]
   799   C0036025:yeast [Fungus]
   799   C0043392:Yeast [Food]
   799   C0043393:Yeast [Fungus]
   799   C0205448:Two [Quantitative Concept]
   799   C0449851:Method [Functional Concept]
   799   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   799   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.51: S. cerevisiae EGY48 cells were sequentially transformed as above with pLexA expressing human insulin receptor kinase (residues 9401343) as bait, pB42AD expressing various human IRS-1 constructs as prey, and in most cases JNK11 in the third pDis plasmid. 

Phrase: "S. cerevisiae EGY48 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "sequentially"

Phrase: "transformed as above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1510411:Transformed [Pathologic Function]

Phrase: "with pLexA expressing human insulin receptor kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(residues 9401343"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "as"

Phrase: "bait,"

Phrase: "pB42AD"

Phrase: "expressing"

Phrase: "various human IRS-1 constructs as prey,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C2827421:Construct [Classification]

Phrase: "and in most cases JNK11"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0868928:Cases [Functional Concept]
   760   C1515981:And [Idea or Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "in the third pDis plasmid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.52: pDis was derived from the p426:Gal1 plasmid (ATCC) by replacing its multiple cloning region with another having a nuclear localization signal under Gal1 promoter control. 

Phrase: "pDis"

Phrase: "was"

Phrase: "derived from the p426"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: ":"

Phrase: "Gal1 plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(ATCC) by replacing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0598079:ATCC [Intellectual Product]

Phrase: "its multiple cloning region with another"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "having"

Phrase: "a nuclear localization signal under Gal1 promoter control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0525021:Nuclear Localization Signal [Amino Acid Sequence]
   744   C0475264:Localisation [Functional Concept]
   744   C0521447:Nuclear [Spatial Concept]
   744   C1710082:Signal [Phenomenon or Process]
   744   C1744691:localisation [Biologic Function]
Processing 00000000.tx.53: In selected experiments alternative kinases were expressed in the pDis plasmid, including GSK3(S9A), IKK, IKK(S177E/S181E), p38 MAPK, PKA, PKC, PKC2, PKC, and PKC. 

Phrase: "In selected experiments alternative kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "expressed in the pDis plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(S9A"

Phrase: ")"

Phrase: ","

Phrase: "IKK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "(S177E/S181E"

Phrase: ")"

Phrase: ","

Phrase: "p38 MAPK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PKA,"

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "PKC2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418928:PKC2 [Gene or Genome]

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "and"

Phrase: "PKC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]
Processing 00000000.tx.54: Transformants were grown on the appropriate synthetic dextrose plates for 3 days at 30 C. 

Phrase: "Transformants"

Phrase: "were"

Phrase: "grown on the appropriate synthetic dextrose plates"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0017725:Dextrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C1139930:plates [Medical Device]
   748   C1548787:Appropriate [Qualitative Concept]
   748   C1883254:synthetic [Activity]
   714 E C0005971:Plate [Medical Device]
   714 E C3537155:Plate [Manufactured Object]

Phrase: "for 3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "at 30 C."
Processing 00000000.tx.55: Four independent colonies were streaked on synthetic dextrose plates, incubated overnight, and replicaplated on GR plates. 

Phrase: "Four independent colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439158:colonies [Quantitative Concept]
   793 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "streaked on synthetic dextrose plates,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0017725:Dextrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1139930:plates [Medical Device]
   760   C1883254:synthetic [Activity]
   726 E C0005971:Plate [Medical Device]
   726   C2348542:Streak [Idea or Concept]
   726 E C3537155:Plate [Manufactured Object]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "replicaplated on GR plates."
Processing 00000000.tx.56: The plates were immediately replica-cleaned, incubated overnight, replica-cleaned, and incubated at 30 C for 5 days to induce expression of pDis and B42 fusion proteins. 

Phrase: "The plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "immediately replica-cleaned,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1947930:Cleaned [Activity]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "replica-cleaned,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947930:Cleaned [Activity]

Phrase: "and"

Phrase: "incubated at 30 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 5 days to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C1442466:5 Days [Temporal Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expression of pDis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "B42 fusion proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.57: Cell CultureFao hepatoma cells were maintained in RPMI medium containing 25 mM glucose and 10% heat-inactivated fetal bovine serum (Sigma) under 5% CO2. 

Phrase: "Cell CultureFao hepatoma cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0677626:hepatoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0023903:Hepatoma [Neoplastic Process]
   812   C2239176:Hepatoma [Neoplastic Process]
   812   C3282337:Cells [Cell]

Phrase: "were"

Phrase: "maintained in RPMI medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1314677:Maintained [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C0024501:Maintain [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "10% heat-inactivated fetal bovine serum"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0007452:Bovine [Mammal]
   799   C0015965:Fetal [Embryonic Structure]
   799   C0018837:Heat [Natural Phenomenon or Process]
   799   C0229671:Serum [Body Substance]
   799   C0521457:Fetal [Functional Concept]
   799   C1140701:bovine [Mammal]
   799   C1546774:Serum [Intellectual Product]
   799   C1550100:Serum [Body Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "under 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.58: Before experiments, Fao cells were serum-starved for 16 h in RPMI containing 0.1% bovine serum albumin. 

Phrase: "Before experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "Fao cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "starved for 16 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   737   C2348531:Starve [Activity]

Phrase: "in RPMI"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% bovine serum albumin."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
Processing 00000000.tx.59: After treatment, cells were washed (phosphate-buffered saline containing 1.0 mM phenylmethylsulfonyl fluoride, 3.0 M aprotinin, 10 M leupeptin, 5.0 M pepstatin A, 25 mM benzamidine, 25 mM sodium vanadate, 5.0 mM glycerol phosphate, 100 mM NaF, 1.0 mM ammonium molybdate, 30 mM tetrasodium pyrophosphate, 5 mM EGTA) and lysed (in 30 mM HEPES, 150 mM NaCl, 1.0 mM phenylmethylsulfonyl fluoride, 3.0 M aprotinin, 10 M leupeptin, 5.0 M pepstatin A, 25 mM benzamidine, 25 mM sodium vanadate, 5.0 mM glycerol phosphate, 100 mM NaF, 1.0 mM ammonium molybdate, 30 mM tetrasodium pyrophosphate, 5.0 mM EGTA, 10% glycerol, 1% Triton X-100, and 0.5% sodium deoxycholate, pH 7.4) for immunoprecipitation and Western-blotting experiments. 

Phrase: "After treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "(phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1.0 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "3.0 M aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "10 M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "5.0 M pepstatin A,"

Phrase: "25 mM benzamidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "25 mM sodium vanadate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037568:Sodium Vanadate [Inorganic Chemical,Pharmacologic Substance]
   812   C0042305:Vanadate [Inorganic Chemical]

Phrase: "5.0 mM glycerol phosphate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100 mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "1.0 mM ammonium molybdate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0051721:ammonium molybdate [Inorganic Chemical,Pharmacologic Substance]
   804   C0002611:Ammonium [Inorganic Chemical]
   804   C0066695:molybdate [Inorganic Chemical]

Phrase: "30 mM tetrasodium pyrophosphate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0074764:Tetrasodium pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5 mM EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "and"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "("

Phrase: "in 30 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1.0 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "3.0 M aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "10 M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "5.0 M pepstatin A,"

Phrase: "25 mM benzamidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "25 mM sodium vanadate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037568:Sodium Vanadate [Inorganic Chemical,Pharmacologic Substance]
   812   C0042305:Vanadate [Inorganic Chemical]

Phrase: "5.0 mM glycerol phosphate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100 mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "1.0 mM ammonium molybdate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0051721:ammonium molybdate [Inorganic Chemical,Pharmacologic Substance]
   804   C0002611:Ammonium [Inorganic Chemical]
   804   C0066695:molybdate [Inorganic Chemical]

Phrase: "30 mM tetrasodium pyrophosphate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0074764:Tetrasodium pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5.0 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "0.5% sodium deoxycholate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Western-blotting experiments."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   717 E C0949466:Western Blot [Laboratory Procedure]
Processing 00000000.tx.60: CHO-IR cells were maintained in F-12 medium supplemented with 10% fetal bovine serum in the presence of 0.4 mg/ml G418 and 2 mM glutamine in 5% CO2. 

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0085080:CHO Cells [Cell]
   858   C0030281:Insulin Cell [Cell]
   827   C1514760:Receptor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in F-12 medium"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   760   C0009458:Medium [Intellectual Product]
   760   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   760   C0439133:(f) [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1553038:[f] [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C0024501:Maintain [Activity]

Phrase: "supplemented with 10% fetal bovine serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.4 mg/ml G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "2 mM glutamine in 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.61: Cells at 5060% confluence were transfected using FuGENE 6 (Roche Applied Science) with pCMV(WT IRS-1), pCMV-(IRS-1 S307A), pCMV(IRS-1 S312A), or pCMV(IRS-1 S307A/S3012A). 

Phrase: "Cells at 5060% confluence"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "FuGENE 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0916399:FuGene 6 [Lipid]
           FuGene

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "with pCMV(WT IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C2362085:WT-1 [Gene or Genome]
   861   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "pCMV-(IRS-1 S307A"

Phrase: ")"

Phrase: ","

Phrase: "pCMV(IRS-1 S312A"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "pCMV(IRS-1 S307A/S3012A"

Phrase: ")."
Processing 00000000.tx.62: Cells were incubated for 24 h, serum-starved overnight, treated for 30 min with 20 M anisomycin or 20 nM calyculin A (Bio-Mol) and for 5 min with 1 nM insulin and lysed as describe above. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 24 h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "serum-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: "overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "treated for 30 min"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0702093:/min [Temporal Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with 20 M anisomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "or"

Phrase: "20 nM calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   812   C0597861:calyculin [Pharmacologic Substance]

Phrase: "(Bio-Mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]

Phrase: ")"

Phrase: "and for 5 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "with 1 nM insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "as"

Phrase: "describe"

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.63: In Vivo Animal StudiesFourteen week-old ob/ob (Lepob/ob) mice and congenic Lep+/+ controls were sacrificed after an overnight fast. 

Phrase: "In Vivo Animal StudiesFourteen week-old ob/ob (Lepob/ob) mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C0025914:Mice [Mammal]
   788   C0025929:mice [Mammal]
   788   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "congenic Lep+/+ controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "sacrificed after an overnight fast."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015663:Fast [Finding]
   760   C0439583:Overnight [Temporal Concept]
   760   C0456962:Fast [Qualitative Concept]
   726   C0681205:Sacrifice [Idea or Concept]
Processing 00000000.tx.64: For the "diet-induced obesity" study, 8 week-old C57BL/6 (Jackson Laboratories) mice were fed a high fat diet (Research Diet D12451 [GenBank] , 45% of calories from fat) for 8 weeks; 

Phrase: "For the ""diet-induced obesity"" study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "8 week-old C57BL/6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1521751:C57BL/6 [Mammal]
   804   C0025921:C57BL [Mammal]
   804   C0332174:/week [Temporal Concept]
   804   C0439230:week [Temporal Concept]
   804   C0580836:Old [Temporal Concept]

Phrase: "(Jackson Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "a"

Phrase: "high fat diet"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "(Research Diet D12451"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0452400:Research diet [Therapeutic or Preventive Procedure]

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "] ,"

Phrase: "45% of calories"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1556156:calories [Quantitative Concept]
   756 E C1879985:calorie [Quantitative Concept]

Phrase: "from fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: ")"

Phrase: "for 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.65: controls were fed regular chow that derives 17% of calories from fat. 

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "regular chow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0324335:chow [Mammal]

Phrase: "that"

Phrase: "derives"

Phrase: "17% of calories"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1556156:calories [Quantitative Concept]
   756 E C1879985:calorie [Quantitative Concept]

Phrase: "from fat."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]
Processing 00000000.tx.66: After an overnight fast the 16-week-old mice were sacrificed. 

Phrase: "After an overnight fast"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015663:Fast [Finding]
   861   C0439583:Overnight [Temporal Concept]
   861   C0456962:Fast [Qualitative Concept]

Phrase: "the 16-week-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "sacrificed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]
Processing 00000000.tx.67: To determine the effects of acute, high dose insulin, chow-fed 12-week-old C57BL/6 mice were fasted overnight, injected intraperitoneally with 1 units/kg of insulin, and sacrificed after 10 min. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the effects of acute, high dose insulin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "chow-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324335:chow [Mammal]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "12-week-old C57BL/6 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   850   C1521751:C57BL/6 Mouse [Mammal]
   839   C0025921:Mice, C57BL [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "fasted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intraperitoneally with 1 units/kg of insulin,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   762   C1300561:unit/kg [Quantitative Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0022718:KG [Geographic Area]
   748   C0439148:Units [Quantitative Concept]
   748   C0439209:kg [Quantitative Concept]
   748   C1519795:Units [Quantitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C1704753:Unit [Manufactured Object]
   714 E C1880519:Unit [Quantitative Concept]

Phrase: "and"

Phrase: "sacrificed after 10 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   737   C0681205:Sacrifice [Idea or Concept]
Processing 00000000.tx.68: Harvested livers, stored until use in liquid N2, were pulverized and homogenized with a Polytron for 30 s in lysis buffer. 

Phrase: "Harvested livers,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0023884:Livers [Body Part, Organ, or Organ Component]
   827 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   827 E C1278929:Liver [Body Part, Organ, or Organ Component]
   827 E C2346688:LIVER [Food]
   789 E C0205054:Hepatic [Body Location or Region]

Phrase: "stored until use"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]
   756   C1698986:Store [Functional Concept]

Phrase: "in liquid N2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441960:N2 [Finding]

Phrase: "were"

Phrase: "pulverized"

Phrase: "and"

Phrase: "homogenized with a Polytron"

Phrase: "for 30 s"

Phrase: "in lysis buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.69: Cleared lysates were used for immunoprecipitations and Western blotting. 

Phrase: "Cleared lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "used for immunoprecipitations"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   756   C0021069:Immunoprecipitation [Laboratory Procedure]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.70: Antibody Preparation and UsePhosphospecific antibodies against IRS-1 Ser(P)-302 were generated in rabbits. 

Phrase: "Antibody Preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "UsePhosphospecific antibodies against IRS-1 Ser(P)-302"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "generated in rabbits."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034493:Rabbit [Mammal]
   790   C3146294:Generated [Activity]
Processing 00000000.tx.71: Phosphopeptide RRSRTEpSITATSP (p indicates phosphorylated serine) was coupled to keyhole limpet hemocyanin for use as antigen. 

Phrase: "Phosphopeptide RRSRTEpSITATSP"

Phrase: "(p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "indicates"

Phrase: "phosphorylated serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "coupled to keyhole limpet hemocyanin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   862   C0064332:keyhole-limpet haemocyanin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018999:Haemocyanin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0324030:Limpet [Eukaryote]
   760   C1948027:Coupled [Functional Concept]
   760   C2350000:Limpet [Food]
   726 E C0010222:couple [Family Group]

Phrase: "for use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "as antigen."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigen [Immunologic Factor]
   900 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.72: Rabbit antisera were passed first over immobilized RRSRTESITATSP to remove antibodies that recognized the unphosphorylated sequence. 

Phrase: "Rabbit antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "passed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828386:Passed [Finding]

Phrase: "first over immobilized RRSRTESITATSP to"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "recognized"

Phrase: "the unphosphorylated sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.73: Phosphospecific antibodies were affinity-isolated by passing the precleared sera over immobilized RRSRTEpSITATSP followed by a low pH elution (62). 

Phrase: "Phosphospecific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "affinity-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by passing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006539:BY [Geographic Area]
   827   C2828386:Pass [Finding]

Phrase: "the precleared sera over immobilized RRSRTEpSITATSP"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0229671:Sera [Body Substance]
   753   C1151254:SerA [Molecular Function]
   719 E C1546774:Serum [Intellectual Product]
   719 E C1550100:Serum [Body Substance]

Phrase: "followed by a low pH elution"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0332283:Followed by [Temporal Concept]
           followed
   790   C0728725:Low pH [Finding]
   753   C0020283:[pH] [Quantitative Concept]
   753   C0205251:low [Qualitative Concept]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]
   753   C1299352:Low [Qualitative Concept]
   753   C1441565:Elution [Laboratory Procedure]
   753   C1550472:low [Idea or Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.74: Phosphospecific IRS-1 Ser(P)-307 antibody was either purchased from Cell Signaling or kindly provided by Morris White (Joslin Diabetes Center), anti-insulin receptor and IRS-1 antibodies were described previously (42, 43), anti-phosphotyrosine (4G10) antibody was from Upstate Biotechnology Inc., and horseradish peroxidase-conjugated goat anti-rabbit or goat anti-mouse IgG (Amersham Biosciences) was used for Western blotting. 

Phrase: "Phosphospecific IRS-1 Ser(P)-307 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   893   C1257988:Phosphospecific Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "either"

Phrase: "purchased from Cell Signaling"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0037083:Cell Signaling [Cell Function]
           Signaling
   770   C0007634:Cell [Cell]
   770   C0869011:purchased [Activity]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C3537152:signaling [Biologic Function]

Phrase: "or"

Phrase: "kindly"

Phrase: "provided by Morris White"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007457:White [Population Group]
   770   C0043157:White [Population Group]
   770   C0220938:White [Qualitative Concept]
   770   C1999230:Provided [Activity]

Phrase: "(Joslin Diabetes Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-insulin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "IRS-1 antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(42,"

Phrase: "43"

Phrase: ")"

Phrase: ","

Phrase: "anti-phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(4G10"

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was from Upstate Biotechnology Inc.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]

Phrase: "and"

Phrase: "horseradish peroxidase-conjugated goat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0018019:goat [Mammal]
   812   C1265549:goat [Mammal]
   812   C1510458:Goat [Mammal]

Phrase: "anti-rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]

Phrase: "or"

Phrase: "goat anti-mouse IgG (Amersham Biosciences"

Phrase: ")"

Phrase: "was"

Phrase: "used for Western blotting."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1273517:used [Finding]
   770   C1705493:Western [Spatial Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.75: Proteins were immunoprecipitated from cell or tissue lysates for 2 h at 4 C using immobilized anti-IRS-1 and anti-IR antibodies (protein A-Sepharose beads, Amersham Biosciences). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoprecipitated from cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0007634:Cell [Cell]
   790   C1269647:Cell [Cell]
   790   C1704653:Cell [Medical Device]
   790   C1948049:Cell [Spatial Concept]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "tissue lysates for 2 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1881488:Lysate [Physical Object]

Phrase: "at 4 C"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immobilized anti-IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "anti-IR antibodies"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   977   C0443876:Anti-insulin receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Insulin receptor antibody
   923   C0021644:anti insulin antibodies [Immunologic Factor]
           Insulin Antibodies
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(protein A-Sepharose beads,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]
   756   C0075172:protein A-sepharose [Carbohydrate]

Phrase: "Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.76: After extensive washing, proteins were eluted with Laemmli sample buffer, separated by SDS-PAGE, and transferred to nitrocellulose membranes (Bio-Rad). 

Phrase: "After extensive washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Washing [Activity]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with Laemmli sample buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0258024:Laemmli buffer [Organic Chemical]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "separated by SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Bio-Rad"

Phrase: ")."
Processing 00000000.tx.77: Blots were probed with the indicated antibodies, and proteins were detected by chemiluminescence (Pierce). 

Phrase: "Blots"

Phrase: "were"

Phrase: "probed with the indicated antibodies,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected by chemiluminescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   790   C0442726:Detected [Finding]
   790   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.78: For transfection experiments, FLAG-tagged IRS-1 was immunoprecipitated using anti-FLAG antibody (Stratagene).  

Phrase: "For transfection experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "FLAG-tagged IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C1413560:TAG-1 [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-FLAG antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Stratagene"

Phrase: ")."
Processing 00000000.tx.79: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Identification of Ser-302 Is an Inhibitory Phosphorylation Site in IRS-1Gustafson (63) first used a conventional LexA yeast two-hybrid (Y2H) assay to identify direct interactions between IR and IRS-1. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Identification of Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "Is"

Phrase: "an Inhibitory Phosphorylation Site in IRS-1Gustafson"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1519063:Phosphorylation Site [Amino Acid Sequence]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0205145:Site [Spatial Concept]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "(63"

Phrase: ")"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a conventional LexA yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "two-hybrid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599647:Two Hybrid [Molecular Biology Research Technique]
   861   C0020205:Hybrid [Organism]
   861   C0205448:Two [Quantitative Concept]

Phrase: "(Y2H) assay to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "identify"

Phrase: "direct interactions between IR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1373083:Insulin Receptor Interactions [Molecular Function]
   781   C1372999:Receptor Interactions [Molecular Function]
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "IRS-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.80: We modified this assay to develop a method to identify proteins that block IR-IRS interactions and potential molecular mechanisms for disruption. 

Phrase: "We"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "this assay to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "develop"

Phrase: "a method to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "identify"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "IR-IRS interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   906   C1373083:Insulin Receptor Interactions [Molecular Function]
   858   C1372999:Receptor Interactions [Molecular Function]
   779   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "potential molecular mechanisms for disruption."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.81: In our "disruptive yeast tri-hybrid" (Y3H) assay, bait and prey are expressed as usual using pLexA and pB42AD plasmids, respectively, but we removed p8op-lacZ and replaced it with a distinct third plasmid (termed pDis or pDisruptor) for the expression of proteins that might modulate protein-protein interactions. 

Phrase: "In our ""disruptive yeast tri-hybrid"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0020205:Hybrid [Organism]
   804   C0814229:TRI [Intellectual Product]

Phrase: "(Y3H"

Phrase: ")"

Phrase: "assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "bait"

Phrase: "and"

Phrase: "prey"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540252:PreY [Gene or Genome]

Phrase: "are"

Phrase: "expressed as usual"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3538928:Usual [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pLexA"

Phrase: "and"

Phrase: "pB42AD plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "respectively,"

Phrase: "but"

Phrase: "we"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "p8op-lacZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022959:LacZ [Gene or Genome]

Phrase: "and"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "it with a distinct third plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205437:Third [Quantitative Concept]

Phrase: "(termed pDis"

Phrase: "or"

Phrase: "pDisruptor"

Phrase: ")"

Phrase: "for the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "might"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "protein-protein interactions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.82: IR and IRS-1 bind one another under Y2H conditions and in the disruptive Y3H assay with an empty disruptive (pDis) plasmid (Fig. 1B). 

Phrase: "IR"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "another under Y2H conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and in the disruptive Y3H assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1515981:And [Idea or Concept]

Phrase: "with an empty disruptive"

Phrase: "(pDis"

Phrase: ")"

Phrase: "plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.83: When JNK1 was expressed in the third plasmid the interaction was disrupted (Fig. 1, A and B) (18). 

Phrase: "When"

Phrase: "JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "was"

Phrase: "expressed in the third plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205437:Third [Quantitative Concept]

Phrase: "the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B) (18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.84: Kinase activity was required for disruption, as kinase deficient (KD) JNK1 having T183A/Y185F substitutions within its kinase activation loop did not disrupt IR/IRS-1 binding. 

Phrase: "Kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "required for disruption,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332453:Disruption [Functional Concept]
   790   C1514873:Required [Functional Concept]

Phrase: "as"

Phrase: "kinase deficient (KD) JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1367731:JNK1 [Gene or Genome]
   827   C1705632:JNK1 [Gene or Genome]

Phrase: "having"

Phrase: "T183A/Y185F substitutions within its kinase activation loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1555721:Substitution [Idea or Concept]
   711   C1706204:Substitution [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "IR/IRS-1 binding."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   897   C1623517:insulin binding [Molecular Function]
   894   C1149501:insulin receptor binding [Molecular Function]
   858   C0597358:Receptor Binding [Molecular Function]
   853   C1623518:IRS binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
Processing 00000000.tx.85: Binding of IR to IRS-1 was retained after removal of the IRS-1 PH domain (1101242) or the PH domain plus interdomain (1501242), and phosphorylation by JNK1 disrupted these interactions (Fig. 1A). 

Phrase: "Binding of IR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   865   C1149501:insulin receptor binding [Molecular Function]
   819   C1623517:insulin binding [Molecular Function]
   802   C0597358:Receptor Binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "retained after removal of the IRS-1 PH domain"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1518792:PH Domain [Amino Acid Sequence]
   742   C0015252:Removal [Therapeutic or Preventive Procedure]
   742   C0020283:[pH] [Quantitative Concept]
   742   C0333118:Retained [Functional Concept]
   742   C0450407:ph+ [Finding]
   742   C0450408:ph++ [Finding]
   742   C0450409:ph+++ [Finding]
   742   C0728940:Removal [Therapeutic or Preventive Procedure]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "(1101242"

Phrase: ")"

Phrase: "or"

Phrase: "the PH domain plus interdomain"

Phrase: "(1501242"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "phosphorylation by JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "these interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.86: These data are consistent with the suggestion that phosphorylation of Ser-307, a site C-terminal to the PTB domain, is involved in JNK1-mediated disruption (17, 18). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the suggestion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that phosphorylation of Ser-307,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "a site C-terminal to the PTB domain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1707271:C-Terminal [Amino Acid Sequence]
   744   C0205088:Terminal [Temporal Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]

Phrase: "is"

Phrase: "involved in JNK1-mediated disruption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0332453:Disruption [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1367731:JNK1 [Gene or Genome]
   760   C1705632:JNK1 [Gene or Genome]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.87: Also consistent with these previous findings, a region in the C terminus of IRS-1 is required for JNK1-mediated disruption. 

Phrase: "Also consistent with these previous findings,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent
   731   C0332529:Consistency finding [Qualitative Concept]

Phrase: "a region in the C terminus of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]

Phrase: "is"

Phrase: "required for JNK1-mediated disruption."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0332453:Disruption [Functional Concept]
   760   C1367731:JNK1 [Gene or Genome]
   760   C1514873:Required [Functional Concept]
   760   C1705632:JNK1 [Gene or Genome]
Processing 00000000.tx.88: In the disruptive Y3H assay shorter segments of IRS-1 such as one encompassing its PH and PTB domains (1330) or its PTB domain alone (140260) bound IR, but binding was not disrupted by JNK1 in either of these cases (Fig. 1A). 

Phrase: "In the disruptive Y3H"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "shorter segments of IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0441635:Segment [Spatial Concept]

Phrase: "such as one encompassing"

Phrase: "its PH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "PTB domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1518827:PTB Domain [Amino Acid Sequence]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(1330"

Phrase: ")"

Phrase: "or"

Phrase: "its PTB domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1518827:PTB Domain [Amino Acid Sequence]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(140260"

Phrase: ")"

Phrase: "bound IR,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   867 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "disrupted by JNK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332454:Disrupted [Qualitative Concept]
   790   C1367731:JNK1 [Gene or Genome]
   790   C1705632:JNK1 [Gene or Genome]

Phrase: "in either"

Phrase: "of these cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.89: Aguirre and White (17, 18) showed that JNK1 disruption requires binding at a C-terminal JNK binding domain (JBD) (residues 857863) in addition to phosphorylation at Ser-307. 

Phrase: "Aguirre"

Phrase: "and"

Phrase: "White"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "(17,"

Phrase: "18"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that JNK1 disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]

Phrase: "requires"

Phrase: "binding at a C-terminal JNK binding domain (JBD)"

Phrase: "(residues 857863"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "in addition to phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Ser-307."
Processing 00000000.tx.90: View larger version (55K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(55K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557702:Window [Manufactured Object]
   827   C1272706:Window [Temporal Concept]
   827   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.91: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.92: Disruptive Y3H identifies Ser-302 as a new inhibitory phosphorylation site for blocking IR/IRS-1 interactions. 

Phrase: "Disruptive Y3H"

Phrase: "identifies"

Phrase: "Ser-302 as a new inhibitory phosphorylation site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1519063:Phosphorylation Site [Amino Acid Sequence]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C0205145:Site [Spatial Concept]
   744   C0205314:New [Temporal Concept]
   744   C1158886:Phosphorylation [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]
   744   C3463820:Inhibitory [Activity]

Phrase: "for blocking IR/IRS-1 interactions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   869   C1373083:Insulin Receptor Interactions [Molecular Function]
   841   C1372999:Receptor Interactions [Molecular Function]
   766   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.93: Insulin receptor kinase (9401343) was used as bait, the indicated wild-type or mutated or truncated versions of IRS-1 were used as prey, and either WT or kinase-deficient (KD) JNK1 was expressed from the pDis disruptive plasmid. 

Phrase: "Insulin receptor kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "(9401343"

Phrase: ")"

Phrase: "was"

Phrase: "used as bait,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "the indicated wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "or"

Phrase: "truncated versions of IRS-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: "were"

Phrase: "used as prey,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   790   C3540252:PreY [Gene or Genome]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "either WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "or"

Phrase: "kinase-deficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011155:Deficient [Functional Concept]
   861   C1636779:% deficient [Quantitative Concept]

Phrase: "(KD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011155:Deficient [Functional Concept]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1636779:% deficient [Quantitative Concept]

Phrase: ")"

Phrase: "JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "was"

Phrase: "expressed from the pDis disruptive plasmid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.94: A, interactions of the insulin receptor and IRS-1 were determined by growth of transformants on medium lacking leucine. 

Phrase: "A,"

Phrase: "interactions of the insulin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1373083:Insulin Receptor Interactions [Molecular Function]
   797   C1372999:Receptor Interactions [Molecular Function]
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "determined by growth of transformants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "on medium lacking leucine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.95: Plus signs indicate an interaction (growth), whereas minus signs denote disruption (no growth). 

Phrase: "Plus signs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0220912:signs [Functional Concept]
  1000   C0220913:signs [Manufactured Object]
  1000   C0311392:SIGNS [Finding]
   966 E C1547188:Sign [Idea or Concept]

Phrase: "indicate"

Phrase: "an interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "(growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "minus signs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "denote"

Phrase: "disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332453:Disruption [Functional Concept]

Phrase: "("

Phrase: "no growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: ")."
Processing 00000000.tx.96: B, images are of yeast growing on selective media. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "are of yeast"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   790   C1551058:Are [Quantitative Concept]

Phrase: "growing on selective media."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.97: Insulin receptor kinase is bait, the indicated IRS-1 proteins are prey, and either no kinase () or WT or kinase dead JNK1 were expressed from pDis.  

Phrase: "Insulin receptor kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "is"

Phrase: "bait,"

Phrase: "the indicated IRS-1 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "prey,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540252:PreY [Gene or Genome]

Phrase: "and"

Phrase: "either"

Phrase: "no kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "or"

Phrase: "kinase dead JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1367731:JNK1 [Gene or Genome]
   827   C1705632:JNK1 [Gene or Genome]

Phrase: "were"

Phrase: "expressed from pDis."
Processing 00000000.tx.98: We next substituted Ser-307 with glutamic acid instead of alanine, as glutamate has been found to mimic phosphoserine in other proteins. 

Phrase: "We next substituted Ser-307 with glutamic acid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0523665:Glutamic Acid [Laboratory Procedure]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0205117:next [Spatial Concept]
   744   C0332282:Next [Temporal Concept]
   744   C1883708:Next [Temporal Concept]

Phrase: "instead of alanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mimic"

Phrase: "phosphoserine in other proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031721:Phosphoserine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.99: Unlike S307A-substituted IRS-1, which was resistant to JNK1-mediated disruption, S307E-substituted IRS-1 behaved like the wild-type protein. 

Phrase: "Unlike S307A-substituted IRS-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "was"

Phrase: "resistant to JNK1-mediated disruption,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "S307E-substituted IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "behaved like the wild-type protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.100: IRS-1 S307E interacted with IR in the absence of disruptive protein, and binding was blocked by JNK1 phosphorylation. 

Phrase: "IRS-1 S307E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacted with IR"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   799 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of disruptive protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "blocked by JNK1 phosphorylation."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0028778:Blocked [Pathologic Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0332206:Blocked [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1367731:JNK1 [Gene or Genome]
   770   C1705632:JNK1 [Gene or Genome]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.101: Because glutamate cannot be phosphorylated yet acts as though it were, these findings demonstrated that glutamate is indeed a phosphorylation mimic in this system. 

Phrase: "Because"

Phrase: "glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cannot"

Phrase: "be"

Phrase: "phosphorylated"

Phrase: "yet"

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "as though"

Phrase: "it"

Phrase: "were"

Phrase: ","

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrated"

Phrase: "that glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "indeed"

Phrase: "a"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "mimic in this system."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449913:System [Functional Concept]
   770   C1553451:System [Manufactured Object]
   770   C1704459:System [Medical Device]
Processing 00000000.tx.102: Much more importantly, however, these findings indicated that although Ser-307 phosphorylation is necessary for disruption, it is not sufficient. 

Phrase: "Much more importantly,"

Phrase: "however,"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "although"

Phrase: "Ser-307 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "necessary for disruption,"

Phrase: "it"

Phrase: "is"

Phrase: "not sufficient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]
Processing 00000000.tx.103: If phosphorylation at Ser-307 were sufficient, then binding would have been disrupted in the absence of kinase or the presence of catalytically inactive kinase, which clearly wasn't the case (Fig. 1, A and B). 

Phrase: "If"

Phrase: "phosphorylation at Ser-307"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "were"

Phrase: "sufficient, then binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "would"

Phrase: "have"

Phrase: "been"

Phrase: "disrupted in the absence of kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0332197:absence [Quantitative Concept]
   753   C0332454:Disrupted [Qualitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "the presence of catalytically inactive kinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "which clearly"

Phrase: "wasn't"

Phrase: "the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.104: These findings prompted a search for additional phosphorylation site(s) potentially involved in JNK1 disruption. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "a search for additional phosphorylation site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552603:search [Intellectual Product]
   753   C1706202:Search [Activity]

Phrase: "("

Phrase: "s)"

Phrase: "potentially"

Phrase: "involved in JNK1 disruption."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332453:Disruption [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1367731:JNK1 [Gene or Genome]
   770   C1705632:JNK1 [Gene or Genome]
Processing 00000000.tx.105: We looked first at the interdomain region between the PH and PTB domains because it contains a discrete number of serines. 

Phrase: "We"

Phrase: "looked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0233426:look [Organism Attribute]

Phrase: "first at the interdomain region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]

Phrase: "between the PH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "PTB domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1518827:PTB Domain [Amino Acid Sequence]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "because"

Phrase: "it"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a discrete number of serines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.106: We reasoned that phosphorylation(s) within the Ser-135, Ser-137, Ser-139, and Ser-140 cluster might inhibit IR/IRS-1 interactions by interacting with the PH or PTB domain. 

Phrase: "We"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "("

Phrase: "s) within the Ser-135,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2603362:S' [Clinical Attribute]

Phrase: "Ser-137,"

Phrase: "Ser-139,"

Phrase: "and"

Phrase: "Ser-140 cluster"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555715:Cluster [Idea or Concept]
   827   C1704332:Cluster [Quantitative Concept]

Phrase: "might"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IR/IRS-1 interactions by interacting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C1373083:Insulin Receptor Interactions [Molecular Function]
   757   C1372999:Receptor Interactions [Molecular Function]
   714   C1704675:Interaction [Functional Concept]

Phrase: "with the PH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "or"

Phrase: "PTB domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1518827:PTB Domain [Amino Acid Sequence]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.107: Each serine was substituted with alanine, independently and together. 

Phrase: "Each serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "substituted with alanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "independently"

Phrase: "and"

Phrase: "together."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]
Processing 00000000.tx.108: The substituted proteins behaved exactly like wild-type IRS-1 under Y3H conditions (Fig. 1A), clearly indicating that these sites are not involved in JNK1-mediated inhibition. 

Phrase: "The substituted proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "behaved"

Phrase: "exactly like wild-type IRS-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0441729:Type 1 [Classification]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "under Y3H conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "clearly"

Phrase: "indicating"

Phrase: "that"

Phrase: "these sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in JNK1-mediated inhibition."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1314939:Involved [Functional Concept]
   760   C1367731:JNK1 [Gene or Genome]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C1705632:JNK1 [Gene or Genome]
   760   C3463820:Inhibition [Activity]
Processing 00000000.tx.109: We next hypothesized that the site(s) neighboring Ser-307 might be phosphorylated, and since Ser-302 is closest, this was mutated. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "s)"

Phrase: "neighboring Ser-307"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205107:neighboring [Spatial Concept]

Phrase: "might"

Phrase: "be"

Phrase: "phosphorylated"

Phrase: ","

Phrase: "and"

Phrase: "since Ser-302"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711239:Since [Temporal Concept]

Phrase: "is"

Phrase: "closest,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522666:Closest [Spatial Concept]
   966 E C0587267:Close [Functional Concept]

Phrase: "this"

Phrase: "was"

Phrase: "mutated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.110: The S302A substitution rendered IRS-1 resistant to JNK-1 inhibition (Fig. 1, A and B), exactly as had been seen previously with Ser-307. 

Phrase: "The S302A substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555721:Substitution [Idea or Concept]
   861   C1706204:Substitution [Activity]

Phrase: "rendered"

Phrase: "IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resistant to JNK-1 inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "exactly"

Phrase: "as"

Phrase: "had"

Phrase: "been"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "previously with Ser-307."
Processing 00000000.tx.111: Perhaps not surprisingly, given that both of the singly substituted S302A or S307A proteins were resistant to JNK1-mediated inhibition, doubly substituted IRS-1 S302/307A was similarly resistant. 

Phrase: "Perhaps"

Phrase: "not surprisingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "both of the singly substituted S302A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0238767:Both [Spatial Concept]
   753   C1706086:Both [Qualitative Concept]

Phrase: "or"

Phrase: "S307A proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "resistant to JNK1-mediated inhibition,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "doubly substituted IRS-1 S302/307A"

Phrase: "was"

Phrase: "similarly resistant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332325:Resistant [Functional Concept]
   861   C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.112: We proceeded to ask whether glutamate mimicked phosphoserine in this case as well. 

Phrase: "We"

Phrase: "proceeded"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ask"

Phrase: "whether"

Phrase: "glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mimicked"

Phrase: "phosphoserine in this case"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031721:Phosphoserine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]

Phrase: "as well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]
Processing 00000000.tx.113: Analogous to the situation for IRS-1 S307E, the S302E-substituted protein behaved like wild-type IRS-1; 

Phrase: "Analogous to the situation"

Phrase: "for IRS-1 S307E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the S302E-substituted protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "behaved like wild-type IRS-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0441729:Type 1 [Classification]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.114: it interacted with IR in the absence of disruptive protein, and binding was blocked by JNK1 phosphorylation (Fig. 1, A and B). 

Phrase: "it"

Phrase: "interacted with IR"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   799 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of disruptive protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "blocked by JNK1 phosphorylation"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0028778:Blocked [Pathologic Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0332206:Blocked [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1367731:JNK1 [Gene or Genome]
   770   C1705632:JNK1 [Gene or Genome]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.115: These findings indicated that phosphorylation at both Ser-302 and Ser-307 is necessary for disruption by JNK1 but that phosphorylation at either site alone is insufficient. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that phosphorylation at both Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser-307"

Phrase: "is"

Phrase: "necessary for disruption"

Phrase: "by JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "but"

Phrase: "that phosphorylation at either site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1519063:Phosphorylation Site [Amino Acid Sequence]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "insufficient."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205412:Insufficient [Qualitative Concept]
  1000   C0231180:Insufficient [Qualitative Concept]
   928 E C0231179:Insufficiency [Functional Concept]
Processing 00000000.tx.116: Doubly substituted IRS-1 S302E/S307E tested whether the two sites together are sufficient for disruption. 

Phrase: "Doubly substituted IRS-1 S302E/S307E"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "the two sites together"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "sufficient for disruption."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205410:Sufficient [Qualitative Concept]
Processing 00000000.tx.117: If phosphorylation at Ser-302 and Ser-307 were sufficient, then binding would have been disrupted in the absence of kinase or the presence of catalytically inactive kinase. 

Phrase: "If"

Phrase: "phosphorylation at Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser-307"

Phrase: "were"

Phrase: "sufficient, then binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "would"

Phrase: "have"

Phrase: "been"

Phrase: "disrupted in the absence of kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0332197:absence [Quantitative Concept]
   753   C0332454:Disrupted [Qualitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "the presence of catalytically inactive kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.118: This was not the case (Fig. 1, A and B), suggesting that in addition to Ser-302 and Ser-307, JNK1-mediated disruption of IR/IRS-1 binding requires phosphorylation at additional site(s). 

Phrase: "This"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that in addition to Ser-302"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "and"

Phrase: "Ser-307,"

Phrase: "JNK1-mediated disruption of IR/IRS-1 binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332453:Disruption [Functional Concept]

Phrase: "requires"

Phrase: "phosphorylation at additional site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1519063:Phosphorylation Site [Amino Acid Sequence]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.119: We concluded that disruption by JNK1 requires a cluster of three or more phosphorylated serine residues. 

Phrase: "We"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that disruption by JNK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "requires"

Phrase: "a cluster of three"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1555715:Cluster [Idea or Concept]
   770   C1704332:Cluster [Quantitative Concept]

Phrase: "or"

Phrase: "more phosphorylated serine residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.120: Preventing phosphorylation at one or both sites (S302A, S307A, or S302/307A) renders IRS-1 resistant to JNK1-mediated inhibition. 

Phrase: "Preventing phosphorylation at one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "both sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "(S302A,"

Phrase: "S307A,"

Phrase: "or"

Phrase: "S302/307A"

Phrase: ")"

Phrase: "renders"

Phrase: "IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resistant to JNK1-mediated inhibition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.121: Selectivity of the Ser-302 or Ser-307 Sites for JNK1-mediated DisruptionWe have subcloned several additional kinases into pDis to ask (a) whether they disrupt IR/IRS-1 binding and (b), if they disrupt, whether Ser-302 or Ser-307 is involved. 

Phrase: "Selectivity of the Ser-302"

Phrase: "or"

Phrase: "Ser-307 Sites for JNK1-mediated DisruptionWe"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "have"

Phrase: "subcloned several additional kinases into pDis to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ask (a)"

Phrase: "whether"

Phrase: "they"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "IR/IRS-1 binding and (b)"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   876   C1623517:insulin binding [Molecular Function]
   869   C1149501:insulin receptor binding [Molecular Function]
   841   C0597358:Receptor Binding [Molecular Function]
   839   C1623518:IRS binding [Molecular Function]
   827   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   827   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   793 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ","

Phrase: "if"

Phrase: "they"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: ","

Phrase: "whether"

Phrase: "Ser-302"

Phrase: "or"

Phrase: "Ser-307"

Phrase: "is"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.122: We examined the effects of GSK3, IKK, IKK, p38 MAPK, PKA, PKC, PKCI, PKC2, PKC, and PKC, as each of these kinases has been proposed to be a potential mediator of insulin resistance (15, 17, 18, 20, 2830, 3442, 59). 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of GSK3,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "IKK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "IKK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "p38 MAPK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PKA,"

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "PKCI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418921:PKCI [Gene or Genome]
  1000   C3539729:PKCI [Gene or Genome]

Phrase: "PKC2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418928:PKC2 [Gene or Genome]

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "and"

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "as"

Phrase: "each of these kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1457900:Each [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a potential mediator of insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(15,"

Phrase: "17,"

Phrase: "18,"

Phrase: "20,"

Phrase: "2830,"

Phrase: "3442,"

Phrase: "59"

Phrase: ")."
Processing 00000000.tx.123: IKK and IKK do not block IR/IRS-1 binding in the disruptive Y3H assay. 

Phrase: "IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "and"

Phrase: "IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "IR/IRS-1 binding in the disruptive Y3H assay."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   761   C1149501:insulin receptor binding [Molecular Function]
   757   C1623517:insulin binding [Molecular Function]
   757   C1623518:IRS binding [Molecular Function]
   741   C0597358:Receptor Binding [Molecular Function]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
Processing 00000000.tx.124: Negative findings with the IKKs have been consistent in our hands under a variety of cellular and biochemical conditions (data not shown) (15), despite a claim to the contrary (59). 

Phrase: "Negative findings with the IKKs"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1513916:Negative Finding [Finding]
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "consistent in our hands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332290:Consistent [Idea or Concept]

Phrase: "under a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883525:Variety [Conceptual Entity]
   861   C2346866:Variety [Conceptual Entity]

Phrase: "of cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "biochemical conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "despite a claim"

Phrase: "to the contrary"

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.125: By contrast, GSK3, p38 MAPK, PKA, PKC, PKCI, PKC2, PKC, and PKC all disrupt IR/IRS-1 binding like JNK1 (Table I). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "p38 MAPK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PKA,"

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "PKCI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418921:PKCI [Gene or Genome]
  1000   C3539729:PKCI [Gene or Genome]

Phrase: "PKC2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418928:PKC2 [Gene or Genome]

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "and"

Phrase: "PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "all"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "IR/IRS-1 binding like JNK1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   788   C1149501:insulin receptor binding [Molecular Function]
   774   C1623517:insulin binding [Molecular Function]
   774   C1623518:IRS binding [Molecular Function]
   757   C0597358:Receptor Binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.126: The substituted forms of IRS-1, S302A, S307A, or S302/307A, were used to determine whether these sites were involved in disruption by each of the kinases. 

Phrase: "The substituted forms of IRS-1,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "S302A,"

Phrase: "S307A,"

Phrase: "or"

Phrase: "S302/307A,"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "these sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "involved in disruption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332453:Disruption [Functional Concept]
   790   C1314939:Involved [Functional Concept]

Phrase: "by each"

Phrase: "of the kinases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.127: Each substitution was tested with every kinase, and each failed to rescue the interaction, with the exception of JNK1 as the kinase (Table I). 

Phrase: "Each substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1555721:Substitution [Idea or Concept]
  1000   C1706204:Substitution [Activity]

Phrase: "was"

Phrase: "tested with every kinase,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0392366:tested [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "each"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "rescue"

Phrase: "the interaction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "as the kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.128: These findings demonstrate that whereas Ser-302 and Ser-307 are involved in disruption by JNK1, neither site, alone or in combination, is involved in disruption by GSK3, p38 MAPK, PKA, PKC, PKCI, PKC2, PKC, and PKC. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "whereas"

Phrase: "Ser-302"

Phrase: "and"

Phrase: "Ser-307"

Phrase: "are"

Phrase: "involved in disruption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332453:Disruption [Functional Concept]
   790   C1314939:Involved [Functional Concept]

Phrase: "by JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "neither site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "is"

Phrase: "involved in disruption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332453:Disruption [Functional Concept]
   790   C1314939:Involved [Functional Concept]

Phrase: "by GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "p38 MAPK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PKA,"

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "PKCI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418921:PKCI [Gene or Genome]
  1000   C3539729:PKCI [Gene or Genome]

Phrase: "PKC2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418928:PKC2 [Gene or Genome]

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "and"

Phrase: "PKC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]
Processing 00000000.tx.129: View this table: [in this window] [in a new window]  TABLE I Disruptive Y3H assays with different kinases IR/IRS-1 interactions are denoted by plus signs, and disrupted interactions are noted by minus signs. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557702:Window [Manufactured Object]
   827   C1272706:Window [Temporal Concept]
   827   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I Disruptive Y3H assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]

Phrase: "with different kinases IR/IRS-1 interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   851   C1373083:Insulin Receptor Interactions [Molecular Function]
   829   C1372999:Receptor Interactions [Molecular Function]
   762   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "denoted by plus signs,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0220912:signs [Functional Concept]
   770   C0220913:signs [Manufactured Object]
   770   C0311392:SIGNS [Finding]
   770   C0332287:Plus [Qualitative Concept]
   737 E C1547188:Sign [Idea or Concept]

Phrase: "and"

Phrase: "disrupted interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "noted by minus signs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0220912:signs [Functional Concept]
   770   C0220913:signs [Manufactured Object]
   770   C0311392:SIGNS [Finding]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]
   737 E C1547188:Sign [Idea or Concept]
Processing 00000000.tx.130: ND, not determined.  

Phrase: "ND,"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "determined."
Processing 00000000.tx.131: Ser-302 Phosphorylation in Cultured CellsPhosphospecific antibodies were prepared to determine whether Ser-302 is phosphorylated in cultured cells or in vivo. 

Phrase: "Ser-302 Phosphorylation in Cultured CellsPhosphospecific antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "Ser-302"

Phrase: "is"

Phrase: "phosphorylated in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "or"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.132: The antibodies were prepared against a phosphopeptide sequence corresponding to the region of IRS-1 surrounding Ser-302 (RRSRTEpSITATSP) that is identical in rats (Ser-302), mice (Ser-302), and humans (Ser-307) (4547). 

Phrase: "The antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "prepared against a phosphopeptide sequence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0031684:phosphopeptide [Amino Acid, Peptide, or Protein]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   726   C1521827:Prepare [Functional Concept]

Phrase: "corresponding to the region of IRS-1 surrounding Ser-302"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0017446:Region [Geographic Area]
   739   C0205147:Region [Spatial Concept]
   739   C1282914:Surrounding [Spatial Concept]

Phrase: "(RRSRTEpSITATSP"

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "identical in rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "(Ser-302"

Phrase: ")"

Phrase: ","

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(Ser-302"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "(Ser-307"

Phrase: ")"

Phrase: "(4547"

Phrase: ")."
Processing 00000000.tx.133: The affinity-purified antibodies were used for Western blotting experiments. 

Phrase: "The affinity-purified antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "used for Western blotting experiments."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   806   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   790 E C0949466:Western Blot [Laboratory Procedure]
   760   C0681814:Experiments [Research Activity]
   760   C1273517:used [Finding]
   760   C1705493:Western [Spatial Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.134: Chinese hamster ovary cells transfected with WT or mutated IRS-1 constructs were stimulated with insulin and anisomycin to test antibody efficacy and specificity. 

Phrase: "Chinese hamster ovary cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2700323:WT [Fish]

Phrase: "or"

Phrase: "mutated IRS-1 constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "anisomycin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "antibody efficacy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280519:Efficacy [Qualitative Concept]
   861   C1707887:EFFICACY [Research Activity]

Phrase: "and"

Phrase: "specificity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.135: The FLAG-tagged IRS-1 proteins were immunoprecipitated with anti-FLAG antibodies and blotted with our new Ser(P)-302 antibodies or antibodies directed against p307, Tyr(P), or IRS-1 (Fig. 2). 

Phrase: "The FLAG-tagged IRS-1 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoprecipitated with anti-FLAG antibodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1708067:Flag [Functional Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "blotted with our new Ser(P)-302 antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0205314:New [Temporal Concept]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against p307,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1421250:TYR [Gene or Genome]

Phrase: "(P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.136: The Ser(P)-302 antibodies recognized WT IRS-1, indicating that IRS-1 is phosphorylated at Ser-302 in insulin-stimulated cells. 

Phrase: "The Ser(P)-302 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognized"

Phrase: "WT IRS-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C2362085:WT-1 [Gene or Genome]
   901   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "indicating"

Phrase: "that IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "phosphorylated at Ser-302"

Phrase: "in insulin-stimulated cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.137: The WT protein was recognized as well by anti-Ser(P)-307, anti-Tyr(P), and anti-IRS-1 antibodies. 

Phrase: "The WT protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "recognized as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205170:Well [Qualitative Concept]
   790   C3146287:Well [Manufactured Object]

Phrase: "by anti-Ser(P)-307,"

Phrase: "anti-Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "(P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti-IRS-1 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.138: Expression of mutated forms of IRS-1 tested specificity. 

Phrase: "Expression of mutated forms of IRS-1 tested specificity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   720   C1554102:Formal Expression [Idea or Concept]
Processing 00000000.tx.139: The anti-Ser(P)-302 antibodies did not recognize IRS-1 S302A, but anti-Ser(P)-307, anti-Tyr(P), and anti-IRS-1 antibodies did recognize IRS-1 S302A. 

Phrase: "The anti-Ser(P)-302 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   897   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   881 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recognize"

Phrase: "IRS-1 S302A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "anti-Ser(P)-307,"

Phrase: "anti-Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "(P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti-IRS-1 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did"

Phrase: "recognize"

Phrase: "IRS-1 S302A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.140: In contrast, IRS-1 S307A was recognized by anti-Ser(P)-302(IRS-1) but not anti-Ser(P)-307(IRS-1) antibodies (Fig. 2). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "IRS-1 S307A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "recognized by anti-Ser(P)-302"

Phrase: "(IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "but"

Phrase: "not anti-Ser(P)-307"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1518422:Not [Functional Concept]

Phrase: "(IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.141: These findings verify that the two antibodies are equivalently specific for the sites they were raised against. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that"

Phrase: "the two antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "equivalently specific for the sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0449604:Specific site [Spatial Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "they"

Phrase: "were"

Phrase: "raised against."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0442818:Raised [Quantitative Concept]
Processing 00000000.tx.142: View larger version (38K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557702:Window [Manufactured Object]
   827   C1272706:Window [Temporal Concept]
   827   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.143: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.144: Antibody specificity and insulin/anisomycin-induced phosphorylation. 

Phrase: "Antibody specificity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0003264:Antibody Specificity [Molecular Function]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "insulin/anisomycin-induced phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.145: A, CHO-IR cells expressed FLAG-tagged forms of full-length IRS-1: WT, S307A, S312A, or S307A/S312A. 

Phrase: "A,"

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0085080:CHO Cells [Cell]
   858   C0030281:Insulin Cell [Cell]
   827   C1514760:Receptor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressed"

Phrase: "FLAG-tagged forms of full-length IRS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: ":"

Phrase: "WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "S307A,"

Phrase: "S312A,"

Phrase: "or"

Phrase: "S307A/S312A."
Processing 00000000.tx.146: The cells were treated sequentially with or without anisomycin (20 M, 30 min) and insulin (all cells, 1 nM, 5 min). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "sequentially with"

Phrase: "or without anisomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "(20 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "30 min)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "all cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "1 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "5 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.147: Cells were lysed, and IRS-1 proteins were immunoprecipitated (IP) with FLAG antibody and immunoblotted (IB) with anti-Ser(P)-302 (pS302), anti-Ser(P)-307 (pS307), anti-Tyr(P) (pY), or anti-IRS-1 antibodies. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "IRS-1 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoprecipitated (IP) with FLAG antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1708067:Flag [Functional Concept]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "immunoblotted (IB) with anti-Ser(P)-302"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(pS302"

Phrase: ")"

Phrase: ","

Phrase: "anti-Ser(P)-307"

Phrase: "(pS307"

Phrase: ")"

Phrase: ","

Phrase: "anti-Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "(P) (pY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030428:PY [Geographic Area]
   861   C3538810:PY [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-IRS-1 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.148: B, combined results for three separate experiments (mean  S.E.; *, p < 0.05) were plotted relative to WT IRS-1 (no anisomycin, + insulin).  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "combined results for three separate experiments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C1548228:Combined result [Intellectual Product]
   725   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: ";"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "plotted"

Phrase: "relative to WT IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "("

Phrase: "no anisomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "+ insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.149: Interestingly, under the conditions used in this assay phosphorylation of IRS-1 S307A was reduced at Ser-302. 

Phrase: "Interestingly,"

Phrase: "under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "used in this assay phosphorylation of IRS-1 S307A"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   764   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C1524063:Use of [Functional Concept]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0243073:assay [Qualitative Concept]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1273517:used [Finding]
   742   C1510438:Assay [Laboratory Procedure]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "reduced at Ser-302."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.150: Under more intensive phosphorylation conditions, for example in cells treated simultaneously with insulin and calyculin A, which promote Ser/Thr phosphorylation and inhibit Ser/Thr dephosphorylation, respectively, there were equivalent amounts of phosphorylation at Ser-302 in WT IRS-1 and IRS-1 S307A. 

Phrase: "Under more intensive phosphorylation conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "for example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "simultaneously with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0521115:simultaneously [Temporal Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "calyculin A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   861   C0597861:calyculin [Pharmacologic Substance]

Phrase: "which"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Ser/Thr phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Ser/Thr dephosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1158884:Dephosphorylation [Molecular Function]
   827   C3160734:Dephosphorylation [Molecular Function]

Phrase: "respectively,"

Phrase: "there"

Phrase: "were"

Phrase: "equivalent amounts of phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "at Ser-302"

Phrase: "in WT IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C2362085:WT-1 [Gene or Genome]
   901   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "IRS-1 S307A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.151: These findings suggest that Ser-307 phosphorylation might be required for efficient Ser-302 phosphorylation. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Ser-307 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "might"

Phrase: "be"

Phrase: "required for efficient Ser-302 phosphorylation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0442799:Efficient [Qualitative Concept]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1514873:Required [Functional Concept]
Processing 00000000.tx.152: Ordered phosphorylation or "priming" mechanisms are well established in the kinase field but have not been described previously for IRS-1. 

Phrase: "Ordered phosphorylation or ""priming"" mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0441712:Mechanisms [Functional Concept]
   771 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "well established in the kinase field"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205170:Well [Qualitative Concept]
   753   C0443211:Established [Qualitative Concept]
   753   C1272684:Established [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "but"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously for IRS-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.153: Anisomycin, an activator of stress kinases including JNK1, had little or no effect in stimulating phosphorylation further than insulin at either Ser-302 or Ser-307 (Fig. 2). 

Phrase: "Anisomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "an activator of stress kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   781   C2247123:kinase activator [Molecular Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "had"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no effect in stimulating phosphorylation further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "than insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "at either Ser-302"

Phrase: "or"

Phrase: "Ser-307"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.154: Nevertheless, anisomycin led to a 30% reduction of WT IRS-1 tyrosine phosphorylation. 

Phrase: "Nevertheless,"

Phrase: "anisomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "a"

Phrase: "30% reduction of WT IRS-1 tyrosine phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.155: Anisomycin similarly decreased the tyrosine phosphorylation of singly substituted IRS-1 S302A and IRS-1 S307A and doubly substituted IRS-1 S302/307A by 3050%. 

Phrase: "Anisomycin similarly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the tyrosine phosphorylation of singly substituted IRS-1 S302A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1519726:Tyrosine Phosphorylation [Molecular Function]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "IRS-1 S307A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "doubly substituted IRS-1 S302/307A by 3050%."
Processing 00000000.tx.156: These findings suggested that anisomycin-mediated inhibition involves phosphorylation sites in addition to Ser-302 and Ser-307 and probably kinases other than JNK1, as JNK1-mediated inhibition of IR/IRS-1 binding was reversed by these identical mutations in disruptive Y3H assays (Fig. 1). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that anisomycin-mediated inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "involves"

Phrase: "phosphorylation sites in addition to Ser-302"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0205145:Sites [Spatial Concept]
   748   C1158886:Phosphorylation [Molecular Function]
   745   C1519063:Phosphorylation Site [Amino Acid Sequence]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "Ser-307"

Phrase: "and"

Phrase: "probably kinases other than JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0380051:JNK1 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "JNK1-mediated inhibition of IR/IRS-1 binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   796   C3269586:inhibition of receptor binding [Molecular Function]
   784   C2259198:inhibition of binding [Molecular Function]
   745   C1514761:Receptor Inhibition [Cell Function]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "reversed by these identical mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0026882:Mutations [Genetic Function]
   760   C0205280:Identical [Qualitative Concept]
   726   C1555029:Reverse [Idea or Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in disruptive Y3H assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.157: Calyculin A is an inhibitor of Ser/Thr phosphatases, which increases Ser/Thr phosphorylation in cells through direct mechanisms as well as through the activation of numerous kinases. 

Phrase: "Calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   861   C0597861:calyculin [Pharmacologic Substance]

Phrase: "is"

Phrase: "an inhibitor of Ser/Thr phosphatases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Ser/Thr phosphorylation in cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "through direct mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "as well as through the activation of numerous kinases."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205170:Well [Qualitative Concept]
   742   C0439064:Numerous [Quantitative Concept]
   742   C1879547:Activation [Activity]
   742   C3146287:Well [Manufactured Object]
Processing 00000000.tx.158: Treatment of cells with calyculin A induces a large shift in the electrophoretic mobility of IRS-1, apparently due to the phosphorylation of many Ser/Thr residues (Fig. 3A) (15). 

Phrase: "Treatment of cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   861   C0597861:calyculin [Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a large shift in the electrophoretic mobility of IRS-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0333051:Shift [Functional Concept]
   739   C2347509:Shift [Phenomenon or Process]

Phrase: "apparently due to the phosphorylation of many Ser/Thr residues"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   777   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   760   C0678226:Due to [Functional Concept]
           due
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0750541:apparently [Idea or Concept]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C3146286:Due [Idea or Concept]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.159: Calyculin A stimulated phosphorylation at both Ser-302 and Ser-307, as evidenced by increased intensity of the bands recognized by the sequence-specific anti-Ser(P)-302(IRS-1) and anti-Ser(P)-307(IRS-1) antibodies. 

Phrase: "Calyculin A stimulated phosphorylation at both Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser-307,"

Phrase: "as"

Phrase: "evidenced by increased intensity of the bands"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   757   C0332120:Evidence of [Functional Concept]
           Evidence
   748   C0175723:Bands [Medical Device]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0522510:Intensity [Qualitative Concept]
   714 E C0439645:Band [Spatial Concept]
   714 E C1521913:band [Cell Component]

Phrase: "recognized by the sequence-specific anti-Ser(P)-302"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0205369:Specific [Qualitative Concept]
   742   C1519249:Sequence [Functional Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "(IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "anti-Ser(P)-307"

Phrase: "(IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.160: The S302A and S307A substitutions abrogated recognition by the anti-Ser(P)-302(IRS-1) and anti-Ser(P)-307(IRS-1) antibodies, respectively, although the substitutions either alone or in combination had no appreciable effect on the magnitude of the shift in electrophoretic mobility. 

Phrase: "The S302A"

Phrase: "and"

Phrase: "S307A substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555721:Substitution [Idea or Concept]
   827   C1706204:Substitution [Activity]

Phrase: "abrogated"

Phrase: "recognition by the anti-Ser(P)-302"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0524637:Recognition [Mental Process]

Phrase: "(IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "anti-Ser(P)-307"

Phrase: "(IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively,"

Phrase: "although"

Phrase: "the substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555721:Substitution [Idea or Concept]
   966   C1706204:Substitution [Activity]

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "had"

Phrase: "no appreciable effect on the magnitude of the shift"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "in electrophoretic mobility."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0425245:Mobility [Finding]
   861   C0449580:Mobility [Qualitative Concept]
   789   C0013855:Electrophoreses [Laboratory Procedure]
   789 E C0231435:Mobile [Functional Concept]
   789 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.161: These results demonstrate that although phosphorylation of Ser-302 and Ser-307 is promoted by calyculin A, many additional Ser/Thr sites in IRS-1 are similarly affected. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "although"

Phrase: "phosphorylation of Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser-307"

Phrase: "is"

Phrase: "promoted by calyculin A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   770   C0597861:calyculin [Pharmacologic Substance]
   737   C0033414:Promote [Activity]

Phrase: "many additional Ser/Thr sites in IRS-1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "similarly"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.162: View larger version (38K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557702:Window [Manufactured Object]
   827   C1272706:Window [Temporal Concept]
   827   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.164: Calyculin A-induced phosphorylation. 

Phrase: "Calyculin A-induced phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.165: CHO-IR cells expressing FLAG-tagged forms of full-length IRS-1 (WT, S307A, S312A, or S307A/S312A) were treated with calyculin A (20 nM, 30 min) alone (A) or sequentially with calyculin A (20 nM, 30 min) and insulin (1 nM, 5 min) (B). 

Phrase: "CHO-IR cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0085080:CHO Cells [Cell]
   858   C0030281:Insulin Cell [Cell]
   827   C1514760:Receptor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "FLAG-tagged forms of full-length IRS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "(WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "S307A,"

Phrase: "S312A,"

Phrase: "or"

Phrase: "S307A/S312A"

Phrase: ")"

Phrase: "were"

Phrase: "treated with calyculin A"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0597861:calyculin [Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(20 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "30 min)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(A)"

Phrase: "or"

Phrase: "sequentially with calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   770   C0597861:calyculin [Pharmacologic Substance]

Phrase: "(20 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "30 min)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "5 min) (B"

Phrase: ")."
Processing 00000000.tx.166: Cells were lysed, and IRS-1 proteins were immunoprecipitated (IP) with FLAG antibody and immunoblotted (IB) with anti-Ser(P)-302(IRS-1) (pS302), anti-Ser(P)-307(IRS-1) (pS307), anti-Tyr(P) (pY), or anti-IRS-1 antibodies. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: ","

Phrase: "and"

Phrase: "IRS-1 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: "with FLAG antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: ")"

Phrase: "with anti-Ser(P)-302"

Phrase: "(IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(pS302"

Phrase: ")"

Phrase: ","

Phrase: "anti-Ser(P)-307"

Phrase: "(IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(pS307"

Phrase: ")"

Phrase: ","

Phrase: "anti-Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "(P) (pY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030428:PY [Geographic Area]
   861   C3538810:PY [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-IRS-1 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.167: C, combined results for two separate experiments (mean  S.E.; *, p < 0.05) were plotted relative to WT IRS-1 (no calyculin A).  

Phrase: "C,"

Phrase: "combined results for two separate experiments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C1548228:Combined result [Intellectual Product]
   725   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: ";"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "plotted"

Phrase: "relative to WT IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "("

Phrase: "no calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   861   C0597861:calyculin [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.168: Cells were subsequently treated with insulin to assess the effects of calyculin A on insulin-stimulated IRS-1 Tyr-phosphorylation (Fig. 3B). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "treated with insulin to"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C1292734:TREAT [Functional Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effects of calyculin A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin-stimulated IRS-1 Tyr-phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.169: Not surprisingly, given the large number of Ser/Thr phosphorylations involved, calyculin A effectively abolished Tyr phosphorylation of WT IRS-1. 

Phrase: "Not surprisingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the large number of Ser/Thr phosphorylations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "calyculin A effectively abolished Tyr phosphorylation of WT IRS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.170: Neither S302A nor S307A alone or in combination noticeably rescued insulin-stimulated Tyr phosphorylation. 

Phrase: "Neither S302A"

Phrase: "nor"

Phrase: "S307A"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination noticeably rescued insulin-stimulated Tyr phosphorylation."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0205195:Combination [Qualitative Concept]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1421250:TYR [Gene or Genome]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1947911:Combination [Physical Object]
   742   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.171: The findings demonstrate that calyculin A promotes inhibitory phosphorylations at a Ser/Thr site or sites in addition to IRS-1 Ser-302 and Ser-307. 

Phrase: "The findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   861   C0597861:calyculin [Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "inhibitory phosphorylations at a Ser/Thr site"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   793   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   789   C1515418:Threonine Phosphorylation Site [Amino Acid Sequence]
   789   C1519254:Serine Phosphorylation Site [Amino Acid Sequence]
   757   C1519063:Phosphorylation Site [Amino Acid Sequence]
   748   C0031715:Phosphorylations [Molecular Function]
   714 E C1158886:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "sites in addition to IRS-1 Ser-302"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "Ser-307."
Processing 00000000.tx.172: Ser-302 Phosphorylation of Endogenous IRS-1 in Cultured CellsHaving established the specificity of the antibodies, we went on to ask whether endogenous IRS-1 in cultured cells was phosphorylated at Ser-302 under conditions known to promote Ser/Thr phosphorylation (3337). 

Phrase: "Ser-302 Phosphorylation of Endogenous IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "in Cultured CellsHaving"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "the specificity of the antibodies,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0003264:antibodies specificity [Molecular Function]
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]
   745 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "we"

Phrase: "went on to"

Phrase: "ask"

Phrase: "whether"

Phrase: "endogenous IRS-1 in cultured cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "phosphorylated at Ser-302"

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Ser/Thr phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "(3337"

Phrase: ")."
Processing 00000000.tx.173: Fao (rat) hepatoma cells were pretreated with PMA (a phorbol ester that activates PKC isoforms), anisomycin, calyculin A (an inhibitor of Ser/Thr phosphatases), or insulin (overnight). 

Phrase: "Fao (rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: ")"

Phrase: "hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0677626:hepatoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C2825188:PMA [Intellectual Product]

Phrase: "(a phorbol ester"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0031586:Phorbol Ester [Hazardous or Poisonous Substance,Organic Chemical]
   827   C0014898:Ester [Organic Chemical]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]

Phrase: "that"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "PKC isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "anisomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   861   C0597861:calyculin [Pharmacologic Substance]

Phrase: "("

Phrase: "an inhibitor of Ser/Thr phosphatases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.174: The reagents were removed, and cells were stimulated acutely with insulin. 

Phrase: "The reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "acutely with insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.175: PMA and calyculin A induced Ser/Thr phosphorylation of the insulin receptor, as judged by small shifts in electrophoretic mobility (Fig. 4A). 

Phrase: "PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "and"

Phrase: "calyculin A induced Ser/Thr phosphorylation of the insulin receptor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   782   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "as"

Phrase: "judged by small shifts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0333051:shifts [Functional Concept]
   770   C0700321:Small [Quantitative Concept]
   737   C0221191:Judge [Professional or Occupational Group]
   737 E C2347509:Shift [Phenomenon or Process]

Phrase: "in electrophoretic mobility"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0425245:Mobility [Finding]
   861   C0449580:Mobility [Qualitative Concept]
   789   C0013855:Electrophoreses [Laboratory Procedure]
   789 E C0231435:Mobile [Functional Concept]
   789 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.176: All four conditions produced shifts in the electrophoretic mobility of IRS-1, consistent with even greater increases in Ser/Thr phosphorylation (Fig. 4B). 

Phrase: "All four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "produced shifts in the electrophoretic mobility of IRS-1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0333051:shifts [Functional Concept]
   708 E C2347509:Shift [Phenomenon or Process]

Phrase: "consistent with even greater increases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in Ser/Thr phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.177: Insulin-stimulated tyrosine phosphorylation of IRS-1 was decreased after each treatment (Fig. 4, B and C), consistent with Ser/Thr phosphorylation inhibiting tyrosine phosphorylation and downstream signaling. 

Phrase: "Insulin-stimulated tyrosine phosphorylation of IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "decreased after each treatment"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C), consistent with Ser/Thr phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "downstream signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.178: Calyculin A produced the largest shift in electrophoretic mobility of IRS-1, presumably due to the greatest increase in Ser/Thr phosphorylation, and essentially abolished tyrosine phosphorylation of IRS-1 (Fig. 4C). 

Phrase: "Calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   861   C0597861:calyculin [Pharmacologic Substance]

Phrase: "produced"

Phrase: "the largest shift in electrophoretic mobility of IRS-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0333051:Shift [Functional Concept]
   742   C2347509:Shift [Phenomenon or Process]

Phrase: "presumably due to the greatest increase"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0205393:Greatest [Quantitative Concept]
   753   C0442805:Increase [Functional Concept]
   753   C3146286:Due [Idea or Concept]
   719 E C0549177:Great [Quantitative Concept]
   719 E C1704243:Great [Quantitative Concept]

Phrase: "in Ser/Thr phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "essentially abolished tyrosine phosphorylation of IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.179: View larger version (49K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557702:Window [Manufactured Object]
   827   C1272706:Window [Temporal Concept]
   827   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.180: 4. 

Phrase: "4."
Processing 00000000.tx.181: Conditions that affect Ser-302 and Ser-307 phosphorylation of endogenous IRS-1. 

Phrase: "Conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "Ser-302"

Phrase: "and"

Phrase: "Ser-307 phosphorylation of endogenous IRS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.182: Fao hepatoma cells were pretreated with 10 M PMA (30 min), 20 M anisomycin (30 min), 20 nM calyculin A (30 min), or 10 nM insulin (16 h) and after these reagents were washed off and stimulated acutely with 10 nM insulin (5 min). 

Phrase: "Fao hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0677626:hepatoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0023903:Hepatoma [Neoplastic Process]
   827   C2239176:Hepatoma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with 10 M PMA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C2825188:PMA [Intellectual Product]

Phrase: "(30 min),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "20 M anisomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "(30 min),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "20 nM calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   812   C0597861:calyculin [Pharmacologic Substance]

Phrase: "(30 min),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "or"

Phrase: "10 nM insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(16 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Human [Human]

Phrase: ")"

Phrase: "and after these reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   770   C1515981:And [Idea or Concept]

Phrase: "were"

Phrase: "washed off"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1548982:Washed [Idea or Concept]
   799 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "acutely with 10 nM insulin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(5 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.183: Proteins were immunoprecipitated (IP) from cell lysates with anti-insulin receptor antibody (A) or anti-IRS-1 antibody (B) and immunoblotted (IB) as indicated with anti-Tyr(P) (pY), anti-IR, anti-Ser(P)-302(IRS-1) (pS302), anti-Ser(P)-307(IRS-1) (pS307), or anti-IRS-1 antibodies. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: "from cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "with anti-insulin receptor antibody"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0443876:Anti-insulin receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Insulin receptor antibody
   923   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(A)"

Phrase: "or"

Phrase: "anti-IRS-1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: ")"

Phrase: "as"

Phrase: "indicated with anti-Tyr"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1421250:TYR [Gene or Genome]
   770   C1444656:Indicated [Finding]

Phrase: "(P) (pY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030428:PY [Geographic Area]
   861   C3538810:PY [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-IR,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   867 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "anti-Ser(P)-302"

Phrase: "(IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(pS302"

Phrase: ")"

Phrase: ","

Phrase: "anti-Ser(P)-307"

Phrase: "(IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "(pS307"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-IRS-1 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.184: C, combined results for four separate experiments (mean  S.E.) were plotted relative to control IRS-1 (+ acute insulin, no other addition). 

Phrase: "C,"

Phrase: "combined results for four separate experiments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C1548228:Combined result [Intellectual Product]
   725   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "were"

Phrase: "plotted"

Phrase: "relative to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(+ acute insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "no"

Phrase: "other addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: ")."
Processing 00000000.tx.185: Ser(P)-302 and Ser(P)-307: *, p < 0.05 versus control IRS-1 (minus acute insulin, no other addition); 

Phrase: "Ser(P)-302"

Phrase: "and"

Phrase: "Ser(P)-307"

Phrase: ":"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "control IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(minus acute insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "no"

Phrase: "other addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.186: pY, (Tyr(P)): **, p < 0.05 versus control IRS-1 (plus acute insulin, no other addition).  

Phrase: "pY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030428:PY [Geographic Area]
  1000   C3538810:PY [Idea or Concept]

Phrase: "(Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1421250:TYR [Gene or Genome]

Phrase: "(P)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ":"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "control IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(plus acute insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "no"

Phrase: "other addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: ")."
Processing 00000000.tx.187: Blots with the phosphospecific antibodies showed that each of these conditions promoted phosphorylation at both Ser-302 and Ser-307. 

Phrase: "Blots with the phosphospecific antibodies"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "each of these conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1457900:Each [Quantitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "phosphorylation at both Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser-307."
Processing 00000000.tx.188: Levels of Ser/Thr phosphorylation promoted by PMA, anisomycin, or calyculin A were similar in the absence or presence of insulin stimulation. 

Phrase: "Levels of Ser/Thr phosphorylation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "promoted by PMA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C2825188:PMA [Intellectual Product]
   756   C0033414:Promote [Activity]

Phrase: "anisomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "or"

Phrase: "calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   861   C0597861:calyculin [Pharmacologic Substance]

Phrase: "were"

Phrase: "similar in the absence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "or"

Phrase: "presence of insulin stimulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.189: Insulin itself led to small but definite increases as well. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "itself"

Phrase: "led to small"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0700321:Small [Quantitative Concept]
   790   C1708698:LED [Manufactured Object]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C1522538:Lead [Functional Concept]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "definite increases as well."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:increases [Functional Concept]
Processing 00000000.tx.190: These results indicated that phosphorylation at Ser-302 and Ser-307 occurs in parallel under a wide range of conditions. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that phosphorylation at Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser-307"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "in parallel under a wide range of conditions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0150312:In [Quantitative Concept]
   744   C0332285:In [Spatial Concept]
   744   C2348042:Parallel [Qualitative Concept]
   744   C2826345:PARALLEL [Research Activity]
Processing 00000000.tx.191: Ser-302 Phosphorylation in Genetically Obese MiceFollowing the goals of the laboratory to identify in vivo mechanisms of insulin resistance, we next asked whether Ser-302 was phosphorylated in animal models of insulin resistance. 

Phrase: "Ser-302 Phosphorylation in Genetically Obese MiceFollowing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "the goals of the laboratory to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0018017:Goals [Intellectual Product]
   719 E C1571704:Goal [Idea or Concept]

Phrase: "identify"

Phrase: "in vivo mechanisms of insulin resistance,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1522618:resistance mechanism [Clinical Attribute]
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "asked"

Phrase: "whether"

Phrase: "Ser-302"

Phrase: "was"

Phrase: "phosphorylated in animal models of insulin resistance."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C0599779:Models, Animal [Animal]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0003062:Animal [Animal]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C3161035:Models [Intellectual Product]
Processing 00000000.tx.192: Livers were isolated from ob/ob (Lepob/ob) mice, a genetic model in which a defect in leptin structure leads to loss of function. 

Phrase: "Livers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0023884:Livers [Body Part, Organ, or Organ Component]
   966 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   966 E C1278929:Liver [Body Part, Organ, or Organ Component]
   966 E C2346688:LIVER [Food]
   928 E C0205054:Hepatic [Body Location or Region]

Phrase: "were"

Phrase: "isolated from ob/ob (Lepob/ob) mice,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205409:Isolated [Functional Concept]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "a genetic model in which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0026343:Model, Genetic [Intellectual Product]
   760   C3161035:Model [Intellectual Product]

Phrase: "a"

Phrase: "defect in leptin structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1457869:Defect [Functional Concept]
   770   C1861101:DEFECT [Disease or Syndrome]

Phrase: "leads to loss of function."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   797   C3640044:Lead Function [Conceptual Entity]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0031843:function [Physiologic Function]
   760   C0181586:leads [Medical Device]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1517945:Loss [Quantitative Concept]
   760   C1522538:Lead [Functional Concept]
   760   C1705273:Function [Intellectual Product]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.193: Lepob/ob mice are hyperphagic, profoundly obese, insulin-resistant, and hyperglycemic. 

Phrase: "Lepob/ob mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "hyperphagic, profoundly obese, insulin-resistant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332325:Resistant [Functional Concept]
   804   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "hyperglycemic."
Processing 00000000.tx.194: Immunoprecipitated IRS-1 was analyzed by Western blotting with Ser(P)-302 and Ser(P)-307 antibodies. 

Phrase: "Immunoprecipitated IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with Ser(P)-302"

Phrase: "and"

Phrase: "Ser(P)-307 antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.195: Both of the antibodies consistently identified increased IRS-1 Ser phosphorylation in Lepob/ob mice relative to congenic Lep+/+ (C57Bl/6) controls (Fig. 5). 

Phrase: "Both of the antibodies consistently"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0238767:Both [Spatial Concept]
   760   C1706086:Both [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "increased IRS-1 Ser phosphorylation in Lepob/ob mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "relative to congenic Lep+/+ (C57Bl/6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: ")"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.196: Levels of Ser(P)-302 were 5.80-fold (1.50) greater in Lepob/ob mice relative to Lep+/+ controls (0.41, p = 0.036); 

Phrase: "Levels of Ser(P)-302"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "5.80-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(1.50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "greater in Lepob/ob mice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "relative to Lep+/+ controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "(0.41,"

Phrase: "p = 0.036"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.197: comparable levels of Ser(P)-307 were 3.06-fold (0.47) greater (0.31, p = 0.022). 

Phrase: "comparable levels of Ser(P)-307"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "3.06-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(0.47"

Phrase: ")"

Phrase: "greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "(0.31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "p = 0.022"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450305:0.022" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.198: Similar increases suggest that in Lepob/ob mice, phosphorylation at these two sites occurs in parallel. 

Phrase: "Similar increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that in Lepob/ob mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "phosphorylation at these two sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1519063:Phosphorylation Site [Amino Acid Sequence]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "in parallel."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]
Processing 00000000.tx.199: View larger version (43K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557702:Window [Manufactured Object]
   827   C1272706:Window [Temporal Concept]
   827   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.200: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.201: Obesity promotes Ser-302 and Ser-307 phosphorylation. 

Phrase: "Obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Ser-302"

Phrase: "and"

Phrase: "Ser-307 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.202: Lepob/ob mice and control Lep+/+ mice were fasted overnight and sacrificed (n = 4 of each). 

Phrase: "Lepob/ob mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "control Lep+/+ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "fasted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "sacrificed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]

Phrase: "(n = 4 of each"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.203: Proteins were immunoprecipitated (IP) from liver lysates with anti-IRS-1 antibody, and separated proteins were immunoblotted (IB) with anti-Ser(P)-302 (pS302), anti-Ser(P)-307 (pS302), or anti-IRS-1 antibodies. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: "from liver lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "with anti-IRS-1 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "separated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: ")"

Phrase: "with anti-Ser(P)-302"

Phrase: "(pS302"

Phrase: ")"

Phrase: ","

Phrase: "anti-Ser(P)-307"

Phrase: "(pS302"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-IRS-1 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.204: B, combined results for three separate experiments (mean  S.E.; *, p < 0.04) were plotted relative to Lep+/+ controls.  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "combined results for three separate experiments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C1548228:Combined result [Intellectual Product]
   725   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: ";"

Phrase: "*,"

Phrase: "p < 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "plotted"

Phrase: "relative to Lep+/+ controls."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.205: Ser-302 Phosphorylation in Diet-induced ObesityDiet-induced obesity offers a second model for insulin resistance in mice. 

Phrase: "Ser-302 Phosphorylation in Diet-induced ObesityDiet-induced obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "offers"

Phrase: "a second model for insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.206: Eight-week-old C57Bl/6 mice were fed either a high fat diet (45% of calories from fat) or control chow (17% of calories from fat) for 8 weeks. 

Phrase: "Eight-week-old C57Bl/6 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   850   C1521751:C57BL/6 Mouse [Mammal]
   839   C0025921:Mice, C57BL [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "either a high fat diet"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   884   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   840   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   804   C0012155:Diet [Food]
   804   C0205250:High [Qualitative Concept]
   804   C0424612:FAT [Organism Attribute]
   804   C1299351:High [Qualitative Concept]
   804   C1442959:Diet [Organism Function]
   804   C1519433:DIET [Therapeutic or Preventive Procedure]
   804   C2700149:HIGH [Intellectual Product]
   804   C2983588:DIET [Food]
   733 E C2699635:DIETARY [Functional Concept]

Phrase: "(45% of calories"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1556156:calories [Quantitative Concept]
   756 E C1879985:calorie [Quantitative Concept]

Phrase: "from fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "control chow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0324335:chow [Mammal]

Phrase: "(17% of calories"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1556156:calories [Quantitative Concept]
   756 E C1879985:calorie [Quantitative Concept]

Phrase: "from fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424612:FAT [Organism Attribute]

Phrase: ")"

Phrase: "for 8 weeks."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.207: Consistent with appropriate dietary responses, mice fed the high fat diet weighed 17% more than controls (39.8 versus 34.0 g; p = 0.016), due to >250% increases in fat mass as assessed by Dexa scanning. 

Phrase: "Consistent with appropriate dietary responses,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "the high fat diet"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "weighed"

Phrase: "17% more than controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "(39.8"

Phrase: "versus"

Phrase: "34.0 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "; p = 0.016"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450303:0.016" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "due to"

Phrase: ">250% increases in fat mass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "as"

Phrase: "assessed by Dexa scanning."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   816   C1510486:DEXA scan [Diagnostic Procedure]
           DEXA
   816   C1959592:DEXA Scan [Diagnostic Procedure]
   770   C0034606:Scanning [Diagnostic Procedure]
   770   C0441633:Scanning [Diagnostic Procedure]
   770   C1516048:Assessed [Activity]
   737 E C2826292:SCAN [Finding]
Processing 00000000.tx.208: Fasting glucose (5.33  0.23 mM versus 4.65  0.29 mM, p = 0.034) and insulin levels (148.0  10.3 microunits/ml versus 67.1  12.2 microunits /ml, p = 0.003) were used for HOMA-IR (homeostatic model assessment) calculations, which demonstrated significantly increased insulin resistance in mice fed the high fat diet (34.8  1.5) relative to chow-fed controls (14.05  3.04; p = 0.003). 

Phrase: "Fasting glucose"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0015663:Fasting [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1550565:fasting [Intellectual Product]
   827 E C0456962:Fast [Qualitative Concept]

Phrase: "(5.33  0.23 mM"

Phrase: "versus"

Phrase: "4.65  0.29 mM,"

Phrase: "p = 0.034"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0202098:insulin levels [Laboratory Procedure]
  1000   C0428405:insulin levels [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(148.0  10.3 microunits/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C1883313:10^3/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "versus"

Phrase: "67.1  12.2 microunits /ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439526:/mL [Quantitative Concept]

Phrase: "p = 0.003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "used for HOMA-IR"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   806   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   797   C0240016:Insulin used [Finding]
   773 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1273517:used [Finding]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(homeostatic model assessment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   976   C1829779:Homeostasis model assessment [Laboratory Procedure]
   976   C1830060:Homeostasis model assessment [Clinical Attribute]
   827   C1261322:Assessment [Health Care Activity]
   827   C1516048:Assessment [Activity]

Phrase: ")"

Phrase: "calculations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441506:Calculation [Activity]

Phrase: "which"

Phrase: "demonstrated"

Phrase: "significantly increased insulin resistance in mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0020459:increased insulin [Disease or Syndrome]
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "the high fat diet"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "(34.8  1.5"

Phrase: ")"

Phrase: "relative to chow-fed controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "(14.05  3.04"

Phrase: "; p = 0.003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.209: Under these conditions HOMA-IR correlates well with more complex measurements, including sensitivity indices (SI) determined using the hyperinsulinemic-euglycemic clamp method (64, 65). 

Phrase: "Under these conditions HOMA-IR"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   827 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "correlates"

Phrase: "well with more complex measurements,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205170:Well [Qualitative Concept]
   760   C0242485:measurements [Functional Concept]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C3146287:Well [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "sensitivity indices (SI)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the hyperinsulinemic-euglycemic clamp method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "(64,"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.210: IRS-1 isolated from the livers of these mice was analyzed for Ser-302 and Ser-307 phosphorylation. 

Phrase: "IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "isolated from the livers of these mice"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   748   C0023884:Livers [Body Part, Organ, or Organ Component]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205409:Isolated [Functional Concept]
   748   C1548221:Isolated [Idea or Concept]
   741   C1517914:Mouse Liver [Tissue]
   714 E C0370215:Isolate [Substance]
   714 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   714 E C1278929:Liver [Body Part, Organ, or Organ Component]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
   714 E C2346688:LIVER [Food]

Phrase: "was"

Phrase: "analyzed for Ser-302"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "Ser-307 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.211: Both of the phosphospecific antibodies (Ser(P)-302 and Ser(P)-307) identified consistent increases in serine phosphorylation of IRS-1 from mice fed the high fat diet compared with control chow (Fig. 6). 

Phrase: "Both of the phosphospecific antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0238767:Both [Spatial Concept]
   760   C1706086:Both [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Ser(P)-302"

Phrase: "and"

Phrase: "Ser(P)-307"

Phrase: ")"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "consistent increases in serine phosphorylation of IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:increases [Functional Concept]

Phrase: "from mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "the high fat diet"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "compared with control chow"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C0324335:chow [Mammal]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.212: High fat diet increased Ser(P)-302 by 3.3-fold (0.47) relative to chow controls (0.001, p = 0.035) and similarly increased Ser(P)-307 by 2.2-fold (0.19) relative to chow controls (0.01, p = 0.01). 

Phrase: "High fat diet"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "Ser(P)-302 by 3.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332462:Fold [Spatial Concept]
   748   C1880834:FOLD [Phenomenon or Process]

Phrase: "(0.47"

Phrase: ")"

Phrase: "relative to chow controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "(0.001,"

Phrase: "p = 0.035"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "similarly increased Ser(P)-307 by 2.2-fold"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205217:Increased [Quantitative Concept]
   742   C0332462:Fold [Spatial Concept]
   742   C0442805:Increased [Functional Concept]
   742   C1880834:FOLD [Phenomenon or Process]

Phrase: "(0.19"

Phrase: ")"

Phrase: "relative to chow controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "(0.01,"

Phrase: "p = 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.213: View larger version (60K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(60K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557702:Window [Manufactured Object]
   827   C1272706:Window [Temporal Concept]
   827   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.214: 6. 

Phrase: "6."
Processing 00000000.tx.215: High fat diet promotes Ser-302 and Ser-307 phosphorylation. 

Phrase: "High fat diet"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Ser-302"

Phrase: "and"

Phrase: "Ser-307 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.216: A, C57BL/6 mice fed normal chow (n = 4) or high fat diet (HFD) (n = 6) were fasted overnight and sacrificed. 

Phrase: "A,"

Phrase: "C57BL/6 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "normal chow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0324335:chow [Mammal]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "high fat diet (HFD)"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "fasted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "sacrificed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]
Processing 00000000.tx.217: Proteins were immunoprecipitated (IP) from liver lysates with anti-IRS-1 antibody, and separated proteins were immunoblotted (IB) with anti-Ser(P)-302 (pS302), anti-Ser(P)-307 (pS307), or anti-IRS-1 antibodies. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: "from liver lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "with anti-IRS-1 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "separated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: ")"

Phrase: "with anti-Ser(P)-302"

Phrase: "(pS302"

Phrase: ")"

Phrase: ","

Phrase: "anti-Ser(P)-307"

Phrase: "(pS307"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-IRS-1 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.218: B, combined results for two separate experiments (mean  S.E.; *, p < 0.04; **, p < 0.02) were plotted relative to chow-fed controls.  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "combined results for two separate experiments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C1548228:Combined result [Intellectual Product]
   725   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: ";"

Phrase: "*,"

Phrase: "p < 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "plotted"

Phrase: "relative to chow-fed controls."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.219: Ser-302 Phosphorylation in HyperinsulinemiaHyperinsulinemia represents a third model in which Ser/Thr phosphorylation might mediate insulin resistance. 

Phrase: "Ser-302 Phosphorylation in HyperinsulinemiaHyperinsulinemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a third model in which Ser/Thr phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]

Phrase: "might"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.220: To test whether Ser-302 and Ser-307 are phosphorylated during acute hyperinsulinemia, chow-fed C57Bl/6 mice were injected intraperitoneally with a single, large 1.0-unit/kg dose of insulin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "Ser-302"

Phrase: "and"

Phrase: "Ser-307"

Phrase: "are"

Phrase: "phosphorylated during acute hyperinsulinemia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020459:Hyperinsulinaemia [Disease or Syndrome]
   770   C0205178:acute [Temporal Concept]

Phrase: "chow-fed C57Bl/6 mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   873   C1521751:C57BL/6 Mouse [Mammal]
   853   C0025921:Mice, C57BL [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intraperitoneally with a single, large 1.0-unit/kg dose"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   760   C1300561:unit/kg [Quantitative Concept]
   757   C0869039:Unit dose [Quantitative Concept]
           Dose
   757   C1548560:Unit Dose [Idea or Concept]
   757   C1578476:Unit Dose [Health Care Activity]
   739   C0022718:KG [Geographic Area]
   739   C0037179:Single [Population Group]
   739   C0087136:single [Finding]
   739   C0178602:Dose [Quantitative Concept]
   739   C0205171:Single [Quantitative Concept]
   739   C0439148:Unit [Quantitative Concept]
   739   C0439209:kg [Quantitative Concept]
   739   C0549177:Large [Quantitative Concept]
   739   C1114758:Dose # [Clinical Attribute]
   739   C1519795:Unit [Quantitative Concept]
   739   C1704753:Unit [Manufactured Object]
   739   C1880519:Unit [Quantitative Concept]

Phrase: "of insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.221: Tissues were harvested within 10 min before the development of severe hypoglycemia, and liver IRS-1 was analyzed for Ser-302 and Ser-307 phosphorylation. 

Phrase: "Tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "harvested within 10 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   737   C1512335:Harvest [Health Care Activity]

Phrase: "before the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of severe hypoglycemia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0020615:Hypoglycaemia [Disease or Syndrome]
   861   C0205082:Severe [Qualitative Concept]
   789 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "and"

Phrase: "liver IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "analyzed for Ser-302"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "Ser-307 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.222: Acute hyperinsulinemia increased Ser(P)-302 by 2.3-fold (0.47) relative to saline-injected controls (0.19, p = 0.04). 

Phrase: "Acute hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "Ser(P)-302 by 2.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332462:Fold [Spatial Concept]
   748   C1880834:FOLD [Phenomenon or Process]

Phrase: "(0.47"

Phrase: ")"

Phrase: "relative to saline-injected controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "(0.19,"

Phrase: "p = 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.223: This maneuver similarly increased Ser(P)-307 by 1.8-fold (0.31) relative to saline-injected controls (0.03, p = 0.09) (Fig. 7). 

Phrase: "This maneuver similarly increased Ser(P)-307"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0205217:Increased [Quantitative Concept]
   799   C0442805:Increased [Functional Concept]

Phrase: "by 1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(0.31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "relative to saline-injected controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "(0.03,"

Phrase: "p = 0.09"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.224: We conclude that in vivo Ser/Thr phosphorylation is promoted at both sites by acute hyperinsulinemia. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that in vivo Ser/Thr phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "promoted at both sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205145:Sites [Spatial Concept]
   737   C0033414:Promote [Activity]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "by acute hyperinsulinemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020459:Hyperinsulinaemia [Disease or Syndrome]
Processing 00000000.tx.225: We were, thus, able to see consistent increases in Ser-302 and Ser-307 phosphorylation in three diverse models of murine insulin resistance, obesity, high fat diet, and hyperinsulinemia, suggesting that Ser-302 and Ser-307 might play important roles in related human conditions. 

Phrase: "We"

Phrase: "were"

Phrase: ","

Phrase: "thus,"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "consistent increases in Ser-302"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "Ser-307 phosphorylation in three diverse models of murine insulin resistance,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0031715:Phosphorylation [Molecular Function]
   738   C1158886:Phosphorylation [Molecular Function]

Phrase: "obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "high fat diet,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   901   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   827   C0012155:Diet [Food]
   827   C0205250:High [Qualitative Concept]
   827   C0424612:FAT [Organism Attribute]
   827   C1299351:High [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2700149:HIGH [Intellectual Product]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "and"

Phrase: "hyperinsulinemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Ser-302"

Phrase: "and"

Phrase: "Ser-307"

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "important roles in related human conditions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.226: View larger version (47K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557702:Window [Manufactured Object]
   827   C1272706:Window [Temporal Concept]
   827   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.227: 7. 

Phrase: "7."
Processing 00000000.tx.228: Hyperinsulinemia promotes Ser-302 and Ser-307 phosphorylation. 

Phrase: "Hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Ser-302"

Phrase: "and"

Phrase: "Ser-307 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.229: A, fasting C57BL/6 mice (n = 4, each group) were injected intraperitoneally with insulin (Ins, 1 units/kg) or carrier, and after 10 min, the mice were sacrificed, and tissues were harvested. 

Phrase: "A,"

Phrase: "fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "C57BL/6 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(n = 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "each group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intraperitoneally with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "Ins,"

Phrase: "1 units/kg)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1300561:unit/kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]

Phrase: "or"

Phrase: "carrier,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007294:Carrier [Finding]
  1000   C0560175:Carrier [Finding]
  1000   C1706209:Carrier [Medical Device]
  1000   C3273162:Carrier [Intellectual Product]

Phrase: "and after 10 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "the mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "sacrificed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]

Phrase: ","

Phrase: "and"

Phrase: "tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "harvested."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.230: Proteins were immunoprecipitated (IP) from liver lysates with anti-IRS-1 antibody, and separated proteins were immunoblotted (IB) with anti-Ser(P)-302 (pS302), anti-Ser(P)-307 (pS307), or anti-IRS-1 antibodies. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: "from liver lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "with anti-IRS-1 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "separated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(IB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: ")"

Phrase: "with anti-Ser(P)-302"

Phrase: "(pS302"

Phrase: ")"

Phrase: ","

Phrase: "anti-Ser(P)-307"

Phrase: "(pS307"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-IRS-1 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.231: B, combined results for four separate experiments (mean  S.E.; *, p < 0.05) were plotted relative to controls.   

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "combined results for four separate experiments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C1548228:Combined result [Intellectual Product]
   725   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "(mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: ";"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "plotted"

Phrase: "relative to controls."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.232: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Deletion of IRS-1 in mice causes insulin resistance and diabetes, consistent with a relevant role for this adapter protein in insulin signaling (6669). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Deletion of IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "consistent with a relevant role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for this adapter protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599697:adapter protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "(6669"

Phrase: ")."
Processing 00000000.tx.233: These findings clearly demonstrate that alterations in IRS-1 amount can have serious consequences. 

Phrase: "These findings clearly"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that alterations in IRS-1 amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "can"

Phrase: "have"

Phrase: "serious consequences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]
Processing 00000000.tx.234: Although controversial, the G972R polymorphism in the human irs1 gene has been correlated with both insulin resistance and insulin secretory defects. 

Phrase: "Although"

Phrase: "controversial,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "the G972R polymorphism in the human irs1 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0678951:gene polymorphism [Genetic Function]
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "correlated with both insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1707520:Correlated [Qualitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin secretory defects."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0243067:defects [Functional Concept]
   793 E C1457869:Defect [Functional Concept]
   793 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.235: Most relevant to this study, although patients with type 2 diabetes have near normal amounts of the protein, functional deficiencies in IRS-1 have been identified (70). 

Phrase: "Most relevant to this study,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevant [Qualitative Concept]

Phrase: "although"

Phrase: "patients with type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1550335:Patient type [Classification]
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "near normal amounts of the protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "functional deficiencies in IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0011155:Deficiency [Functional Concept]
   726   C0162429:Deficiency [Disease or Syndrome]
   726   C1623416:deficiency [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(70"

Phrase: ")."
Processing 00000000.tx.236: In particular, tyrosine phosphorylation appears to be reduced (7174). 

Phrase: "In particular, tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1519726:Tyrosine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(7174"

Phrase: ")."
Processing 00000000.tx.237: Ser/Thr phosphorylation has been increasingly recognized as a negative counterbalance to positive IRS signaling through tyrosine phosphorylation (23). 

Phrase: "Ser/Thr phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "increasingly"

Phrase: "recognized as a negative counterbalance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205160:Negative [Qualitative Concept]
   760   C1513916:Negative [Finding]
   760   C1707527:Counterbalance [Manufactured Object]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]

Phrase: "to positive IRS signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "through tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.238: Thus Ser/Thr phosphorylation could be a generalized mechanism for insulin resistance. 

Phrase: "Thus Ser/Thr phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1519253:Serine/Threonine Phosphorylation [Molecular Function]
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "could"

Phrase: "be"

Phrase: "a generalized mechanism for insulin resistance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1522618:resistance mechanism [Clinical Attribute]
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.239: From a molecular perspective it has been difficult, however, to identify discrete sites that are both phosphorylated in vivo and when phosphorylated, have relevant functional consequences. 

Phrase: "From a molecular perspective"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "difficult, however,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "discrete sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "both"

Phrase: "phosphorylated"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "when"

Phrase: "phosphorylated"

Phrase: ","

Phrase: "have"

Phrase: "relevant functional consequences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0686907:consequences [Functional Concept]
Processing 00000000.tx.240: Most investigations in this area have relied on the overexpression of candidate kinases in cultured cells and analyses of sites of Ser/Thr phosphorylation through protein sequencing or mass spectrometry. 

Phrase: "Most investigations in this area"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1261322:Investigations [Health Care Activity]
   726 E C1552578:investigation [Idea or Concept]

Phrase: "have"

Phrase: "relied on the overexpression of candidate kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1514559:Overexpression [Genetic Function]

Phrase: "in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "analyses of sites of Ser/Thr phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "through protein sequencing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002518:protein sequencing [Amino Acid Sequence]
  1000   C0751971:Protein Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "or"

Phrase: "mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.241: However, overexpression carries with it the potential for spurious phosphorylations outside of either usual sites or stoichiometries found physiologically. 

Phrase: "However,"

Phrase: "overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "carries with it"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0206243:Carry [Activity]
   790   C0699809:Carries [Finding]

Phrase: "the potential for spurious phosphorylations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:Potential [Qualitative Concept]

Phrase: "outside of either usual sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "or"

Phrase: "stoichiometries"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "physiologically."
Processing 00000000.tx.242: This could be due to greater than normal concentrations of the transfected candidate kinase or even more insidious in its ability to mislead, the transfected kinase may activate other kinases or inhibit phosphatases that are responsible for the detected phosphorylation. 

Phrase: "This"

Phrase: "could"

Phrase: "be due to greater"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   770   C2987476:Be [Conceptual Entity]
   770   C3146286:Due [Idea or Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "than normal concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C1277200:Normal concentration [Finding]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of the transfected candidate kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "even more insidious in its ability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1288298:Insidious [Qualitative Concept]

Phrase: "to"

Phrase: "mislead"

Phrase: ","

Phrase: "the transfected kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "other kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "phosphatases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031678:Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1149880:phosphatase [Molecular Function]

Phrase: "that"

Phrase: "are"

Phrase: "responsible for the detected phosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.243: Virtually all of the candidate "insulin resistance" kinases that have been identified function in signaling cascades that involve other kinases and phosphatases. 

Phrase: "Virtually"

Phrase: "all of the candidate ""insulin resistance"" kinases"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0237834:Resistance [Mental Process]
   748   C0444868:All [Quantitative Concept]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C3539085:All [Idea or Concept]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "function in signaling"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0031843:function [Physiologic Function]
   790   C0037083:Signaling [Cell Function]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]
   790   C3537152:signaling [Biologic Function]

Phrase: "cascades"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]

Phrase: "that"

Phrase: "involve"

Phrase: "other kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "phosphatases."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031678:Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.244: As an alternative approach that circumvents some of these problems, we developed the disruptive Y3H method. 

Phrase: "As an alternative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1523987:Alternative [Conceptual Entity]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "that"

Phrase: "circumvents"

Phrase: "some of these problems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C1546466:Problems [Idea or Concept]
   770   C3540770:Some [Intellectual Product]
   737 E C0033213:Problem [Finding]

Phrase: "we"

Phrase: "developed"

Phrase: "the disruptive Y3H method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.245: Ser-307 has attracted significant attention as a targeted site for phosphorylation in cultured cells and in vivo (20, 42, 51, 54, 5456, 59, 61). 

Phrase: "Ser-307"

Phrase: "has"

Phrase: "attracted"

Phrase: "significant attention as a targeted site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0004268:Attention [Mental Process]

Phrase: "for phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(20,"

Phrase: "42,"

Phrase: "51,"

Phrase: "54,"

Phrase: "5456,"

Phrase: "59,"

Phrase: "61"

Phrase: ")."
Processing 00000000.tx.246: In disruptive Y3H experiments phosphorylation of Ser-307 blocks IR/IRS-1 binding (Fig. 1) (18), providing a consistent and coherent mechanism that spans the biological and biochemical findings. 

Phrase: "In disruptive Y3H experiments phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "of Ser-307"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "IR/IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "a"

Phrase: "consistent"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332290:Consistent [Idea or Concept]
   928 E C0332529:Consistencies [Qualitative Concept]
   928 E C1547017:Consistency [Quantitative Concept]

Phrase: "and"

Phrase: "coherent mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "spans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1711300:Span [Conceptual Entity]
  1000   C2700613:Span [Quantitative Concept]

Phrase: "the biological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005532:Biological [Biomedical Occupation or Discipline]
  1000   C0205460:biological [Qualitative Concept]

Phrase: "and"

Phrase: "biochemical findings."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C0428132:Biochemical finding [Laboratory or Test Result]
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]
Processing 00000000.tx.247: We have now used disruptive Y3H to identify a second site in IRS-1 that is phosphorylated in cells and in vivo under equivalent conditions of insulin resistance. 

Phrase: "We"

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "disruptive Y3H to"

Phrase: "identify"

Phrase: "a second site in IRS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "phosphorylated in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "in vivo under equivalent conditions of insulin resistance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.248: Both of these sites were identified as JNK1 targets. 

Phrase: "Both of these sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   802   C2945843:Site of [Qualitative Concept]
   770   C0205145:Sites [Spatial Concept]
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "identified as JNK1 targets."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205396:Identified [Qualitative Concept]
   770   C1367731:JNK1 [Gene or Genome]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1705632:JNK1 [Gene or Genome]
   737   C1521840:Target [Functional Concept]
   737   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.249: Previous studies had shown that Ser-307 was a necessary JNK1-mediated disruption (18), and we now show that Ser-302 is similarly necessary. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "had"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Ser-307"

Phrase: "was"

Phrase: "a necessary JNK1-mediated disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0332453:Disruption [Functional Concept]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "we now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Ser-302"

Phrase: "is"

Phrase: "similarly necessary."
Processing 00000000.tx.250: A host of other kinases disrupt IR/IRS-1 binding in Y3H assays (Table I), including GSK3, p38 MAPK, PKA, PKC, PKC2, PKC, and PKC, yet their molecular mechanisms are distinct as disruption by these other kinases definitely does not involve either Ser-302 or Ser-307. 

Phrase: "A host of other kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1167395:Host [Organism]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "IR/IRS-1 binding in Y3H assays"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   776   C1149501:insulin receptor binding [Molecular Function]
   767   C1623517:insulin binding [Molecular Function]
   767   C1623518:IRS binding [Molecular Function]
   750   C0597358:Receptor Binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "p38 MAPK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "PKA,"

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "PKC2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418928:PKC2 [Gene or Genome]

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "and"

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "yet"

Phrase: "their molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "distinct as disruption"

Phrase: "by these"

Phrase: "other kinases definitely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involve"

Phrase: "either Ser-302"

Phrase: "or"

Phrase: "Ser-307."
Processing 00000000.tx.251: Several kinases associated with inflammatory processes like JNK1 do not disrupt IR/IRS-1 interactions, including the NF-B-activating kinases IKK and IKK. 

Phrase: "Several kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "associated with inflammatory processes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0333348:Inflammatory [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "like JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "IR/IRS-1 interactions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   894   C1373083:Insulin Receptor Interactions [Molecular Function]
   858   C1372999:Receptor Interactions [Molecular Function]
   771   C1704675:Interaction [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the NF-B-activating kinases IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1150571:IKK [Molecular Function]

Phrase: "and"

Phrase: "IKK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]
Processing 00000000.tx.252: The strengths of our findings lie in showing unequivocally that JNK-mediated phosphorylation at either Ser-302 or Ser-307 (a) abrogates IR/IRS-1 binding and (b) that this occurs in vivo in three distinct animal models of insulin resistance; 

Phrase: "The strengths of our findings"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0808080:strengths [Idea or Concept]
   726 E C0237897:Strength [Quantitative Concept]
   726 E C1705922:Strength [Qualitative Concept]

Phrase: "lie in showing unequivocally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "that JNK-mediated phosphorylation at either Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "Ser-307"

Phrase: "(a)"

Phrase: "abrogates"

Phrase: "IR/IRS-1 binding and ("
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   876   C1623517:insulin binding [Molecular Function]
   869   C1149501:insulin receptor binding [Molecular Function]
   841   C0597358:Receptor Binding [Molecular Function]
   839   C1623518:IRS binding [Molecular Function]
   827   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   827   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   793 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "b)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "that"

Phrase: "this"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "in vivo in three distinct animal models of insulin resistance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   761   C1515657:In Vivo Model [Research Activity]
   760   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: ";"
Processing 00000000.tx.253: genetically obese Lepob/ob mice, diet-induced obesity, and hyper-insulinemia. 

Phrase: "genetically obese Lepob/ob mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0025933:Mice, Obese [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "diet-induced obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0028754:Obesity [Disease or Syndrome]
   827   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "hyper-insulinemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0424295:HYPER [Finding]
Processing 00000000.tx.254: Our findings are consistent with a role for JNK1 in insulin resistance, as JNK1 phosphorylates Ser-302 and Ser-307 under Y3H conditions, and these sites are phosphorylated in vivo in models of insulin resistance. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with a role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "in insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as"

Phrase: "JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "phosphorylates"

Phrase: "Ser-302"

Phrase: "and"

Phrase: "Ser-307 under Y3H conditions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "these sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "phosphorylated"

Phrase: "in vivo in models of insulin resistance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C1515657:In Vivo Model [Research Activity]
   778   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.255: Nine other Ser/Thr kinases that are potentially associated with insulin resistance do not target Ser-302 and Ser-307 in Y3H experiments (Table I), making it highly unlikely that these kinases target Ser-302 and Ser-307 in vivo. 

Phrase: "Nine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205455:Nine [Quantitative Concept]

Phrase: "other Ser/Thr kinases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0072402:Serine-Threonine Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
   988 E C1414387:serine/threonine kinase [Gene or Genome]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "are"

Phrase: "potentially"

Phrase: "associated with insulin resistance"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "Ser-302"

Phrase: "and"

Phrase: "Ser-307 in Y3H experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "it highly unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "these kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "Ser-302"

Phrase: "and"

Phrase: "Ser-307 in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.256: Yet, with 395 Ser/Thr kinases in the human and mouse genomes (75, 76), it should not be concluded that JNK1 alone is responsible for either the in vivo phosphorylation of Ser-302 or Ser-307 or insulin resistance. 

Phrase: "Yet,"

Phrase: "with 395 Ser/Thr kinases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0072402:Serine-Threonine Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
   912 E C1414387:serine/threonine kinase [Gene or Genome]
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse genomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017428:Genomes [Gene or Genome]
   827 E C2338314:Genome [Conceptual Entity]

Phrase: "(75,"

Phrase: "76"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "responsible for either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "the in vivo phosphorylation of Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "Ser-307"

Phrase: "or"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.257: During the review of our manuscript, two additional studies have implicated IRS-1 Ser-302 as a potential phosphorylation site. 

Phrase: "During the review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "of our manuscript,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "two additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "implicated IRS-1 Ser-302 as a potential phosphorylation site."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1519063:Phosphorylation Site [Amino Acid Sequence]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0205145:Site [Spatial Concept]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]
   739   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.258: Greene et al. 

Phrase: "Greene et al."
Processing 00000000.tx.259: (77) used PKC to radioactively label IRS-1 in vitro and a phosphopeptide-mapping approach to identify phosphorylations at Ser-302, Ser-319, and Ser-570 (in their manuscript they used the equivalent human IRS-1 numbering: Ser-307, Ser-324, and Ser-575). 

Phrase: "(77"

Phrase: ")"

Phrase: "used PKC to radioactively label IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3539645:PKC [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "a phosphopeptide-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031684:phosphopeptide [Amino Acid, Peptide, or Protein]

Phrase: "mapping"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1283195:Mapping [Activity]
   966 E C0024779:Map [Manufactured Object]
   966 E C1706473:Map [Conceptual Entity]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "phosphorylations at Ser-302,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0031715:Phosphorylations [Molecular Function]
   737 E C1158886:Phosphorylation [Molecular Function]

Phrase: "Ser-319,"

Phrase: "and"

Phrase: "Ser-570"

Phrase: "("

Phrase: "in their manuscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "they"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the equivalent human IRS-1 numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0449788:numbering [Quantitative Concept]
   771 E C0237753:*Number [Quantitative Concept]

Phrase: ":"

Phrase: "Ser-307,"

Phrase: "Ser-324,"

Phrase: "and"

Phrase: "Ser-575"

Phrase: ")."
Processing 00000000.tx.260: Under the conditions of their assays, PKC did not appreciably phosphorylate Ser-307. 

Phrase: "Under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of their assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "did"

Phrase: "not appreciably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "phosphorylate"

Phrase: "Ser-307."
Processing 00000000.tx.261: Giraud et al. 

Phrase: "Giraud et al."
Processing 00000000.tx.262: (78) used a phosphospecific antibody/candidate phosphorylation site approach to identify Ser-302. 

Phrase: "(78"

Phrase: ")"

Phrase: "used a phosphospecific antibody/candidate phosphorylation site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C1519063:Phosphorylation Site [Amino Acid Sequence]
   795   C0031715:Phosphorylation [Molecular Function]
   795   C0205145:Site [Spatial Concept]
   795   C1158886:Phosphorylation [Molecular Function]
   795   C1515974:Site [Body Location or Region]
   795   C2825164:Site [Spatial Concept]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "Ser-302."
Processing 00000000.tx.263: They reported that activation of mTOR signaling induced Ser-302 phosphorylation and that this positively influenced signaling through the IR/IRS-1 axis. 

Phrase: "They"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that activation of mTOR signaling induced Ser-302 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   784   C2248185:activation of phosphorylation [Cell Function]
   742   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "that"

Phrase: "this positively"

Phrase: "influenced"

Phrase: "signaling through the IR/IRS-1 axis."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   770   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   770   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0945855:axis 1 [Clinical Attribute]
   750   C1514762:Receptor Signaling [Molecular Function]
   744   C0004457:Axis [Body Part, Organ, or Organ Component]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0037083:Signaling [Cell Function]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   744   C0999597:Axis [Mammal]
   744   C1522496:Axis [Spatial Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C3537152:signaling [Biologic Function]
   737 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   711 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.264: The three studies identified Ser-302 using independent methods. 

Phrase: "The three studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "Ser-302"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "independent methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.265: Our data and the complementary findings of Greene et al. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "the complementary findings of Greene et al."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C2607943:findings [Functional Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C3539655:Findings [Intellectual Product]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714 E C2825141:Finding [Finding]
Processing 00000000.tx.266: (77) clearly show that Ser-302 phosphorylation disrupts IR/IRS-1 signaling. 

Phrase: "(77"

Phrase: ")"

Phrase: "clearly"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Ser-302 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "IR/IRS-1 signaling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1514762:Receptor Signaling [Molecular Function]
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
Processing 00000000.tx.267: Although we cannot speak to reasons that Giraud et al. 

Phrase: "Although"

Phrase: "we"

Phrase: "cannot"

Phrase: "speak"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0234856:Speak [Daily or Recreational Activity]
  1000   C0600116:speak [Finding]
  1000   C1547187:Speak [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reasons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "that Giraud et al."
Processing 00000000.tx.268: (78) came to the opposite conclusion, this suggestion is clearly inconsistent with our findings. 

Phrase: "(78"

Phrase: ")"

Phrase: "came to the opposite conclusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521805:Opposite [Spatial Concept]
   760   C1707478:Conclusion [Idea or Concept]

Phrase: "this suggestion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038659:Suggestion [Idea or Concept]
  1000   C1705535:suggestion [Idea or Concept]

Phrase: "is"

Phrase: "clearly inconsistent with our findings."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442809:Inconsistent [Qualitative Concept]
Processing 00000000.tx.269: Phosphorylation at Ser-302 and Ser-307 is equivalently inhibitory in our studies, and it occurs at these two sites in parallel in yeast, in cultured cells, and in vivo under conditions of insulin resistance. 

Phrase: "Phosphorylation at Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser-307"

Phrase: "is"

Phrase: "equivalently inhibitory in our studies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3463820:Inhibitory [Activity]

Phrase: "and"

Phrase: "it"

Phrase: "occurs at these two sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205145:Sites [Spatial Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "in parallel in yeast,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0150312:In [Quantitative Concept]
   770   C0332285:In [Spatial Concept]
   770   C2348042:Parallel [Qualitative Concept]
   770   C2826345:PARALLEL [Research Activity]

Phrase: "in cultured cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "in vivo under conditions of insulin resistance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.270: One of our more interesting and provocative findings relates to potential mechanisms of IR/IRS-1 disruption. 

Phrase: "One of our more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "and"

Phrase: "provocative findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "relates to potential mechanisms of IR/IRS-1 disruption."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   760   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   760   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0163712:Relate [Organic Chemical]
   739   C0332453:Disruption [Functional Concept]
   739   C0441712:Mechanisms [Functional Concept]
   739   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C3245505:Potential [Qualitative Concept]
   726 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   706 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.271: Although we clearly show that JNK1 phosphorylates IRS-1 at Ser-302 and Ser-307 and both are necessary for disruption, these two phosphorylations either alone or in combination are not sufficient for disruption (Fig. 1). 

Phrase: "Although"

Phrase: "we clearly"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "phosphorylates"

Phrase: "IRS-1 at Ser-302"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Ser-307"

Phrase: "and"

Phrase: "both"

Phrase: "are"

Phrase: "necessary for disruption,"

Phrase: "these two phosphorylations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031715:Phosphorylations [Molecular Function]
   827 E C1158886:Phosphorylation [Molecular Function]

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "are"

Phrase: "not sufficient for disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205410:Sufficient [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.272: This means that phosphorylation of Ser-302 and Ser-307 and additional site or sites are required. 

Phrase: "This means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "that phosphorylation of Ser-302"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser-307"

Phrase: "and"

Phrase: "additional site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "or"

Phrase: "sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.273: In other words, a cluster of phosphorylated serines and possibly threonines mediates disruption. 

Phrase: "In other words,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C1705313:Word [Idea or Concept]
   928 E C0439824:Verbal [Qualitative Concept]
   900 E C0871946:verb [Intellectual Product]

Phrase: "a cluster of phosphorylated serines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1555715:Cluster [Idea or Concept]
   760   C1704332:Cluster [Quantitative Concept]

Phrase: "and"

Phrase: "possibly threonines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "disruption."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.274: Although we continue to identify additional sites, the notion of "clustering" lends itself to considering new and testable hypotheses for potential mechanisms of disruption and, by extension, potential mechanisms for insulin resistance. 

Phrase: "Although"

Phrase: "we"

Phrase: "continue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "additional sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "the notion of ""clustering"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0009085:Clustering [Research Activity]

Phrase: "lends"

Phrase: "itself to considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750591:considering [Idea or Concept]

Phrase: "new"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205314:New [Temporal Concept]

Phrase: "and"

Phrase: "testable hypotheses for potential mechanisms of disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1512571:Hypothesis [Idea or Concept]

Phrase: "and"

Phrase: ","

Phrase: "by extension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extension [Functional Concept]
  1000   C1880641:Extension [Conceptual Entity]

Phrase: "potential mechanisms for insulin resistance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1522618:resistance mechanism [Clinical Attribute]
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.275: The disruptive Y3H approach provides a general method for analyzing macromolecular complexes in addition to identifying potential mechanisms of insulin resistance. 

Phrase: "The disruptive Y3H approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a general method for analyzing macromolecular complexes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "in addition to identifying potential mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "of insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.276: Related methods have been published, including Vidal's forward and reverse YNH approaches (79), but we were unable to apply these methods to the insulin resistance problem. 

Phrase: "Related methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Vidal's"

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "reverse YNH approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]

Phrase: "(79"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "apply"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185125:Apply [Health Care Activity]
  1000   C1632850:Apply [Functional Concept]
  1000   C1879355:Apply [Functional Concept]

Phrase: "these methods to the insulin resistance problem."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0025663:Methods [Intellectual Product]
   748   C0025664:methods [Intellectual Product]
   748   C0449851:Methods [Functional Concept]
   714 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.277: In this study we specifically used our disruptive Y3H to investigate mechanisms for disruption of a protein-protein interaction. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we specifically"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "our disruptive Y3H to"

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "mechanisms for disruption of a protein-protein interaction."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.278: A similar Y3H approach is equally useful for studying the formation of ternary and higher order complexes. 

Phrase: "A similar Y3H approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "is"

Phrase: "equally useful for studying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C0869040:study use [Research Activity]

Phrase: "the formation of ternary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "higher order complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.279: As one example, we have used a variant of the approach, termed "bridging" Y3H, to analyze quaternary complexes between JAKs and APS or SH2-B proteins (80).3 These methods appear to be both robust and of general utility. 

Phrase: "As one example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707959:Example [Conceptual Entity]

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a variant of the approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]

Phrase: "termed ""bridging"" Y3H,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "quaternary complexes between JAKs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1704241:Complexes [Chemical Viewed Structurally]
   737 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "APS"

Phrase: "or"

Phrase: "SH2-B proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1709985:SH2-B [Gene or Genome]

Phrase: "(80"

Phrase: ").3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "These methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "both robust"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986815:Robust [Qualitative Concept]

Phrase: "and of general utility."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205246:General [Spatial Concept]
   770   C0582205:utility [Organization]
   770   C1515981:And [Idea or Concept]
   770   C1553889:General [Idea or Concept]
Processing 00000000.tx.280: In summary, we have developed a new approach for disrupting protein-protein interactions and used the method to analyze mechanisms for inhibiting IR/IRS-1 interactions. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "developed"

Phrase: "a"

Phrase: "new approach for disrupting protein-protein interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449445:Approach [Spatial Concept]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "analyze"

Phrase: "mechanisms for inhibiting IR/IRS-1 interactions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.281: We identified Ser-302 as a new phosphorylation site in IRS-1 and showed that Ser-302 phosphorylation blocks IR/IRS-1 binding. 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "Ser-302 as a new phosphorylation site"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1519063:Phosphorylation Site [Amino Acid Sequence]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0205145:Site [Spatial Concept]
   748   C0205314:New [Temporal Concept]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "in IRS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Ser-302 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "IR/IRS-1 binding."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   897   C1623517:insulin binding [Molecular Function]
   894   C1149501:insulin receptor binding [Molecular Function]
   858   C0597358:Receptor Binding [Molecular Function]
   853   C1623518:IRS binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
Processing 00000000.tx.282: Disruptive Y3H was further used to investigate and identify clustering as a potential mechanism for JNK1 mediated disruption. 

Phrase: "Disruptive Y3H"

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "and"

Phrase: "identify"

Phrase: "clustering as a potential mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009085:Clustering [Research Activity]

Phrase: "for JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "disruption."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.283: Phosphospecific antibodies were developed and used to show that Ser-302 is phosphorylated in cells and in vivo in a variety of models of obesity, insulin resistance, and type 2 diabetes. 

Phrase: "Phosphospecific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "developed"

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Ser-302"

Phrase: "is"

Phrase: "phosphorylated in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "in vivo in a variety of models of obesity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1515657:In Vivo Model [Research Activity]
   764   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.284: These approaches should have general utility in analyzing potential mechanisms of insulin resistance by identifying other disruptive kinases and additional, functionally relevant phosphorylation sites. 

Phrase: "These approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approaches [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "should"

Phrase: "have"

Phrase: "general utility in analyzing potential mechanisms of insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0582205:utility [Organization]

Phrase: "by identifying"

Phrase: "other disruptive kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "additional, functionally relevant phosphorylation sites."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C1519063:Phosphorylation Site [Amino Acid Sequence]
   804   C0031715:Phosphorylation [Molecular Function]
   804   C0205145:Sites [Spatial Concept]
   804   C1158886:Phosphorylation [Molecular Function]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.285: This should help to provide a more complete understanding of the molecular basis of insulin resistance.  

Phrase: "This"

Phrase: "should"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a more"

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "understanding of the molecular basis of insulin resistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162340:Understanding [Mental Process]
Processing 00000000.tx.286: FOOTNOTES  * These studies were funded by National Institutes of Health Grants DK63225 (to J. L.), DK43123 (to S. E. S.), DK45943 (to S. E. S.), and DK36836 (Joslin Diabetes Center, Diabetes Endocrinology Research Center), National Institutes of Health Fellowship DK09393 (to E. D. W.), and by the Helen and Morton Adler Chair (to S. E. S.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "funded by National Institutes of Health Grants DK63225"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0016820:funded [Quantitative Concept]
   744   C0018173:Grants [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C3245503:national [Intellectual Product]
   711 E C1272753:Institute [Idea or Concept]
   711 E C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "to J. L."

Phrase: ")"

Phrase: ","

Phrase: "DK43123"

Phrase: "("

Phrase: "to S. E."

Phrase: "S."

Phrase: ")"

Phrase: ","

Phrase: "DK45943"

Phrase: "("

Phrase: "to S. E."

Phrase: "S."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "DK36836"

Phrase: "(Joslin Diabetes Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "Diabetes Endocrinology Research Center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0683939:research center [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "National Institutes of Health Fellowship DK09393"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "("

Phrase: "to E. D. W."

Phrase: ")"

Phrase: ","

Phrase: "and by the Helen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "Morton Adler Chair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0179847:chair [Medical Device]
   827   C1524106:Chair [Professional or Occupational Group]

Phrase: "("

Phrase: "to S. E."

Phrase: "S."

Phrase: ")."
Processing 00000000.tx.287: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.288: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.289: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.290: These authors contributed equally. 

Phrase: "These authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally."
Processing 00000000.tx.291: To whom correspondence may be addressed: Joslin Diabetes Center, One Joslin Place, Boston, MA 02215. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Joslin Diabetes Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "One Joslin Place,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442504:Place [Spatial Concept]
   827   C1704765:Place [Functional Concept]
   827   C1882509:Place [Activity]
   827   C3496241:place [Disease or Syndrome]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02215."
Processing 00000000.tx.292: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.293: 617-713-3422; 

Phrase: "617-713-3422"

Phrase: ";"
Processing 00000000.tx.294: Fax: 617-735-1970; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "617-735-1970"

Phrase: ";"
Processing 00000000.tx.295: E-mail: Jongsoon.Lee{at}joslin.harvard.edu .  To whom correspondence may be addressed: Joslin Diabetes Center, One Joslin Place, Boston, MA 02215. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Jongsoon.Lee{at}joslin.harvard.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Joslin Diabetes Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "One Joslin Place,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442504:Place [Spatial Concept]
   827   C1704765:Place [Functional Concept]
   827   C1882509:Place [Activity]
   827   C3496241:place [Disease or Syndrome]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02215."
Processing 00000000.tx.296: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.297: 617-732-2528; 

Phrase: "617-732-2528"

Phrase: ";"
Processing 00000000.tx.298: Fax: 617-735-1970; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "617-735-1970"

Phrase: ";"
Processing 00000000.tx.299: E-mail: Steven.

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Steven."
Processing 00000000.tx.300: Shoelson{at}joslin.harvard.edu . 1 The abbreviations used are: IR, insulin receptor; 

Phrase: "Shoelson{at}joslin.harvard.edu . 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "IR,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.301: IRS, IR substrate; 

Phrase: "IRS,"

Phrase: "IR substrate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1710236:Substrate [Manufactured Object]
   734   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   701 E C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.302: MAPK, mitogen-activated protein kinase; 

Phrase: "MAPK,"

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.303: PMA, phorbol 12-myristate 13-acetate; 

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "phorbol 12-myristate 13-acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.304: GSK, glycogen synthase kinase; 

Phrase: "GSK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1325174:GSK [Molecular Function]

Phrase: "glycogen synthase kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.305: PKA and PKC, protein kinase A and C, respectively; 

Phrase: "PKA"

Phrase: "and"

Phrase: "PKC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "protein kinase A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "C,"

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.306: JNK, c-Jun NH2-terminal kinase; 

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "c-Jun NH2-terminal kinase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   937   C0248813:jun-NH2-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   708   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: ";"
Processing 00000000.tx.307: Y3H, yeast tri-hybrid; 

Phrase: "Y3H,"

Phrase: "yeast tri-hybrid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020205:Hybrid [Organism]
   827   C0814229:TRI [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.308: WT, wild type; 

Phrase: "WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.309: IKK, IB kinase complex. 

Phrase: "IKK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "IB kinase complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.310: 2 Numbering of IRS-1 in this manuscript refers to rodent (r) sequences. 

Phrase: "2 Numbering of IRS-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449788:numbering [Quantitative Concept]
   726 E C0237753:*Number [Quantitative Concept]

Phrase: "in this manuscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "refers to rodent (r) sequences."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0035804:Rodent [Mammal]
   770   C0162326:Sequences [Nucleotide Sequence]
   770   C0205543:refer [Functional Concept]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.311: Human (h) sequences are identical in the Ser-302/Ser-307 region, although the numbering is offset by 5 residues (rSer-307 = hSer-312; rSer-302 = hSer-307). 

Phrase: "Human (h) sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "identical in the Ser-302/Ser-307 region,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205280:Identical [Qualitative Concept]

Phrase: "although"

Phrase: "the numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "is"

Phrase: "offset by 5 residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1711330:Offset [Quantitative Concept]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(rSer-307"

Phrase: "= hSer-312"

Phrase: "; rSer-302"

Phrase: "= hSer-307"

Phrase: ")."
Processing 00000000.tx.312: hIRS-1, 295SQVGLTRRSRTES307ITATS312PASMVGGKPGSFRVRAS334; 

Phrase: "hIRS-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334140:HIRS-1 [Gene or Genome]
  1000   C1704984:HIRS-1 [Gene or Genome]
   827   C1416586:HIR [Gene or Genome]

Phrase: "295SQVGLTRRSRTES307ITATS312PASMVGGKPGSFRVRAS334"

Phrase: ";"
Processing 00000000.tx.313: rIRS-1, 290SQVGLTRRSRTES302ITATS307PASMVGGKPGSFRVRAS329. 

Phrase: "rIRS-1,"

Phrase: "290SQVGLTRRSRTES302ITATS307PASMVGGKPGSFRVRAS329."
Processing 00000000.tx.314: 3 E. 

Phrase: "3 E."
Processing 00000000.tx.315: Werner and S. 

Phrase: "Werner"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.316: Shoelson, unpublished data.  

Phrase: "Shoelson,"

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.317: ACKNOWLEDGMENTS  We dedicate this manuscript to the memory of our friend and colleague Valerie Fanikos. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "dedicate"

Phrase: "this manuscript to the memory of our friend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "colleague Valerie Fanikos."
Processing 00000000.tx.318: We thank Gus Gustafson (Metabolex, Inc.) for helpful discussions and reagents.  

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Gus Gustafson"

Phrase: "(Metabolex,"

Phrase: "Inc.) for helpful discussions"

Phrase: "and"

Phrase: "reagents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.319: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  National Diabetes Data Group (1994) Diabetes in America, 2nd Ed., NIDDK, National Institutes of Health, Bethesda, MD Mokdad, A. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "National Diabetes Data Group"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1511726:Data [Idea or Concept]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
   812   C3245479:data [Medical Device]
   812   C3245503:national [Intellectual Product]

Phrase: "(1994"

Phrase: ")"

Phrase: "Diabetes in America,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "2nd Ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "NIDDK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513898:NIDDK [Health Care Related Organization]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Bethesda,"

Phrase: "MD Mokdad,"

Phrase: "A."
Processing 00000000.tx.320: H., Ford, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ford,"

Phrase: "E."
Processing 00000000.tx.321: S., Bowman, B. 

Phrase: "S."

Phrase: ","

Phrase: "Bowman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.322: A., Nelson, D. 

Phrase: "A.,"

Phrase: "Nelson,"

Phrase: "D."
Processing 00000000.tx.323: E., Engelgau, M. 

Phrase: "E.,"

Phrase: "Engelgau,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.324: M., Vinicor, F., and Marks, J. 

Phrase: "M."

Phrase: ","

Phrase: "Vinicor,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Marks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]

Phrase: "J."
Processing 00000000.tx.325: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.326: (2000) Diabetes Care 23, 12781283[Abstract] Mokdad, A. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Diabetes Care 23,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0450348:23 [Quantitative Concept]
   827   C1947933:Care [Activity]

Phrase: "12781283"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mokdad,"

Phrase: "A."
Processing 00000000.tx.327: H., Serdula, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Serdula,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.328: K., Dietz, W. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dietz,"

Phrase: "W."
Processing 00000000.tx.329: H., Bowman, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bowman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.330: A., Marks, J. 

Phrase: "A.,"

Phrase: "Marks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]

Phrase: "J."
Processing 00000000.tx.331: S., and Koplan, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Koplan,"

Phrase: "J."
Processing 00000000.tx.332: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.333: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.334: Am. 

Phrase: "Am."
Processing 00000000.tx.335: Med. 

Phrase: "Med."
Processing 00000000.tx.336: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.337: 284, 16501651[Free FullText] Mokdad, A. 

Phrase: "284,"

Phrase: "16501651"

Phrase: "[Free FullText"

Phrase: "] Mokdad,"

Phrase: "A."
Processing 00000000.tx.338: H., Bowman, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bowman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.339: A., Ford, E. 

Phrase: "A.,"

Phrase: "Ford,"

Phrase: "E."
Processing 00000000.tx.340: S., Vinicor, F., Marks, J. 

Phrase: "S."

Phrase: ","

Phrase: "Vinicor,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Marks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]

Phrase: "J."
Processing 00000000.tx.341: S., and Koplan, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Koplan,"

Phrase: "J."
Processing 00000000.tx.342: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.343: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.344: Am. 

Phrase: "Am."
Processing 00000000.tx.345: Med. 

Phrase: "Med."
Processing 00000000.tx.346: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.347: 286, 11951200[Abstract/Free FullText] Mokdad, A. 

Phrase: "286,"

Phrase: "11951200"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mokdad,"

Phrase: "A."
Processing 00000000.tx.348: H., Ford, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ford,"

Phrase: "E."
Processing 00000000.tx.349: S., Bowman, B. 

Phrase: "S."

Phrase: ","

Phrase: "Bowman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.350: A., Dietz, W. 

Phrase: "A.,"

Phrase: "Dietz,"

Phrase: "W."
Processing 00000000.tx.351: H., Vinicor, F., Bales, V. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vinicor,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "V."
Processing 00000000.tx.352: S., and Marks, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Marks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]

Phrase: "J."
Processing 00000000.tx.353: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.354: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.355: Am. 

Phrase: "Am."
Processing 00000000.tx.356: Med. 

Phrase: "Med."
Processing 00000000.tx.357: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.358: 289, 7679[Abstract/Free FullText] Ford, E. 

Phrase: "289,"

Phrase: "7679"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ford,"

Phrase: "E."
Processing 00000000.tx.359: S., Giles, W. 

Phrase: "S."

Phrase: ","

Phrase: "Giles,"

Phrase: "W."
Processing 00000000.tx.360: H., and Dietz, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Dietz,"

Phrase: "W."
Processing 00000000.tx.361: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.362: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.363: Am. 

Phrase: "Am."
Processing 00000000.tx.364: Med. 

Phrase: "Med."
Processing 00000000.tx.365: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.366: 287, 356359[Abstract/Free FullText] Ridker, P. 

Phrase: "287,"

Phrase: "356359"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ridker,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.367: M., Buring, J. 

Phrase: "M."

Phrase: ","

Phrase: "Buring,"

Phrase: "J."
Processing 00000000.tx.368: E., Cook, N. 

Phrase: "E.,"

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.369: R., and Rifai, N. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rifai,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.370: (2003) Circulation 107, 391397[Abstract/Free FullText] Fried, S. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Circulation 107,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: "391397"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fried,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1825319:FRY [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.371: K., Bunkin, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bunkin,"

Phrase: "D."
Processing 00000000.tx.372: A., and Greenberg, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "A."
Processing 00000000.tx.373: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.374: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.375: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.376: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.377: Metab. 

Phrase: "Metab."
Processing 00000000.tx.378: 83, 847850[Abstract/Free FullText] Pickup, J. 

Phrase: "83,"

Phrase: "847850"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pickup,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707710:Pickup [Manufactured Object]

Phrase: "J."
Processing 00000000.tx.379: C., Mattock, M. 

Phrase: "C., Mattock,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.380: B., Chusney, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Chusney,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.381: D., and Burt, D. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Burt,"

Phrase: "D."
Processing 00000000.tx.382: (1997) Diabetologia 40, 12861292[CrossRef][Medline] [OrderarticleviaInfotrieve] Kern, P. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Diabetologia 40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "12861292"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kern,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.383: A., Saghizadeh, M., Ong, J. 

Phrase: "A.,"

Phrase: "Saghizadeh,"

Phrase: "M."

Phrase: ","

Phrase: "Ong,"

Phrase: "J."
Processing 00000000.tx.384: M., Bosch, R. 

Phrase: "M."

Phrase: ","

Phrase: "Bosch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.385: J., Deem, R., and Simsolo, R. 

Phrase: "J.,"

Phrase: "Deem"

Phrase: ","

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Simsolo,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.386: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.387: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.388: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.389: Investig. 

Phrase: "Investig."
Processing 00000000.tx.390: 95, 21112119[Medline] [OrderarticleviaInfotrieve] Hotamisligil, G. 

Phrase: "95,"

Phrase: "21112119"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hotamisligil,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.391: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.392: (2000) Int. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.393: J. 

Phrase: "J."
Processing 00000000.tx.394: Obes. 

Phrase: "Obes."
Processing 00000000.tx.395: Relat. 

Phrase: "Relat."
Processing 00000000.tx.396: Metab. 

Phrase: "Metab."
Processing 00000000.tx.397: Disord. 

Phrase: "Disord."
Processing 00000000.tx.398: 24, Suppl. 

Phrase: "24,"

Phrase: "Suppl."
Processing 00000000.tx.399: 4, 2327[CrossRef] Moller, D. 

Phrase: "4,"

Phrase: "2327"

Phrase: "[CrossRef"

Phrase: "] Moller,"

Phrase: "D."
Processing 00000000.tx.400: E. 

Phrase: "E."
Processing 00000000.tx.401: (2000) Trends Endocrinol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Endocrinol."
Processing 00000000.tx.402: Metab. 

Phrase: "Metab."
Processing 00000000.tx.403: 11, 212217[CrossRef][Medline] [OrderarticleviaInfotrieve] Pradhan, A. 

Phrase: "11,"

Phrase: "212217"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pradhan,"

Phrase: "A."
Processing 00000000.tx.404: D., Manson, J. 

Phrase: "D."

Phrase: ","

Phrase: "Manson,"

Phrase: "J."
Processing 00000000.tx.405: E., Rifai, N., Buring, J. 

Phrase: "E.,"

Phrase: "Rifai,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Buring,"

Phrase: "J."
Processing 00000000.tx.406: E., and Ridker, P. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Ridker,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.407: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.408: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.409: Am. 

Phrase: "Am."
Processing 00000000.tx.410: Med. 

Phrase: "Med."
Processing 00000000.tx.411: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.412: 286, 327334[Abstract/Free FullText] Spranger, J., Kroke, A., Mohlig, M., Hoffmann, K., Bergmann, M. 

Phrase: "286,"

Phrase: "327334"

Phrase: "[Abstract/Free FullText"

Phrase: "] Spranger,"

Phrase: "J.,"

Phrase: "Kroke,"

Phrase: "A.,"

Phrase: "Mohlig,"

Phrase: "M."

Phrase: ","

Phrase: "Hoffmann,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bergmann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.413: M., Ristow, M., Boeing, H., and Pfeiffer, A. 

Phrase: "M."

Phrase: ","

Phrase: "Ristow,"

Phrase: "M."

Phrase: ","

Phrase: "Boeing,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Pfeiffer,"

Phrase: "A."
Processing 00000000.tx.414: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.415: (2003) Diabetes 52, 812817[Abstract/Free FullText] Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Diabetes 52,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "812817"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yuan,"

Phrase: "M."

Phrase: ","

Phrase: "Konstantopoulos,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "J.,"

Phrase: "Hansen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Z."
Processing 00000000.tx.416: W., Karin, M., and Shoelson, S. 

Phrase: "W., Karin,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Shoelson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.417: E. 

Phrase: "E."
Processing 00000000.tx.418: (2001) Science 293, 16731677[Abstract/Free FullText] Kim, J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "16731677"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim,"

Phrase: "J."
Processing 00000000.tx.419: K., Kim, Y. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kim,"

Phrase: "Y."
Processing 00000000.tx.420: J., Fillmore, J. 

Phrase: "J.,"

Phrase: "Fillmore,"

Phrase: "J."
Processing 00000000.tx.421: J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. 

Phrase: "J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Y.,"

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lee,"

Phrase: "J.,"

Phrase: "Yuan,"

Phrase: "M."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Z."
Processing 00000000.tx.422: W., Karin, M., Perret, P., Shoelson, S. 

Phrase: "W., Karin,"

Phrase: "M."

Phrase: ","

Phrase: "Perret,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Shoelson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.423: E., and Shulman, G. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Shulman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.424: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.425: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.426: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.427: Investig. 

Phrase: "Investig."
Processing 00000000.tx.428: 108, 437446[Abstract/Free FullText] Aguirre, V., Uchida, T., Yenush, L., Davis, R., and White, M. 

Phrase: "108,"

Phrase: "437446"

Phrase: "[Abstract/Free FullText"

Phrase: "] Aguirre,"

Phrase: "V.,"

Phrase: "Uchida,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yenush,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Davis,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.429: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.430: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.431: Biol. 

Phrase: "Biol."
Processing 00000000.tx.432: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.433: 275, 90479054[Abstract/Free FullText] Aguirre, V., Werner, E. 

Phrase: "275,"

Phrase: "90479054"

Phrase: "[Abstract/Free FullText"

Phrase: "] Aguirre,"

Phrase: "V.,"

Phrase: "Werner,"

Phrase: "E."
Processing 00000000.tx.434: D., Giraud, J., Lee, Y. 

Phrase: "D."

Phrase: ","

Phrase: "Giraud,"

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "Y."
Processing 00000000.tx.435: H., Shoelson, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shoelson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.436: E., and White, M. 

Phrase: "E.,"

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.437: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.438: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.439: Biol. 

Phrase: "Biol."
Processing 00000000.tx.440: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.441: 277, 15311537[Abstract/Free FullText] Hotamisligil, G. 

Phrase: "277,"

Phrase: "15311537"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hotamisligil,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.442: S., Budavari, A., Murray, D., and Spiegelman, B. 

Phrase: "S."

Phrase: ","

Phrase: "Budavari,"

Phrase: "A.,"

Phrase: "Murray,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Spiegelman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.443: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.444: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.445: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.446: Investig. 

Phrase: "Investig."
Processing 00000000.tx.447: 94, 15431549[Medline] [OrderarticleviaInfotrieve] Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. 

Phrase: "94,"

Phrase: "15431549"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hirosumi,"

Phrase: "J.,"

Phrase: "Tuncman,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gorgun,"

Phrase: "C."
Processing 00000000.tx.448: Z., Uysal, K. 

Phrase: "Z.,"

Phrase: "Uysal,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.449: T., Maeda, K., Karin, M., and Hotamisligil, G. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Karin,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hotamisligil,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.450: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.451: (2002) Nature 420, 333336[CrossRef][Medline] [OrderarticleviaInfotrieve] Czech, M. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nature 420,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "333336"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.452: P., Klarlund, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Klarlund,"

Phrase: "J."
Processing 00000000.tx.453: K., Yagaloff, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yagaloff,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.454: A., Bradford, A. 

Phrase: "A.,"

Phrase: "Bradford,"

Phrase: "A."
Processing 00000000.tx.455: P., and Lewis, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lewis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.456: E. 

Phrase: "E."
Processing 00000000.tx.457: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.458: Biol. 

Phrase: "Biol."
Processing 00000000.tx.459: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.460: 263, 1101711020[Free FullText] Saltiel, A. 

Phrase: "263,"

Phrase: "1101711020"

Phrase: "[Free FullText"

Phrase: "] Saltiel,"

Phrase: "A."
Processing 00000000.tx.461: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.462: (1994) FASEB J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.463: 8, 10341040[Abstract/Free FullText] Zick, Y. 

Phrase: "8,"

Phrase: "10341040"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zick,"

Phrase: "Y."
Processing 00000000.tx.464: (2001) Trends Cell Biol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol."
Processing 00000000.tx.465: 11, 437441[CrossRef][Medline] [OrderarticleviaInfotrieve] Mothe, I., and Van Obberghen, E. 

Phrase: "11,"

Phrase: "437441"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mothe,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Van Obberghen,"

Phrase: "E."
Processing 00000000.tx.466: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.467: Biol. 

Phrase: "Biol."
Processing 00000000.tx.468: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.469: 271, 1122211227[Abstract/Free FullText] Tanti, J. 

Phrase: "271,"

Phrase: "1122211227"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tanti,"

Phrase: "J."
Processing 00000000.tx.470: F., Gremeaux, T., Van Obberghen, E., and Marchand-Brustel, Y. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gremeaux,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Van Obberghen,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Marchand-Brustel,"

Phrase: "Y."
Processing 00000000.tx.471: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.472: Biol. 

Phrase: "Biol."
Processing 00000000.tx.473: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.474: 269, 60516057[Abstract/Free FullText] Kanety, H., Feinstein, R., Papa, M. 

Phrase: "269,"

Phrase: "60516057"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kanety,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Feinstein,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Papa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.475: Z., Hemi, R., and Karasik, A. 

Phrase: "Z.,"

Phrase: "Hemi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285521:Hemi [Intellectual Product]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Karasik,"

Phrase: "A."
Processing 00000000.tx.476: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.477: Biol. 

Phrase: "Biol."
Processing 00000000.tx.478: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.479: 270, 2378023784[Abstract/Free FullText] Paz, K., Hemi, R., LeRoith, D., Karasik, A., Elhanany, E., Kanety, H., and Zick, Y. 

Phrase: "270,"

Phrase: "2378023784"

Phrase: "[Abstract/Free FullText"

Phrase: "] Paz,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hemi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285521:Hemi [Intellectual Product]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "LeRoith,"

Phrase: "D."

Phrase: ","

Phrase: "Karasik,"

Phrase: "A.,"

Phrase: "Elhanany,"

Phrase: "E.,"

Phrase: "Kanety,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Zick,"

Phrase: "Y."
Processing 00000000.tx.480: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.481: Biol. 

Phrase: "Biol."
Processing 00000000.tx.482: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.483: 272, 2991129918[Abstract/Free FullText] Stadtmauer, L., and Rosen, O. 

Phrase: "272,"

Phrase: "2991129918"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stadtmauer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Rosen,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.484: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: (1986) J. 

Phrase: "(1986"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.486: Biol. 

Phrase: "Biol."
Processing 00000000.tx.487: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.488: 261, 34023407[Abstract/Free FullText] Miele, C., Formisano, P., Sohn, K. 

Phrase: "261,"

Phrase: "34023407"

Phrase: "[Abstract/Free FullText"

Phrase: "] Miele,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Formisano,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sohn,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.489: J., Caruso, M., Pianese, M., Palumbo, G., Beguino, L., and Beguinot, F. 

Phrase: "J.,"

Phrase: "Caruso,"

Phrase: "M."

Phrase: ","

Phrase: "Pianese,"

Phrase: "M."

Phrase: ","

Phrase: "Palumbo,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beguino,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beguinot,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.490: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.491: Biol. 

Phrase: "Biol."
Processing 00000000.tx.492: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.493: 270, 1584415852[Abstract/Free FullText] Roth, R. 

Phrase: "270,"

Phrase: "1584415852"

Phrase: "[Abstract/Free FullText"

Phrase: "] Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.494: A., and Beaudoin, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Beaudoin,"

Phrase: "J."
Processing 00000000.tx.495: (1987) Diabetes 36, 123126[Abstract] Paz, K., Liu, Y. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Diabetes 36,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "123126"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Paz,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Liu,"

Phrase: "Y."
Processing 00000000.tx.496: F., Shorer, H., Hemi, R., LeRoith, D., Quan, M., Kanety, H., Seger, R., and Zick, Y. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shorer,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hemi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285521:Hemi [Intellectual Product]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "LeRoith,"

Phrase: "D."

Phrase: ","

Phrase: "Quan,"

Phrase: "M."

Phrase: ","

Phrase: "Kanety,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Seger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Zick,"

Phrase: "Y."
Processing 00000000.tx.497: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.498: Biol. 

Phrase: "Biol."
Processing 00000000.tx.499: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.500: 274, 2881628822[Abstract/Free FullText] Li, J., DeFea, K., and Roth, R. 

Phrase: "274,"

Phrase: "2881628822"

Phrase: "[Abstract/Free FullText"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "DeFea,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.501: A. 

Phrase: "A."
Processing 00000000.tx.502: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.503: Biol. 

Phrase: "Biol."
Processing 00000000.tx.504: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.505: 274, 93519356[Abstract/Free FullText] Jakobsen, S. 

Phrase: "274,"

Phrase: "93519356"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jakobsen,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.506: N., Hardie, D. 

Phrase: "N., Hardie,"

Phrase: "D."
Processing 00000000.tx.507: G., Morrice, N., and Tornqvist, H. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Morrice,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Tornqvist,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.508: E. 

Phrase: "E."
Processing 00000000.tx.509: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.510: Biol. 

Phrase: "Biol."
Processing 00000000.tx.511: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.512: 276, 4691246916[Abstract/Free FullText] Liu, Y. 

Phrase: "276,"

Phrase: "4691246916"

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu,"

Phrase: "Y."
Processing 00000000.tx.513: F., Paz, K., Herschkovitz, A., Alt, A., Tennenbaum, T., Sampson, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Paz,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Herschkovitz,"

Phrase: "A.,"

Phrase: "Alt,"

Phrase: "A.,"

Phrase: "Tennenbaum,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sampson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.514: R., Ohba, M., Kuroki, T., LeRoith, D., and Zick, Y. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ohba,"

Phrase: "M."

Phrase: ","

Phrase: "Kuroki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "LeRoith,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Zick,"

Phrase: "Y."
Processing 00000000.tx.515: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.516: Biol. 

Phrase: "Biol."
Processing 00000000.tx.517: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.518: 276, 1445914465[Abstract/Free FullText] Takayama, S., White, M. 

Phrase: "276,"

Phrase: "1445914465"

Phrase: "[Abstract/Free FullText"

Phrase: "] Takayama,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1491778:Takayama [Eukaryote]

Phrase: "S."

Phrase: ","

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.519: F., and Kahn, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Kahn,"

Phrase: "C."
Processing 00000000.tx.520: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.521: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.522: Biol. 

Phrase: "Biol."
Processing 00000000.tx.523: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.524: 263, 34403447[Abstract/Free FullText] Ravichandran, L. 

Phrase: "263,"

Phrase: "34403447"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ravichandran,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.525: V., Esposito, D. 

Phrase: "V., Esposito,"

Phrase: "D."
Processing 00000000.tx.526: L., Chen, J., and Quon, M. 

Phrase: "L., Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0999213:Chen [Bird]

Phrase: "J.,"

Phrase: "and"

Phrase: "Quon,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.527: J. 

Phrase: "J."
Processing 00000000.tx.528: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.529: Biol. 

Phrase: "Biol."
Processing 00000000.tx.530: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.531: 276, 35433549[Abstract/Free FullText] De Fea, K., and Roth, R. 

Phrase: "276,"

Phrase: "35433549"

Phrase: "[Abstract/Free FullText"

Phrase: "] De Fea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1333620:FEA [Neoplastic Process]
   861   C1850936:FEA [Gene or Genome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.532: A. 

Phrase: "A."
Processing 00000000.tx.533: (1997) Biochemistry 36, 1293912947[CrossRef][Medline] [OrderarticleviaInfotrieve] Griffin, M. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochemistry 36,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "1293912947"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Griffin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.534: E., Marcucci, M. 

Phrase: "E.,"

Phrase: "Marcucci,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.535: J., Cline, G. 

Phrase: "J.,"

Phrase: "Cline,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.536: W., Bell, K., Barucci, N., Lee, D., Goodyear, L. 

Phrase: "W., Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706917:Bell [Manufactured Object]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Barucci,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "D."

Phrase: ","

Phrase: "Goodyear,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.537: J., Kraegen, E. 

Phrase: "J.,"

Phrase: "Kraegen,"

Phrase: "E."
Processing 00000000.tx.538: W., White, M. 

Phrase: "W., White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.539: F., and Shulman, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Shulman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.540: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.541: (1999) Diabetes 48, 12701274[Abstract] De Fea, K., and Roth, R. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Diabetes 48,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "12701274"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] De Fea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1333620:FEA [Neoplastic Process]
   861   C1850936:FEA [Gene or Genome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.542: A. 

Phrase: "A."
Processing 00000000.tx.543: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.544: Biol. 

Phrase: "Biol."
Processing 00000000.tx.545: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.546: 272, 3140031406[Abstract/Free FullText] Eldar-Finkelman, H., and Krebs, E. 

Phrase: "272,"

Phrase: "3140031406"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eldar-Finkelman,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Krebs,"

Phrase: "E."
Processing 00000000.tx.547: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.548: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.549: Natl. 

Phrase: "Natl."
Processing 00000000.tx.550: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.551: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.552: U. 

Phrase: "U."
Processing 00000000.tx.553: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.554: A. 

Phrase: "A."
Processing 00000000.tx.555: 94, 96609664[Abstract/Free FullText] Greene, M. 

Phrase: "94,"

Phrase: "96609664"

Phrase: "[Abstract/Free FullText"

Phrase: "] Greene,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.556: W., and Garofalo, R. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Garofalo,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.557: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.558: (2002) Biochemistry 41, 70827091[CrossRef][Medline] [OrderarticleviaInfotrieve] Lee, Y. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biochemistry 41,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "70827091"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lee,"

Phrase: "Y."
Processing 00000000.tx.559: H., Giraud, J., Davis, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Giraud,"

Phrase: "J.,"

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.560: J., and White, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.561: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.562: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.563: Biol. 

Phrase: "Biol."
Processing 00000000.tx.564: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.565: 278, 28962902[Abstract/Free FullText] Hartman, M. 

Phrase: "278,"

Phrase: "28962902"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hartman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.566: E., Villela-Bach, M., Chen, J., and Freund, G. 

Phrase: "E.,"

Phrase: "Villela-Bach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1825831:BACH [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J.,"

Phrase: "and"

Phrase: "Freund,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.567: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.568: (2001) Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.569: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.570: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.571: Commun. 

Phrase: "Commun."
Processing 00000000.tx.572: 280, 776781[CrossRef][Medline] [OrderarticleviaInfotrieve] Ozes, O. 

Phrase: "280,"

Phrase: "776781"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ozes,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.573: N., Akca, H., Mayo, L. 

Phrase: "N., Akca,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mayo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0454788:Mayo [Geographic Area]
  1000   C1077578:mayo [Plant]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.574: D., Gustin, J. 

Phrase: "D."

Phrase: ","

Phrase: "Gustin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1311420:gustin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1413049:GUSTIN [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.575: A., Maehama, T., Dixon, J. 

Phrase: "A.,"

Phrase: "Maehama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dixon,"

Phrase: "J."
Processing 00000000.tx.576: E., and Donner, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Donner,"

Phrase: "D."
Processing 00000000.tx.577: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.578: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.579: Natl. 

Phrase: "Natl."
Processing 00000000.tx.580: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.581: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.582: U. 

Phrase: "U."
Processing 00000000.tx.583: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.584: A. 

Phrase: "A."
Processing 00000000.tx.585: 98, 46404645[Abstract/Free FullText] Lam, K., Carpenter, C. 

Phrase: "98,"

Phrase: "46404645"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lam,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Carpenter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336362:Carpenter [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.586: L., Ruderman, N. 

Phrase: "L., Ruderman,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.587: B., Friel, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Friel,"

Phrase: "J."
Processing 00000000.tx.588: C., and Kelly, K. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Kelly,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.589: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.590: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.591: Biol. 

Phrase: "Biol."
Processing 00000000.tx.592: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.593: 269, 2064820652[Abstract/Free FullText] Pirola, L., Bonnafous, S., Johnston, A. 

Phrase: "269,"

Phrase: "2064820652"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pirola,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bonnafous,"

Phrase: "S."

Phrase: ","

Phrase: "Johnston,"

Phrase: "A."
Processing 00000000.tx.594: M., Chaussade, C., Portis, F., and Van Obberghen, E. 

Phrase: "M."

Phrase: ","

Phrase: "Chaussade,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Portis,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Van Obberghen,"

Phrase: "E."
Processing 00000000.tx.595: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.596: Biol. 

Phrase: "Biol."
Processing 00000000.tx.597: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.598: 278, 1564115651[Abstract/Free FullText] Lee, A. 

Phrase: "278,"

Phrase: "1564115651"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "A."
Processing 00000000.tx.599: V., Gooch, J. 

Phrase: "V., Gooch,"

Phrase: "J."
Processing 00000000.tx.600: L., Oesterreich, S., Guler, R. 

Phrase: "L., Oesterreich,"

Phrase: "S."

Phrase: ","

Phrase: "Guler,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.601: L., and Yee, D. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Yee,"

Phrase: "D."
Processing 00000000.tx.602: (2000) Mol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.603: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.604: Biol. 

Phrase: "Biol."
Processing 00000000.tx.605: 20, 14891496[Abstract/Free FullText] Hemi, R., Paz, K., Wertheim, N., Karasik, A., Zick, Y., and Kanety, H. 

Phrase: "20,"

Phrase: "14891496"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hemi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285521:Hemi [Intellectual Product]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Paz,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wertheim,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Karasik,"

Phrase: "A.,"

Phrase: "Zick,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Kanety,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.606: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.607: Biol. 

Phrase: "Biol."
Processing 00000000.tx.608: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.609: 277, 89618969[Abstract/Free FullText] Hartley, D., and Cooper, G. 

Phrase: "277,"

Phrase: "89618969"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.610: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.611: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.612: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.613: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.614: 85, 304314[CrossRef][Medline] [OrderarticleviaInfotrieve] Freund, G. 

Phrase: "85,"

Phrase: "304314"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Freund,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.615: G., Wittig, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wittig,"

Phrase: "J."
Processing 00000000.tx.616: G., and Mooney, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Mooney,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.617: A. 

Phrase: "A."
Processing 00000000.tx.618: (1995) Biochem. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.619: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.620: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.621: Commun. 

Phrase: "Commun."
Processing 00000000.tx.622: 206, 272278[CrossRef][Medline] [OrderarticleviaInfotrieve] Greene, M. 

Phrase: "206,"

Phrase: "272278"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Greene,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.623: W., Sakaue, H., Wang, L., Alessi, D. 

Phrase: "W., Sakaue,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Alessi,"

Phrase: "D."
Processing 00000000.tx.624: R., and Roth, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.625: A. 

Phrase: "A."
Processing 00000000.tx.626: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.627: Biol. 

Phrase: "Biol."
Processing 00000000.tx.628: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.629: 278, 81998211[Abstract/Free FullText] Begum, N., Sandu, O. 

Phrase: "278,"

Phrase: "81998211"

Phrase: "[Abstract/Free FullText"

Phrase: "] Begum,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Sandu,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.630: A., Ito, M., Lohmann, S. 

Phrase: "A.,"

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "Lohmann,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.631: M., and Smolenski, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Smolenski,"

Phrase: "A."
Processing 00000000.tx.632: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.633: Biol. 

Phrase: "Biol."
Processing 00000000.tx.634: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.635: 277, 62146222[Abstract/Free FullText] Horike, N., Takemori, H., Katoh, Y., Doi, J., Min, L., Asano, T., Sun, X. 

Phrase: "277,"

Phrase: "62146222"

Phrase: "[Abstract/Free FullText"

Phrase: "] Horike,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takemori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Katoh,"

Phrase: "Y.,"

Phrase: "Doi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348291:DOI [Classification]

Phrase: "J.,"

Phrase: "Min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Asano,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X."
Processing 00000000.tx.636: J., Yamamoto, H., Kasayama, S., Muraoka, M., Nonaka, Y., and Okamoto, M. 

Phrase: "J.,"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kasayama,"

Phrase: "S."

Phrase: ","

Phrase: "Muraoka,"

Phrase: "M."

Phrase: ","

Phrase: "Nonaka,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Okamoto,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.637: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.638: Biol. 

Phrase: "Biol."
Processing 00000000.tx.639: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.640: 278, 1844018447[Abstract/Free FullText] Rui, L., Aguirre, V., Kim, J. 

Phrase: "278,"

Phrase: "1844018447"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rui,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Aguirre,"

Phrase: "V.,"

Phrase: "Kim,"

Phrase: "J."
Processing 00000000.tx.641: K., Shulman, G. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shulman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.642: I., Lee, A., Corbould, A., Dunaif, A., and White, M. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lee,"

Phrase: "A.,"

Phrase: "Corbould,"

Phrase: "A.,"

Phrase: "Dunaif,"

Phrase: "A.,"

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.643: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.644: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.645: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.646: Investig. 

Phrase: "Investig."
Processing 00000000.tx.647: 107, 181189[Abstract/Free FullText] Jiang, G., Dallas-Yang, Q., Liu, F., Moller, D. 

Phrase: "107,"

Phrase: "181189"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jiang,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Dallas-Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945617:yang [Idea or Concept]

Phrase: "Q.,"

Phrase: "Liu,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Moller,"

Phrase: "D."
Processing 00000000.tx.648: E., and Zhang, B. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Zhang,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.649: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.650: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.651: Biol. 

Phrase: "Biol."
Processing 00000000.tx.652: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.653: 278, 180186[Abstract/Free FullText] Yu, C., Chen, Y., Cline, G. 

Phrase: "278,"

Phrase: "180186"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Y.,"

Phrase: "Cline,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.654: W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. 

Phrase: "W., Zhang,"

Phrase: "D."

Phrase: ","

Phrase: "Zong,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "Y.,"

Phrase: "Bergeron,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kim,"

Phrase: "J."
Processing 00000000.tx.655: K., Cushman, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Cushman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.656: W., Cooney, G. 

Phrase: "W., Cooney,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.657: J., Atcheson, B., White, M. 

Phrase: "J.,"

Phrase: "Atcheson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.658: F., Kraegen, E. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kraegen,"

Phrase: "E."
Processing 00000000.tx.659: W., and Shulman, G. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Shulman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.660: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.661: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.662: Biol. 

Phrase: "Biol."
Processing 00000000.tx.663: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.664: 277, 5023050236[Abstract/Free FullText] Delahaye, L., Mothe-Satney, I., Myers, M. 

Phrase: "277,"

Phrase: "5023050236"

Phrase: "[Abstract/Free FullText"

Phrase: "] Delahaye,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mothe-Satney,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Myers,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.665: G., White, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.666: F., and Van Obberghen, E. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Van Obberghen,"

Phrase: "E."
Processing 00000000.tx.667: (1998) Endocrinology 139, 49114919[Abstract/Free FullText] Qiao, L. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Endocrinology 139,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "49114919"

Phrase: "[Abstract/Free FullText"

Phrase: "] Qiao,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.668: Y., Zhande, R., Jetton, T. 

Phrase: "Y.,"

Phrase: "Zhande,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jetton,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.669: L., Zhou, G., and Sun, X. 

Phrase: "L., Zhou,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X."
Processing 00000000.tx.670: J. 

Phrase: "J."
Processing 00000000.tx.671: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.672: Biol. 

Phrase: "Biol."
Processing 00000000.tx.673: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.674: 277, 2653026539[Abstract/Free FullText] Gao, Z., Hwang, D., Bataille, F., Lefevre, M., York, D., Quon, M. 

Phrase: "277,"

Phrase: "2653026539"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gao,"

Phrase: "Z.,"

Phrase: "Hwang,"

Phrase: "D."

Phrase: ","

Phrase: "Bataille,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lefevre,"

Phrase: "M."

Phrase: ","

Phrase: "York,"

Phrase: "D."

Phrase: ","

Phrase: "Quon,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.675: J., and Ye, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "J."
Processing 00000000.tx.676: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.677: Biol. 

Phrase: "Biol."
Processing 00000000.tx.678: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.679: 277, 4811548121[Abstract/Free FullText] Gao, Z., Zuberi, A., Quon, M. 

Phrase: "277,"

Phrase: "4811548121"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gao,"

Phrase: "Z.,"

Phrase: "Zuberi,"

Phrase: "A.,"

Phrase: "Quon,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.680: J., Dong, Z., and Ye, J. 

Phrase: "J.,"

Phrase: "Dong,"

Phrase: "Z.,"

Phrase: "and"

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "J."
Processing 00000000.tx.681: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.682: Biol. 

Phrase: "Biol."
Processing 00000000.tx.683: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.684: 278, 2494424950[Abstract/Free FullText] Gual, P., Gonzalez, T., Gremeaux, T., Barres, R., Marchand-Brustel, Y., and Tanti, J. 

Phrase: "278,"

Phrase: "2494424950"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gual,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gonzalez,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gremeaux,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Barres,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Marchand-Brustel,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Tanti,"

Phrase: "J."
Processing 00000000.tx.685: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.686: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.687: Biol. 

Phrase: "Biol."
Processing 00000000.tx.688: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.689: 278, 2655026557[Abstract/Free FullText] Harlow, E., and Lane, D. 

Phrase: "278,"

Phrase: "2655026557"

Phrase: "[Abstract/Free FullText"

Phrase: "] Harlow,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "D."
Processing 00000000.tx.690: (1988) Antibodies: A Laboratory Manual, Cold Spring Harbor, NY, Cold Spring Harbor Laboratory O'Neill, T. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "A Laboratory Manual, Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0475311:Harbor [Manufactured Object]

Phrase: "NY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: "Cold Spring Harbor Laboratory O'Neill,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.691: J., Craparo, A., and Gustafson, T. 

Phrase: "J.,"

Phrase: "Craparo,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Gustafson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.692: A. 

Phrase: "A."
Processing 00000000.tx.693: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.694: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.695: Biol. 

Phrase: "Biol."
Processing 00000000.tx.696: 14, 64336442[Abstract] Matthews, D. 

Phrase: "14,"

Phrase: "64336442"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Matthews,"

Phrase: "D."
Processing 00000000.tx.697: R., Hosker, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hosker,"

Phrase: "J."
Processing 00000000.tx.698: P., Rudenski, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rudenski,"

Phrase: "A."
Processing 00000000.tx.699: S., Naylor, B. 

Phrase: "S."

Phrase: ","

Phrase: "Naylor,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.700: A., Treacher, D. 

Phrase: "A.,"

Phrase: "Treacher,"

Phrase: "D."
Processing 00000000.tx.701: F., and Turner, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Turner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.702: C. 

Phrase: "C."
Processing 00000000.tx.703: (1985) Diabetologia 28, 412419[Medline] [OrderarticleviaInfotrieve] Radziuk, J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Diabetologia 28,"

Phrase: "412419"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Radziuk,"

Phrase: "J."
Processing 00000000.tx.704: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.705: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.706: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.707: Metab. 

Phrase: "Metab."
Processing 00000000.tx.708: 85, 44264433[Abstract/Free FullText] Araki, E., Lipes, M. 

Phrase: "85,"

Phrase: "44264433"

Phrase: "[Abstract/Free FullText"

Phrase: "] Araki,"

Phrase: "E.,"

Phrase: "Lipes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.709: A., Patti, M.-E., Bruning, J. 

Phrase: "A.,"

Phrase: "Patti,"

Phrase: "M.-"

Phrase: "E.,"

Phrase: "Bruning,"

Phrase: "J."
Processing 00000000.tx.710: C., Haag, B. 

Phrase: "C., Haag,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0062523:HAAg [Immunologic Factor,Pharmacologic Substance]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.711: I., Johnson, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Johnson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.712: S., and Kahn, C. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kahn,"

Phrase: "C."
Processing 00000000.tx.713: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.714: (1994) Nature 372, 186190[CrossRef][Medline] [OrderarticleviaInfotrieve] Tamemoto, H., Kadowaki, T., Tobe, K., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S., Sekihara, H., Yoshioka, S., Horikoshi, H., Furuta, Y., Ikawa, Y., Kasuga, M., Yazaki, Y., and Aizawa, S. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 372,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "186190"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tamemoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kadowaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tobe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yagi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sakura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hayakawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Terauchi,"

Phrase: "Y.,"

Phrase: "Ueki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kaburagi,"

Phrase: "Y.,"

Phrase: "Satoh,"

Phrase: "S."

Phrase: ","

Phrase: "Sekihara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yoshioka,"

Phrase: "S."

Phrase: ","

Phrase: "Horikoshi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Furuta,"

Phrase: "Y.,"

Phrase: "Ikawa,"

Phrase: "Y.,"

Phrase: "Kasuga,"

Phrase: "M."

Phrase: ","

Phrase: "Yazaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Aizawa,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.715: (1994) Nature 372, 182186[CrossRef][Medline] [OrderarticleviaInfotrieve] Kido, Y., Burks, D. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 372,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "182186"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kido,"

Phrase: "Y.,"

Phrase: "Burks,"

Phrase: "D."
Processing 00000000.tx.716: J., Withers, D., Bruning, J. 

Phrase: "J.,"

Phrase: "Withers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230107:Withers [Body Part, Organ, or Organ Component]

Phrase: ","

Phrase: "D."

Phrase: ","

Phrase: "Bruning,"

Phrase: "J."
Processing 00000000.tx.717: C., Kahn, C. 

Phrase: "C., Kahn,"

Phrase: "C."
Processing 00000000.tx.718: R., White, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.719: F., and Accili, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Accili,"

Phrase: "D."
Processing 00000000.tx.720: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.721: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.722: Investig. 

Phrase: "Investig."
Processing 00000000.tx.723: 105, 199205[Abstract/Free FullText] Yamauchi, T., Tobe, K., Tamemoto, H., Ueki, K., Kaburagi, Y., Yamamoto-Honda, R., Takahashi, Y., Yoshizawa, F., Aizawa, S., Akanuma, Y., Sonenberg, N., Yazaki, Y., and Kadowaki, T. 

Phrase: "105,"

Phrase: "199205"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yamauchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tobe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tamemoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ueki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kaburagi,"

Phrase: "Y.,"

Phrase: "Yamamoto-Honda,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Takahashi,"

Phrase: "Y.,"

Phrase: "Yoshizawa,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Aizawa,"

Phrase: "S."

Phrase: ","

Phrase: "Akanuma,"

Phrase: "Y.,"

Phrase: "Sonenberg,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Yazaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Kadowaki,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.724: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.725: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.726: Biol. 

Phrase: "Biol."
Processing 00000000.tx.727: 16, 30743084[Abstract] Virkam, Ueki, K., and Kahn, C. 

Phrase: "16,"

Phrase: "30743084"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Virkam,"

Phrase: "Ueki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kahn,"

Phrase: "C."
Processing 00000000.tx.728: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.729: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.730: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.731: Investig. 

Phrase: "Investig."
Processing 00000000.tx.732: 103, 931943[Free FullText] Freidenberg, G. 

Phrase: "103,"

Phrase: "931943"

Phrase: "[Free FullText"

Phrase: "] Freidenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.733: R., Reichart, D., Olefsky, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Reichart,"

Phrase: "D."

Phrase: ","

Phrase: "Olefsky,"

Phrase: "J."
Processing 00000000.tx.734: M., and Henry, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Henry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582517:henry [Quantitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.735: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.736: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.737: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.738: Investig. 

Phrase: "Investig."
Processing 00000000.tx.739: 82, 13981406[Medline] [OrderarticleviaInfotrieve] Thies, R. 

Phrase: "82,"

Phrase: "13981406"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Thies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1080058:thies [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.740: S., Molina, J. 

Phrase: "S."

Phrase: ","

Phrase: "Molina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1915092:Molina [Eukaryote]

Phrase: "J."
Processing 00000000.tx.741: M., Ciaraldi, T. 

Phrase: "M."

Phrase: ","

Phrase: "Ciaraldi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.742: P., Freidenberg, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Freidenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.743: R., and Olefsky, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Olefsky,"

Phrase: "J."
Processing 00000000.tx.744: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.745: (1990) Diabetes 39, 250259[Abstract] Goodyear, L. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Diabetes 39,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "250259"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Goodyear,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.746: J., Giorgino, F., Sherman, L. 

Phrase: "J.,"

Phrase: "Giorgino,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sherman,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.747: A., Carey, J., Smith, R. 

Phrase: "A.,"

Phrase: "Carey,"

Phrase: "J.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.748: J., and Dohm, G. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Dohm,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.749: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.750: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.751: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.752: Investig. 

Phrase: "Investig."
Processing 00000000.tx.753: 95, 21952204[Medline] [OrderarticleviaInfotrieve] Bjornholm, M., Kawano, Y., Lehtihet, M., and Zierath, J. 

Phrase: "95,"

Phrase: "21952204"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bjornholm,"

Phrase: "M."

Phrase: ","

Phrase: "Kawano,"

Phrase: "Y.,"

Phrase: "Lehtihet,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Zierath,"

Phrase: "J."
Processing 00000000.tx.754: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.755: (1997) Diabetes 46, 524527[Abstract] Venter, J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Diabetes 46,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "524527"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Venter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0224086:Venter [Body Part, Organ, or Organ Component]

Phrase: "J."
Processing 00000000.tx.756: C., Adams, M. 

Phrase: "C., Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331762:Adams [Health Care Related Organization]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.757: D., Myers, E. 

Phrase: "D."

Phrase: ","

Phrase: "Myers,"

Phrase: "E."
Processing 00000000.tx.758: W., Li, P. 

Phrase: "W., Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.759: W., Mural, R. 

Phrase: "W., Mural,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441995:Mural [Spatial Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.760: J., et al. 

Phrase: "J.,"

Phrase: "et al."
Processing 00000000.tx.761: (2001) Science 291, 13041351[Abstract/Free FullText] Manning, G., Whyte, D. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 291,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "13041351"

Phrase: "[Abstract/Free FullText"

Phrase: "] Manning,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0024554:MAN [Finding]
   966   C0025266:Man [Population Group]
   966   C0086418:Man [Human]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Whyte,"

Phrase: "D."
Processing 00000000.tx.762: B., Martinez, R., Hunter, T., and Sudarsanam, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Martinez,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Sudarsanam,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.763: (2002) Science 298, 19121934[Abstract/Free FullText] Greene, M. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Science 298,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "19121934"

Phrase: "[Abstract/Free FullText"

Phrase: "] Greene,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.764: W., Morrice, N., Garofalo, R. 

Phrase: "W., Morrice,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Garofalo,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.765: S., and Roth, R. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.766: A. 

Phrase: "A."
Processing 00000000.tx.767: (2004) Biochem. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.768: J. 

Phrase: "J."
Processing 00000000.tx.769: 378, 105116[CrossRef][Medline] [OrderarticleviaInfotrieve] Giraud, J., Leshan, R., Lee, Y. 

Phrase: "378,"

Phrase: "105116"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Giraud,"

Phrase: "J.,"

Phrase: "Leshan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "Y."
Processing 00000000.tx.770: H., and White, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.771: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.772: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.773: Biol. 

Phrase: "Biol."
Processing 00000000.tx.774: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.775: 279, 34473454[Abstract/Free FullText] Vidal, M., and Legrain, P. 

Phrase: "279,"

Phrase: "34473454"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vidal,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Legrain,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.776: (1999) Nucleic Acids Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.777: 27, 919929[Abstract/Free FullText] Dhe-Paganon, S., Werner, E. 

Phrase: "27,"

Phrase: "919929"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dhe-Paganon,"

Phrase: "S."

Phrase: ","

Phrase: "Werner,"

Phrase: "E."
Processing 00000000.tx.778: D., Nishi, M., Hansen, L., Chi, Y.-I., and Shoelson, S. 

Phrase: "D."

Phrase: ","

Phrase: "Nishi,"

Phrase: "M."

Phrase: ","

Phrase: "Hansen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "Y.-I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Shoelson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.779: E. 

Phrase: "E."
Processing 00000000.tx.780: (2004) Nat. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.781: Struct. 

Phrase: "Struct."
Processing 00000000.tx.782: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.783: Biol., in press

Phrase: "Biol.,"

Phrase: "in press"

